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Abstract
Cardiovascular disease (CVD) is a major health burden globally, and is the single
leading cause of death within Australia. It is well-recognised that a diet high in whole
grains is protective against CVD. Whole grains are rich in many vitamins, minerals and
bioactive constituents, all of which may contribute in part to these effects. However, it
is the dietary fibre of the whole grains (cereal fibre), located primarily within the bran
component, which has been hypothesised to contribute most significantly to
cardiovascular health through improvement of CVD risk factors. To date, it is not
entirely clear to what extent cereal fibre alone would provide the cardiovascular benefits
of whole grains A considerable issue in forming conclusions is the inconsistency in
which whole grain intakes have been defined and estimated in the existing literature,
which also captured intakes of brans and other potentially high-cereal fibre mixed grain
foods. Therefore while it is probable that whole grains are indeed protective against
CVD, it is not clear if diets high in cereal fibre and brans are not similarly protective,
having likely contributed to the whole grain evidence base. This thesis hypothesises that
high cereal fibre intake and high whole grain intake are both independently associated
with similar favourable cardiovascular health outcomes, but research clearly separating
the two is necessary to understand this fully.

Firstly, this thesis evaluates existing literature through systematic review to determine
the level and quality of current evidence separating the effects and associations of whole
grains, brans and cereal fibre for CVD-related outcomes. Interventional and
observational evidence was reviewed separately. Only five interventional studies met
the inclusion criteria. While included studies tended to suggest that whole grain and
18

bran may have a similar effect on total cholesterol response, the evidence was
insufficient to make wider conclusions, and evidence for effects on all other CVD risk
factors was similarly limited. Within the observational evidence, few studies (3 studies,
7 publications) estimated whole grain intake in accordance with an accepted definition
(defined as an ingredient containing all three anatomical components: the bran,
endosperm and germ) and in grams of daily intake. Those using an alternative approach,
such as utilising food-based definitions or food lists including added bran as a whole
grain source and estimating intakes in daily serves, were included in an expanded
analysis (8 additional studies, 13 publications) and evidence was compared. Intakes of
whole grain, cereal fibre and bran were similarly associated with lower risk of CVDrelated outcomes, however, when studies used the accepted definitions and estimation
approaches, whole grain results were less likely to show attenuation after adjustment for
cereal fibre content. The limited interventional studies and considerable discrepancy in
observational studies limits overall conclusions based on the existing evidence alone.

Secondary analyses of two population representative dietary surveys (United Kingdom
(UK) and Australia), with a combined sample of 10,354 adult participants, was
performed to examine associations between whole grain and cereal fibre intakes and
CVD-related outcomes including adiposity measurements, serum lipid concentrations,
C-reactive protein, blood pressure, fasting glucose, HbA1c, homocysteine and a
combined CVD relative risk score. An accepted definition for whole grain and a
methodical approach were used to estimate intakes. Within the UK National Diet and
Nutrition Survey Rolling Programme 2008-14, participants reporting the highest whole
grain intake had significantly lower waist-hip ratio, haemoglobin A1c (HbA1c), and
homocysteine compared to participants reporting the lowest intakes, after adjustment for
19

dietary and lifestyle factors including cereal fibre intake. When analysed separately,
cereal fibre intake was also inversely associated with waist-hip ratio and homocysteine
in multivariate analysis. Participants reporting the highest consumption of whole grains
within the Australian Health Survey 2011-13 had lower body mass index (BMI) and
waist circumference compared to non-consumers, as well as lower fasting glucose and
HbA1c after adjusting for dietary and lifestyle factors including cereal fibre intake.
Cereal fibre intake was independently inversely associated with BMI and waist
circumference, and tended to be inversely associated with lipid profile constituents,
although associations were attenuated after further adjustment for BMI and lipidlowering medication use. These findings suggest that cereal fibre may play a role in
protective associations of whole grains, and this may vary depending on the mediators
involved. However, as whole grain associations often remained significant after
adjustment for cereal fibre intake, a slight advantage of whole grain over separated
cereal fibre appears to exist.

Finally, consumer perceptions of whole grain and added-fibre grain foods were explored
to consider the potential usefulness of cereal fibre outside of whole grains and
opportunities to enhance intake of cereal fibre and whole grains. Focus groups (with
adults with no formal nutrition education) explored factors affecting consumer grain
choice, using inductive thematic analysis to summarise the discussions. Nine focus
groups composed of 52 participants (23 men; 29 women) were conducted. Participants
tended to report choosing ‘grainy’ bread but few other whole grain foods. Most
participants were unaware of long-term health benefits of whole grains, recommended
whole grain intakes, or how to identify foods that were high in whole
grains, thereby limiting motivation to increase intake. Scepticism surrounding the health
20

value of carbohydrate-based foods appeared to hinder grain intakes in general, and some
scepticism towards added-fibre grain foods as unnatural and less healthy was also
evident.

This thesis supports the notion that although cereal fibre is independently associated
with favourable CVD health, whole grain intake may offer a slight advantage over
cereal fibre intake alone. It is therefore prudent that dietary recommendations and
advice continue to encourage whole grain foods. However, in order to continue to build
a reliable body of evidence surrounding whole grains, and to allow more definitive
advice on the role of individual components of the grains, good-quality interventional
evidence comparing whole grain intake to intake of high-fibre grains such as bran or
added-fibre products matched on cereal fibre content is warranted to support the
observational evidence. For this to be most effective, it is critical that researchers using
both interventional and observational methods adopt an accepted and consistent
approach when estimating whole grain intakes. Given the apparent benefits associated
with whole grain intake, it is evident that a widespread effort from the government,
public health agencies and industry is needed to address the knowledge gap that appears
to be a considerable barrier to increased whole grain intakes. Promotion must include
clear, food-based targets and specific food choices, and public education is essential to
directly combat negative perceptions of grain foods health effects that appear to remain
constant. Clear whole grain labelling may improve consumers’ ability to identify good
whole grain choices, and industry innovations focused on increasing availability and
variety of appealing and palatable products high in whole grains may increase incentive
to choose these foods.
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Chapter 1:
Introduction
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1.1 Cardiovascular disease
Cardiovascular disease (CVD) is a collective term encompassing diseases of the heart
and blood vessels, and includes coronary heart disease (CHD), heart failure,
cardiomyopathy, congenital heart disease, peripheral vascular disease and stroke. The
impact of CVD both globally and within Australia is immense. The World Health
Organisation estimates that CVD accounts for an estimated 17.9 million lives lost each
year, representing 31% of deaths world-wide (1). Of deaths attributed to CVD, 85% are
due to heart attack and stroke, which occur prematurely (in people under 70 years of
age) in one third of cases (1). Within Australia, CVD is also the leading cause of death,
accounting for 27% of all deaths in 2017, with one Australian life lost to CVD every 12
minutes (2; 3). Australians in lower socioeconomic groups, those living in regional and
remote areas, and Aboriginal and Torres Strait Islander peoples are over-represented in
these statistics, having higher rates of hospitalisation and deaths due to CVD than other
Australians (2). Not only does CVD impact the lives of many Australians, it is also a
huge cost to the economy. In 2015-16, an estimated $10.4 billion was spent on health
care related to CVD, accounting for 8.9 per cent of total health expenditure (4).

Some risk factors associated with CVD cannot be modified, including age, genetic
disposition, gender and ethnicity (5). However, a significant reduction in CVD burden
can be achieved by addressing modifiable risk factors such as tobacco smoking,
insufficient physical activity, harmful use of alcohol, and a poor diet (6). Additionally, a
higher burden of related conditions such as high blood pressure, high blood cholesterol,
Type-2 diabetes mellitus (T2DM), overweight or obesity, increases the risk of CVD and
are associated with a higher lifetime risk of death from the disease (7; 8). Diet can play a
role in managing and reducing the risk of developing these CVD-related conditions.
23

As one of the four major modifiable risk factors for non-communicable diseases
(NCDs) including CVD, the World Health Organisation (WHO) Global Action Plan for
the prevention and control of NCDs 2013-2020 stresses the importance of promotion of
a healthy diet through creating health-promoting environments and strengthening the
capacity of individuals and populations to make healthier choices (6). In order to achieve
this effectively, the plan also recognises the need to encourage and support research to
strengthen the scientific basis for decision making regarding CVD and other NCDs, as
well as their translation to practice (6). Research exploring the role of diet in preventing
or reducing the prevalence of CVD is therefore necessary.

One dietary factor that is well recognised as protective against CVD is high whole grain
intake. A recent study evaluating consumption across 195 countries found that
approximately three million deaths in 2017, the majority of which were a result of
CVD, could be attributed to low whole grain intake (9). This accounted for 27% of the
11 million deaths attributed to any singular dietary risk factor. A diet low in whole grain
also accounted for 87 million disability-adjusted life years, the leading singular dietary
factor (9). When considering Australian data only, similar findings were uncovered in the
2016 Global Burden of Disease, where 7400 of 27,500 preventable dietary-related
deaths were attributed to low whole grain intake (10). Given the impact of CVD both
globally and within Australia, and the promising evidence for the protection of whole
grains against CVD, further exploration of their health components in efforts to promote
a healthy diet and encourage healthy choices is of interest. Whole grain intake, in the
context of cardiovascular disease, will therefore be the focus of this thesis.
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1.2 Whole grains and cereals
Cereal grains are cultivated from grasses within the Poaceae family known as cereals.
These include barley, maize, millet, oats, rice, rye, sorghum, teff, triticale, and wheat
varieties. Edible grains from other plant families, including buckwheat (Polygonaceae),
quinoa, and amaranth (both Amaranthaceae), are referred to as pseudocereals due to
their similar nutritional composition.

Grain cultivation occurred as early as 12,000 years ago in Western Asia, although
gathering and consumption of wild grains likely occurred far earlier than this (11). Since
the British Agricultural Revolution of the 18th century, agricultural output of cereal
grains saw an unprecedented increase due to advances in production techniques, and
then again in the Green Revolution of the 1960s (12; 13). Today, cereal grains remain one
of the major food staples consumed across the world, with more than 50% of global
daily caloric intake derived from cereal grain consumption (14).

Although consumption is widespread, the varieties of grains and grain products
consumed differs between populations. In Scandinavian countries, dark rye breads are
frequently consumed (15), while within many Asian countries, rice is the major grain
source (16), making up to 80% of caloric intake in Vietnam, Cambodia and Myanmar (14).
In Africa and Latin America, maize is a major staple (17). In Mexico, maize contributes
approximately half of the daily caloric intake as tortillas (18). Minor grains like sorghum
and millet are commonly consumed in other regions of the world, particularly semi-arid
parts of Africa and India (14). Within Australia and the United Kingdom (UK), wheat is
the primary cereal grain consumed (19), often as bread and breakfast cereals (20; 21).
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In their natural form, cereal grains are referred to as ‘whole grains’. The Whole Grain
Initiative (WGI) recently released a definition for whole grains as an ingredient,
intended for global use (22). The definition states:

“Whole grains shall consist of the intact, ground, cracked, flaked or otherwise processed
kernel after the removal of inedible parts such as the hull and husk. All anatomical
components, including the endosperm, germ, and bran must be present in the same
relative proportions as in the intact kernel.” (22)

This is similar to the definition outlined by the American Associations of Cereal
Chemists (AACCI) 1 (23), and nationally, by Food Standards Australia New Zealand
(FSANZ) (24), whereby focus is placed on the endosperm, germ and bran components
being present in similar proportions as they occur in an intact grain (taking into account
some small, unavoidable losses), regardless of processing that has occurred.

Whole grains are a rich source of various nutrients and bioactive compounds, which
include dietary fibre, resistant starch (RS), vitamins, minerals, essential fatty acids and
various phenolic compounds. The bran component of the grain functions as a protective
shell for the germ and endosperm inside (Figure 1.1), and contains the majority of the
dietary fibre. Underneath the outer bran layer (pericarp) is the aleurone layer, and this is
where the majority of the minerals, nutrients and bioactive components are located, as
well as some protein. While technically the outermost layer of the endosperm, the

1

Although the AACCI was renamed as Cereals & Grains Association in 2019, the definition is
still widely referred to as the AACCI definition, as has been used throughout this thesis.
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aleurone is often considered a part of the bran, as it is removed in processing along with
the pericarp component of bran, and is therefore present within milled bran. The germ
component of the grain provides nourishment for the seed and contains essential fatty
acids, vitamin E, and some B vitamins, while the endosperm, comprising more than
80% of the grain, is the main source of energy, providing carbohydrates and protein.

Figure 1.1 Whole grain diagram 2

2

Grains & Legumes Nutrition Council, Grain diagram,
https://www.glnc.org.au/grains/attachment/grain-diagram/, accessed 18 December 2019.
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Most grains cultivated are not consumed as whole grains, and are instead processed to
make refined grain cereals such as white cereal products (e.g. white pasta, white rice).
This process involves removal of the germ and bran (and aleurone) of the grain, to
varying degrees, leaving the endosperm. As the germ and bran contain the
overwhelming majority of nutrients, this process results in significant nutrient loss.
Consequently, intake of refined grain cereals is not associated with the same health
benefits as whole grain intake, although there is debate as to whether refined grain
intake is independently associated with negative health outcomes (25).

The abundance of nutrients and bioactive compounds contained within whole grains are
presumed to be responsible for their superior health benefits, and there are likely a
multitude of pathways involved, with the various components each playing different
roles (26) and interacting in synergistic ways. It is probable that all of the mechanisms
involved in the protective effects of whole grains have not yet been discovered, and
many proposed mechanisms are not yet fully understood in vivo. An overview of the
primary components and proposed mechanisms involved in the diet disease relationship
between whole grains and cardiovascular disease has been outlined below.

1.3 Diet disease relationship: Whole grains and CVD
1.3.1 Cereal fibre
Whole grains are rich in dietary fibre, and high fibre intake is consistently found to be
protective against CVD related outcomes (27). A recent study showed that high fibre
intake was associated with a 31% reduction in the risk of CHD mortality, 16% reduction
in the risk of T2DM incidence, and 15% reduction in the risk of all-cause mortality (28).
Previous studies have shown that for every 10g of additional dietary fibre consumed,
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the mortality risk from CHD decreases by 11-27% (29; 30; 31; 32). Dietary fibre is defined
by FSANZ as “that fraction of the edible part of plants or their extracts, or synthetic
analogues that:
a) are resistant to digestion and absorption in the small intestine, usually with
complete or partial fermentation in the large intestine; and
b) promote one or more of the following beneficial physiological effects: laxation;
reduction in blood cholesterol; modulation of blood glucose; and includes:
c) polysaccharides or oligosaccharides that have a degree of polymerisation greater
than 2; and lignins” (33)

Dietary fibres can be considered insoluble or soluble named based on their solubility in
water. Insoluble fibres pass through the digestive tract relatively undigested, with only
moderate fermentability in the gut, whereas gel-forming, viscous, soluble fibres are
fermented in the gut. Fibres contained within cereal grains (cereal fibre) are mainly
insoluble fibre, including cellulose, lignins and some hemicelluloses (34). However,
some grains are also rich in soluble fibres, including β-glucan (barley, oats) and
arabinoxylans (barley, rye and wheat), as well as small amounts of inulin and fructooligosaccharides (barley, oats, rye and wheat) (34). RS, composed of amylose and
amylopectin, is also found within grains, mainly within the endosperm. RS is named as
such because it is resistant to the usual digestive process of starches, therefore behaving
like a dietary fibre. Although considered insoluble in nature, RS is fermented in the gut
in a similar way to soluble fibres, with the rate and degree of variation depending on the
type of RS (35), categorised as RS1-5 based on this variation.
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RS1 are starch granules surrounded by an indigestible plant matrix, thereby being
physically inaccessible, and are found in unprocessed whole grains and seeds. RS2
occurs naturally in uncooked potato and green bananas, and is also the starch present in
high amylose maize starch. It is inaccessible to enzymes due to the tight conformation
of starch molecules in the endosperm. RS3 is created by the cooking and cooling
process of starch foods, and occurs due to starch retrogradation. RS4 are starches that
have been chemically modified to resist digestion and are not found in nature (34; 36).
RS5 starches are described as amylose-lipid complexes, which can form naturally
during cooking or be artificially created (37; 38).

Cereal fibre specifically has been found to be strongly associated with a reduced risk of
CVD and CVD related events (39; 40). Often, cereal fibre is found to be potentially more
protective than other sources of fibre such as fruits or vegetables when consumed in
similar amounts, for CVD risk (41), risk of related conditions such as T2DM (42; 43) and
hypertension (44), and even risk of all-cause mortality (45).

Cereal fibre may be protective against CVD in several ways. Firstly, all dietary fibres
may play a role in body weight regulation, and obesity is a major risk factor associated
with CVD (8). The low-grade inflammation, metabolic changes and alterations in cardiac
structure and function associated with excess adipose tissue can contribute to the
development of other CVD risk factors such as hypertension, dyslipidaemia and
impaired glucose tolerance (8). Foods high in fibre generally have low energy-density, as
the fibre component, whether insoluble or soluble in nature, provides very little energy,
displacing otherwise available energy and nutrients and thereby diluting metabolisable
energy of a diet (46). Rolls (2000) proposed that humans may tend to consume a
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constant volume of food rather than a constant energy intake, and replacing foods with
lower energy-dense food (for example, higher fibre foods including whole grains as
well as fruits, vegetables and legumes) of the same volume may thereby result in
reduced energy intake and subsequent weight loss (47). A recent meta-analysis of 27
clinical studies found a mean difference (pooled effect estimate) of -0.37 kg (-0.63 to 0.11) comparing high fibre intakes to low fibre intakes (28). Notably, the majority of
studies (19 of 27) analysed naturally occurring fibre, and so the authors note that the
findings may not translate for extracted bran or synthetic fibres. Although, an older
review by Howarth et al. found that an additional 14g/d of fibre for at least 2 days to an
ad libitum diet resulted in an average 10% decrease in energy intake and 1.9kg weight
loss over 3.8 months (48), and in this case, effects occurred when fibre was sourced from
foods or supplements, suggesting extracted fibres may still exert similar effects.

Soluble fibres, contained in higher amounts in whole grains such as oats and barley, as
well as fruits and vegetables, may also be particularly satiating due to their viscous,
bulking properties, which can slow the rate of digestion. Not only does delayed gastric
emptying reduce appetite, it also may slow absorption of nutrients, resulting in lower
post-prandial glucose. Additionally, fibre may stimulate gut hormones Glucagon-like
Peptide 1 (GLP-1), and cholecystokinin (CKK), which are both associated with
increased subjective satiety, and may mediate glycaemic and insulinaemic response to
viscous fibres, leading to improved glycaemic control (49). Numerous meal studies have
shown a blunting effect of dietary fibre on postprandial glucose and insulin responses,
and strong inverse associations have been found between dietary fibre intake
(particularly cereal fibre) and T2DM risk in previous studies (42; 43; 50; 51), suggesting
long term intake to be protective. Although glucose-lowering effects are attributed
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largely to soluble fibre, it is interesting that cereal fibre, which is primarily insoluble, is
frequently found to be more protective than fibre from sources such as fruit, vegetables
and legumes, which are higher in soluble fibre (50; 52; 53). Meyer et al. (2000) found that
women consuming an average of 26g of daily dietary fibre had a 22% lower risk of
developing T2DM compared to those consuming only 13g daily (50). Within this cohort,
the highest daily intakes of energy-adjusted total insoluble fibre (>17.7g) and cereal
fibre (>7.5g) were associated with a 25% and 36% lower risk respectively, while intakes
of soluble fibre and fibre from other sources consumed in similar amounts (fruit and
vegetables) were not associated. It may be that beyond consideration of the individual
fibre types, the grain constituents consumed with cereal fibre are important. For
example, the bran component of the grain, which contains the majority of cereal fibre,
also contains significant quantities of other nutrients including magnesium and zinc,
which may play a role in reducing T2DM risk (54). Higher cereal fibre may thereby also
reflect higher intakes of these constituents.

Cereal fibre may also protect against CVD via reducing blood cholesterol. Elevated
serum cholesterol is a well-known risk factor for CVD. Clinical trials indicate that a 1%
reduction in total cholesterol is associated with a 2% decreased risk of CHD, while a
1% reduction of low density lipoprotein (LDL) cholesterol is associated with 1%
decreased risk of major CHD-related events, but epidemiological evidence suggest
longer term maintenance of a lower serum cholesterol yields even greater reductions in
risk than what can be predicted in the time frame of clinical trials (55). Β-glucan is of
particular interest in its role in cholesterol-lowering. Β-glucan is a soluble and highly
viscous fibre found primarily in the endosperm and bran of barley and oats, both have
been found to reduce serum total and LDL cholesterol in people with
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hypercholesterolaemia (56; 57). The mechanism by which β-glucan may reduce
cholesterol concentrations is through inhibiting intestinal uptake of dietary cholesterol,
as well as preventing reabsorption of bile acid. This causes the body to utilise
circulating cholesterol to produce new bile acid, resulting in reduced levels of
cholesterol in the blood (58). The cholesterol-lowering effects of β-glucan at intakes of
3g/day or above are so well established that they are the focus of several health claims
worldwide, including within Australia, whereby products with greater than 1g of βglucan per serve from oat bran, whole grain oats or whole grain barley are permitted to
make a health claim pertaining that as part of a diet low in saturated fat, 3g of β-glucan
per day can help reduce blood cholesterol (59).

Another way in which cereal fibre intake may indirectly reduce risk of CVD and related
chronic diseases is through production of short chain fatty acids (SCFAs), the major
metabolic end products of soluble dietary fibre and RS fermentation by the gut
microbiota. Acetate, propionate and butyrate are the most abundant SCFAs in the
human body, present in the colon in an approximate molar ratio of 60:20:20
respectively, although this may vary depending on the substrate, microbiota
composition and gut transit time (60). The SCFAs produced have a trophic effect in the
gut and are rapidly absorbed by colonocytes for energy, with butyrate being the
preferred source, or transported distally through the blood to act as an energy source,
substrate or signaling molecule for other organs and tissues.

SCFAs may contribute to reduced risk of CVD through their effects on host
metabolism. SCFAs, particularly butyrate, help to maintain epithelial integrity through
regulation of tight junction proteins, which control the intracellular pathway between
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the lumen and the hepatic portal system (61). This prevents translocation of bacteria
associated with increased gut permeability, which can trigger inflammatory responses
associated with obesity and insulin resistance (61). SCFAs may further improve glucose
metabolism and weight management through stimulation of anorexigenic gut hormones
Peptide YY and GLP-1, which may increase glucose uptake in muscle and adipose
tissue by enhanced insulin sensitivity, as well as reduce appetite and energy intake (60).
This may explain why RS, which is highly fermentable although not viscous, also
exudes positive effects on glucose and insulin responses and satiety (62; 63; 64).

SCFAs may also be protective through activation of fatty acid oxidation and inhibition
of fatty acid synthesis (65). This results in reduced free fatty acids in the plasma, which
are known to be able to induce peripheral and hepatic insulin resistance in humans,
potentially contributing to impaired glucose metabolism and weight gain. Propionate
specifically has also been shown to inhibit cholesterol synthesis, although the exact
mechanisms are still debated (66). In animal studies, direct dietary supplementation with
propionate led to a significant decrease in serum cholesterol, however, human studies
have not shown the same effect (66).

The existing mechanistic studies suggest great potential for the role of SCFAs in
metabolic health. However, there is currently a paucity of high-level evidence from
controlled human trials supporting these effects in human metabolism, and instead a
reliance on animal models and in vitro studies, largely due to the difficulty in accurately
measuring SCFA production in human studies (61). New methodologies are showing
promise (67), therefore with further research in the area, the precise role of SCFAs in
influencing CVD and metabolic risk in humans may be uncovered.
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1.3.2 Food structure and processing
Beyond the presence of fibre in food, the structure of the food may also be important. In
1977, Haber et al. demonstrated that consumption of apple juice and apple puree
compared to intact apples resulted in reduced satiety, disturbed glucose homeostasis,
and an inappropriate insulin response (68). In the context of whole grains, Jenkins et al.
(1988) found that the glycaemic index of wholemeal breads (bread made using whole
grain wheat or barley flour) without intact grains had the same glycaemic index (GI) of
refined flour-based whited bread, while bread with intact grains (50 and 75%)
significantly reduced the GI from 92-96 to 39 (69). This may be because the milling of
the grain to a meal breaks the intact structure of the grain, allowing more rapid
penetration of the pericarp by digestive enzymes leading to quicker digestibility.
Although the relevance of GI to CVD (28), T2DM risk (50), and even satiety (70), remains
inconclusive, a recent trial also found that incremental area under the curve and post
prandial glucose levels at three hours were lowest for the whole grain wheat bread with
the most intact grains compared to finer ground whole grain wheat breads (71). This
raises debate as to the value of wholemeal products (e.g. wholemeal bread) compared to
products containing intact or kibbled grains, which may exert a greater satiety effect and
a more controlled glucose response. Notably, studies here have considered this effect
mainly in wheat, and the effects of processing and structure may behave differently for
other grains including oats and rice (72; 73). Currently, in Australia wholemeal products
are generally accepted as a source of whole grain for food-labelling purposes. However,
if food structure and particle size is as important as fibre content, this suggests that
consumption of wholemeal products would not exert equal effects to whole grain
consumption.
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Furthermore, the development and recent interest in the NOVA food classification
system (74) has sparked debate around the effect of processing on the health value of
foods. The NOVA classification system categorises foods from unprocessed/minimally
processed (Group 1) to ultra-processed (Group 4), using processing as the primary
measure of health value rather than contained nutrients (74). Some studies have applied
this system to diets and have shown higher risk of CVD and all-cause mortality with
higher intakes of ultra-processed foods (75; 76; 77; 78). Using this system, some whole grain
foods would be categorised as Group 1 (for example, rolled oats) while others may be
categorised as Group 4 (for example, commercially packaged whole grain or wholemeal
bread, and whole grain cereals). Although interesting, it should be noted that in the case
of whole grain foods, using the NOVA system alone may be inappropriate because
ultra-processed foods also include foods such as sugar-sweetened beverages,
confectionary, pastries, and reconstituted meat products, which may be contributing
most considerably to the negative health effects attributed to Group 4, unnecessarily
vilifying commercial whole grain and wholemeal breads and whole grain cereals.
Exploration of the differential health effects of whole grain foods across groupings 1 to
4 would be necessary to further elucidate the potential role of processing on the health
value of whole grain foods.

1.3.3 Phenolic compounds
Many major chronic diseases, including CVD, are associated with increased oxidative
stress and inflammation (79). Phenolic compounds derived from whole grains (mainly
phenolic acids, flavonoids and lignans) may exert antioxidant activity by acting as
radical scavengers, helping to neutralise free radicals and inhibit the chain reaction that
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leads to production of oxidative radical compounds, thereby protecting against oxidative
stress and risk of CVD (80). Additionally, these compounds are also thought to be antiinflammatory in humans, supported by a significant reduction of pro-inflammatory
cytokines (79).

One phenolic compound that may be of particular relevance is ferulic acid. Ferulic acid
is a phenolic acid contained primarily in the bran component of cereals, and is
particularly abundant in wheat bran. Ferulic acid has been shown to exert particularly
promising antioxidant and anti-inflammatory activity, resulting in improved endothelial
function in both in vitro and in vivo studies (81; 82). Endothelial dysfunction is recognised
as a major indicator of CVD risk, associated with higher incidence of CVD events and
increased progression of atherosclerosis (83; 84). Moreover, ferulic acid may exert
hypolipidaemic action through inhibition of HMG-CoA reductase (82; 85). In a recent six
week study of 48 participants with hyperlipideamia, supplementation of 1000 mg daily
of ferulic acid significantly improved total lipid profile and significantly reduced the
oxidative stress marker MDA and the inflammatory markers high sensitivity C-reactive
protein (hs-CRP) and tumor necrosis factor alpha (86). Although levels of ferulic acid are
more modest in grains (for example, 100g of whole grain wheat kernels contain
approximately 64-127mg of ferulic acid (87)), its presence may explain some additive
effects of whole grains on those of cereal fibres previously discussed. Ferulic acid has
also been found to be acutely hypotensive in rat models (88; 89), possibly through
improved endothelial function and increased bioavailability of vasodilator nitric oxide
in the arterial vasculature.
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It has been proposed that the dietary fibre component of whole grains may play a key
role in the antioxidant action of phenolic acids within grains against intestinal
epithelium cell damage. Vitaglione et al. (2008) proposed that the fibre within whole
grains may act as a natural carrier, as phenolic acids are often bound to fibre (for
example, 95% of ferulic acid in wheat bran is bound to arabinoxylan fibre) (90). Phenolic
acids may therefore survive small intestine digestion, and stay bound to fibre until they
have reached the colon where they are released and can work to protect epithelial cells.
Such synergistic actions highlight the potential benefits of the grain components when
consumed together as part of the whole grain (or bran) matrix.

While the actions of ferulic acid are fairly well supported, the effects of other phenolic
compounds contained within whole grains are yet to be fully elucidated. Furthermore,
while polyphenol supplementation may see positive effects, it is unclear whether the
amounts contributed through whole grain foods would be sufficient to see effects, or at
least, in part, contribute to effects. More research is needed to explore the role of all
polyphenols within grains to determine the overall antioxidant and anti-inflammatory
capacity of whole grain foods.

1.3.4 Magnesium
Whole grains contain several essential minerals, including iron, selenium, manganese,
and magnesium. Their rich magnesium content particularly may contribute to their
CVD protective effects through the close interactions between magnesium and insulin.
Intracellular magnesium appears to play a key role in insulin-mediated glucose uptake
and improved insulin sensitivity (91). Evidence shows a link between hypomagnesemia
and impairment of insulin action and development of insulin resistance, thought to be
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due to a reduction of tyrosine-kinase activity at the insulin receptor level (92).
Epidemiological studies have shown that high daily magnesium intake is associated
with lower risk of T2DM (42; 50), and daily magnesium administration has been found to
restore depleted intracellular magnesium concentrations in patients with T2DM and
improve insulin sensitivity and glucose control (93).

Magnesium supplementation has also seen positive effects on endothelial function and
blood pressure regulation in patients with hypertension and diabetes, possibly through
its role as a natural calcium antagonist (94). However, most effects found from
magnesium supplementation are from much higher doses than would be consumed
through whole grains. Furthermore, the availability of magnesium (as well as other
nutrients including zinc an iron) within grain products may vary considerably due to
varying concentrations of phytic acids, which bind these minerals and inhibits
absorption. Whole grains that have undergone some processing such as fermentation,
sprouting, soaking and cooking may have lower concentration of phytic acids, whereas
minimally processed or unleavened grains may retain higher concentrations (95). More
evidence is required to determine whether magnesium from whole grain intakes from
varied whole grain foods would contribute similar effects.

1.3.5 Folate
Whole grains are a source of many B-vitamins, including folate (vitamin B9). Both low
serum folate levels and low folate intake have been associated with increased risk of
CVD (96; 97; 98). One of the most well supported mechanisms for this is the effect of folate
supplementation on hyperhomocysteinaemia. Folate is a methyl donor, able to
transform homocysteine to methionine and decrease serum homocysteine levels (99).
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Even when homocysteine and folate are in the normal range, folate treatment (dietary or
synthetic) significantly reduces plasma homocysteine. Elevated homocysteine levels are
suggested as a casual factor in CVD, although this is still debated (100). Alternatively, it
could be that elevated homocysteine levels are a marker for the primary cause of
increased risk of CVD. In fact, it has been suggested that folate deficiency itself may
even be the primary aetiological factor, although it is difficult to separate the two given
their close metabolic relationship (101). Beyond this, folate may be beneficial through its
antioxidant potential and subsequent beneficial effects on endothelial function (102; 103;
, which have been found independent of homocysteine-lowering (105; 106; 107), although

104)

effects are seen at much greater concentrations than those contained within whole
grains.

Notably, although folate can certainly be considered an additional valuable nutrient
naturally contained within whole grains, refined grain flours are often enriched with
folate to levels that exceed those naturally occurring within whole grains, so any
reduced CVD risk found in high whole grains consumers when compared to high
refined grain consumers are unlikely to relate to folate intake alone.

1.4 The role of the cereal fibre in whole grains
There is evidently an array of potential health components contributing to the protective
effect of whole grains. The strength and consistency of evidence surrounding the
protective effects of cereal fibre may suggest that the cereal fibre component in
particular plays a significant role in the overall effects of whole grains, both directly and
indirectly through SCFA production. This has been proposed previously (108), although
many researchers have expressed caution in assuming that the benefits of whole grains
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can be attributed to the cereal fibre component alone. Such a hypothesis underestimates
the potential antioxidant and anti-inflammatory activity attributed to the other nutrients
and bioactive compounds such as phenolic compounds, magnesium and folate, and
properties of the food such as structure and particle size may be equally as important as
the fibre content in promoting satiety (80). Additionally, it is suggested that a synergistic
effect may occur with consumption of the whole grain, producing greater benefit than
the sum of its individual parts (109), and therefore not one single component or
mechanism will account for all benefits.

Nonetheless, when considering the literature for whole grain and cereal fibre intakes in
relation to CVD health, a considerable amount of evidence does suggest that intakes of
both are similarly protective against CVD and CVD-related conditions. Of course, it is
possible that high cereal fibre intake in observational studies simply reflects high whole
grain intake, as whole grains are a primary source of cereal fibre, and it is difficult to
separate the two exposures. Although, inverse associations found in prospective cohort
studies exploring whole grain intake and CVD risk are often explained by cereal fibre
intake, suggesting that the fibre component is, at least in part, explaining the
relationships. Furthermore, intakes of added cereal fibres, including added brans and
functional fibres isolated from cereal sources such as β-glucan, arabinoxylan, and
isolated resistant starches, also show favourable effects on CVD-related risk measures
and outcomes.

A recent meta-analysis of 185 prospective studies found that both fibre and whole grain
were associated with reduced risk of all-cause mortality, coronary heart disease,
incidence of T2DM, stroke mortality and cancer death. Every 8g of dietary fibre
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consumed reduced risk of coronary heart disease by 19%, and every 15g of whole grain
reduced risk by 7% (28). GI or glycaemic load (GL), other carbohydrate properties
thought to determine quality, were not found to significantly reduce risk, although this
may be partly due to fewer available studies. The same study also performed a metaanalysis of 58 clinical trials and found that higher intakes of both dietary fibre and
whole grains consistently reduced bodyweight, whereas only dietary fibre also
consistently lowered blood cholesterol and systolic blood pressure, although notably
there were fewer trials available (28).

In a prospective cohort study of 367,442 individuals by Huang et al. (2015), the highest
quintile of whole grain and cereal fibre intakes were associated with 17% and 20%
lower risk of CVD mortality, respectively (108). However, after the whole grain
association was adjusted for cereal fibre intake, it was no longer significant. The authors
interpreted this to mean that the cereal fibre content at least partly accounts for the
protective effects of whole grains. Other studies of similar cohorts exploring risk of
CHD and CVD have found greater risk reductions for bran and cereal fibre intakes than
whole grain intake (110; 111). In the Health Professionals Follow-up Study (HPFS), the
whole grain association was attenuated after adjustment for cereal fibre (111).

Similar effects between whole grain and cereal fibres are also found in studies exploring
conditions related to CVD, including hypertension, obesity and T2DM. Flint et al.
(2009) found that in a cohort of 31,684 healthy males, those with a median whole grain
intake of 46.0 g/d had a 19% reduced risk of hypertension compared to those with a
median intake of only 3.0 g/d, and those with highest bran intake (12.0 g/d) had a 15%
reduced risk compared to the lowest intakes (0.3 g/d) (112). However, the whole grain
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association was attenuated after adjusting for cereal fibre. In a study of 8-year weight
gain, for every 40 g increase in whole grain intake daily, weight gain was reduced by
1.1 kg (113). Similarly, for every 20 g/d increment in added bran and cereal fibre intake,
weight gain was reduced by 0.36 kg and 0.81 kg, respectively. In several prospective
cohort studies, the association of mixtures of whole grains and bran to reduced T2DM
risk disappeared after adjustments for dietary fibre or cereal fibre intakes (50; 51; 114).

In human trials, oatmeal and oat bran both tend to show a reduction in blood cholesterol
(115; 116)

however, lower amounts of oat bran may be needed to reach a plateau in

cholesterol reduction compared with oatmeal due to the higher β-glucan content of bran
(115)

. Anderson et al. (1991) found that 110g of oat bran daily, for 21 days, significantly

lowered total cholesterol and triglyceride concentrations compared to a control diet (117).
A recent study found that adding oat bran to instant oatmeal reduced post-prandial
glycaemic response dose-dependently, indicating an additional benefit (118). Β-glucan
isolated from the oat source and given as a supplement has been shown to also
effectively lower total and LDL cholesterol when provided at 3g daily or above (119),
although a recent study suggested it may not be as effective as oats or oat bran (120).
While some evidence regarding β-glucan efficacy has been inconsistent, this may be
due to varying molecular weight of β-glucan used within studies, as a high molecular
weight (and high viscosity) β-glucan may be necessary to obtain a significant
cholesterol-lowering effect (121). A meta-analysis of 28 studies examining differences in
serum cholesterol with consumption of high molecular weight oat β-glucan (≥100 kDa)
only compared to a non-β-glucan control, found a -0.25 mmol/L difference in LDLcholesterol and a -0.30 mmol/L difference in total cholesterol for oat β-glucan relative
to control (122).
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Arabinoxylan (AX), a soluble, highly viscous fibre, is another cereal fibre that has been
linked to specific health benefits. AX makes up a major component of the fibre in wheat
and rye, accounting for 64-69% of the fibre in wheat bran and 88% of the fibre in the
wheat endosperm (mostly in the aleurone layer) (34). During wheat flour processing, a
large amount of AX is removed as by-product, making it relatively easy to separate and
extract the isolated fibre, which can then be added back into cereal products such as
breads. Perhaps due to its high viscosity, AX-rich fibre when added in breads has been
found to improve glucose tolerance. Lu et al. (2004) found that fasting blood glucose,
postprandial blood glucose and insulin were all significantly lowered in adults with
T2DM after supplementation of 50% whole wheat bread with added AX-rich fibre
(providing an average of 15g of AX-rich fibre daily) compared to a control 50% whole
wheat bread without added AX-rich fibre (123). Faecal output was also increased by
61.5g per day on the AX diet. Similarly, in healthy adults, a dose dependent effect was
found with AX supplementation in breads whereby postprandial glucose levels were
significantly lowered with 6g of AX-rich fibre daily compared to a control white bread,
although 12g produced the greatest effect (124).

Isolated cereal resistant starches, which can be added to foods as functional fibre, have
also shown promising effects, particularly on glucose homeostasis. An example of this
currently in widespread use in Australia is Hi-Maize®, a resistant starch (RS2) made
from high amylose maize (corn) which can be added to commercial breads, pastas, and
breakfast cereals without altering taste or texture (125). High amylose maize starch has
been found to have favourable effects on satiety (126; 127), postprandial glucose and
insulin response (128), as well as increase faecal output and short chain fatty acid
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production (129; 130), similar to the benefits attributed to whole grain intake and naturallyoccurring resistant starch (80). Notably however, most research compares effects to a
lower-starch products (126; 128; 129) or alternative extracted fibres (127; 130), rather than a
counterpart whole grain cereal.

1.5 Defining and estimating whole grain intakes in the evidence base
An added complication in comparing the health effects of cereal fibre to that of the
whole grain is the inconsistency in methods used to define whole grain and estimate
whole grain intakes in the existing literature. Many of the large meta-analyses providing
evidence for the CVD health associations of whole grains draw conclusions based on
studies that define whole grains in various ways, including those that categorise added
bran and germ as whole grain sources (28; 131; 132).

In fact, Cho et al. conducted a systematic review in 2013 assessing the evidence
available for cereal fibre intake, mixtures of whole grain and bran intake, and whole
grain intake to risk of CVD, as well as obesity and T2DM as related conditions, for the
purpose of establishing an American Society for Nutrition position statement (133). The
research concluded that there was moderate evidence (classified as evidence level B
based on the evidence grading system established by consensus of the writing group) for
both the association between cereal fibre intake and mixtures of whole grain and bran to
reduced risk of CVD. However, when considering only the studies that defined whole
grain as not including added bran, of which there were only two, one study found no
association to CVD risk and the second study found the association became nonsignificant after adjustment for dietary fibre and other dietary factors, therefore
providing limited evidence (evidence level C).
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Another frequent issue is that studies may use whole grain ‘food’ definitions as opposed
to estimating total whole grain intake as a dry ingredient (134). Many studies have
determined whole grain intake based on specific and occasionally arbitrary food
categorisation systems, such as categorising mixed foods as either a whole grain or
refined grain food and then estimating serves of these foods, rather than calculating
whole grain content in grams as a dry weight of the ingredients within all foods. These
methods have the potential to overestimate the contribution to whole grain intakes from
some foods categorically considered whole grain. For example, the categorisation
method developed by Jacobs et al. (1998) categorises all dark breads as whole grain
(135)

, although many dark breads use refined flours.

Alternatively, studies may have defined whole grains, again on a food basis, but using a
percentage cut off such as those that contain at least 25% whole grain or bran (108; 135). In
addition to the problematic inclusion of bran, definitions based on cut-offs such as this,
or the 30% cut-off recommended by the HEALTHGRAIN forum (136) are less helpful in
defining the precise levels of intake needed in research. This is in contrast to the value
they may have in food labelling, whereby only food products likely to provide a
significant contribution to recommended intakes would ideally be able to advertise as
containing whole grain or be labelled as a whole grain food. Categorising foods in this
way fails to capture the whole grain consumed through food products that do not meet
these definitions but which would potentially accumulate to a significant contribution to
total intake. For example, a recent paper shows that when a whole grain ‘food’
definition (the HEALTHGRAIN definition) is applied to Australian population dietary
intake data, the median intake is 19.6 g/day, compared to 24.1 g/day of total whole grain
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when calculated as an ingredient from all food sources, demonstrating the considerable
difference in calculation that can result. Some examples of various definitions and
categorisation systems that have been used in the existing literature is provided in Table
1.1 demonstrating the highly variable nature of the intake data that may be used in
investigating health effects of whole grains.
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Table 1.1 Methods used to estimate whole grain intake
Estimation method/definition used

Includes brans? Units

Studies

Intake of whole grain breakfast cereal (if ≥25% whole grain or bran), dark bread,
popcorn, cooked oatmeal, wheat germ, brown rice, bulgur, kasha, couscous
(Jacobs et al. 1998 definition)

Yes

Servings
(foods)

Jacobs 1998 (135)
McKeown 2009 (137)
Meyer 2000 (50)
Steffen 2003 (138)

Intake from the foods listed in Jacobs et al.1998 definition

Yes

Grams

Juan 2017 (139)

Other food list definitions e.g. intake of whole grain breakfast cereal; oatmeal;
dark bread; bran muffins; brown or wild rice

Yes

Servings
(foods)

Lutsey 2007 (140)

Intake of foods whereby first ingredient listed on label is “whole grain”

Unclear

Servings
(foods)

Rose 2007 (141)

Intake from all ingredients containing the expected proportion of bran, endosperm
and germ for the specific grain type (i.e. in accordance with the AACCI and other
ingredient definitions)

No

Grams

Flint 2009 (112)
Jensen 2004 (142)
de Munter 2007 (143)
Galea (144)

Intake from foods with over ≥10% whole-grain content, on a dry matter basis as a
percentage of the fresh weight of food.

No

Grams

Thane 2007 (145)
Thane 2009 (146)

Intake from foods containing any whole grain (including bran) content listed within
the Pyramid Servings Database

Yes

Grams

Newby 2007 (147)

Intake of foods containing at least 25% whole grain and/or bran as listed within the
Pyramid Servings Database

Yes

Servings
(foods)

Huang 2015 (108)
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As a considerable amount of scientific evidence supporting the protective effect of
whole grains is inconsistent or confounded, typically with bran, germ, or fibre, it is
challenging, based on the current evidence, to determine if the CVD health associations
found within these studies can truly be attributed to grains only when eaten in their
whole form. Perhaps if the cereal fibre component is present (either in whole grain or
added cereal fibre form) then health effects, particularly in relation to CVD, may exist.
Alternatively, some researchers have concluded that based on the evidence, it is more
likely that it is the bran component specifically, which contains most of the cereal fibre
as well as an abundance of other nutrients and minerals located within the aleurone,
may account for the CVD health effects attributes to whole grains (54; 142). MartinezTome et al. (2004) found that oat and wheat bran antioxidant activity were higher than
that of whole oat or wheat flour (148). In this case, both bran consumed as part of a whole
grain, or as a separated, added bran, may be protective.

1.6 Cereal fibre – a solution to improve the health value of grain choices?
While nutrient-based research is considered important to explain the mechanisms by
which healthful foods and diets are protective (149), from a health promotion perspective,
attempting to separate the health benefits of cereal fibre from whole grains may seem
overly precise and reductionist, as people eat food, not nutrients. It is well established
that diets high in fruit, vegetables and minimally-processed grains are beneficial for
cardiovascular health (150; 151). Given this, the value in determining if particular
components of whole grains such as cereal fibre are individually healthful may be
questioned, when there is increasing argument for the importance of whole foods and
dietary patterns, rather than specific nutrients, for the maintenance of health (152; 153; 154).
However, it is as important that dietary recommendations are effective, as it is that they
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are evidenced-based. That is, it is important that in ‘free-living’ conditions, dietary
recommendations or interventions are likely to be impactful (155), taking into account
adherence and acceptability by the target population.

Whole grain foods are currently recommended in the Australian dietary guidelines
(ADG), as well as globally (156; 157). Recommendations range from general advice to
choose mostly whole grain varieties within the UK, through to specific, quantifiable
advice such as to consume a minimum of 75g of whole grains daily within Denmark
(156)

. Within Australia, the ADG recommends that when consuming grain foods,

Australians choose mostly whole grain and/or high cereal fibre varieties, and suggests
that at least half of daily grain intake should be whole grain (157). The Grains & Legumes
Nutrition Council (GLNC), a not-for-profit health organisation, has advised a
recommended intake of 48g (approximately 3 serves) of whole grain per day (158).

Despite these recommendations, whole grain intake is alarmingly low. Based on results
from the 2011-13 Australian Health Survey (AHS), the median daily whole grain intake
was 21 g for adults (19-85 years) and 17 g for children/adolescents (2-18 years) (144),
and approximately 30% of Australian participants consumed no whole grains on the
days of the survey. Unsurprisingly, Australians are also not consuming enough total
dietary fibre, with average adult daily intakes within the AHS of approximately 21 g/d
(159)

, compared to Nutrient Reference Values of 25 and 30g a day for women and men,

respectively (160). Based on the AHS results, only 28% of Australians met the
recommended DTI for whole grain or the AI for dietary fibre (144; 159).
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Past research has investigated consumer perceptions of whole grain foods to identify
potential barriers that may explain why intakes fall short of recommendations. Barriers
may include perceived cost differences, longer cooking and preparation time needed,
and an inability to identify whole grain foods (161; 162; 163). Another potential barrier may
be active reduction in intake due to perceived negative health effects (164; 165), as antigrain, gluten-free and low-carbohydrate diets are gaining increased popularity globally,
often perceived to assist with weight loss or alleviation of gastrointestinal symptoms
(166; 167; 168; 169)

.

Lastly, a major barrier to whole grain intake reported commonly in the literature is
dislike of their organoleptic properties (namely the taste, texture, appearance and smell)
(162; 163; 170; 171)

, with participants often preferring the taste of less healthful and lower-

fibre refined grain options such as white bread and pasta.

Given the CVD benefits of whole grains and dietary fibre are well established, the
currently inadequate intakes present a major public health concern. Although evidence
suggests that consumption of whole grains is beneficial for health, the effectiveness of
whole grain promotion may be limited by the barriers described. Exploring potential
solutions to overcome these barriers is necessary.

Use of added cereal fibres in refined grain foods, whether naturally occurring fibres
from separated brans, or isolated sources such as β-glucan, arabinoxylan or resistant
starch (Hi-Maize®), may present a solution in overcoming the dislike of organoleptic
properties of whole grains, specifically. Such foods could provide consumers with an
alternative healthy grain choice which retain the desired taste and texture of refined
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grain foods, and therefore may be considered more appealing and palatable than whole
grain foods. As grain foods are the biggest contributor to dietary fibre intakes within
Australia (172), they are likely an impactful tool in increasing dietary fibre intakes.
Therefore, exploring the importance of cereal fibre compared to whole grains may be
valuable knowledge in development of evidence-based strategies and initiatives likely to
be most effective in bridging the gaps between dietary recommendations and current
dietary intakes.

In order to estimate the potential value of added-fibre alternatives, not only is there a
need for insight into the comparative health value of cereal fibre to whole grain, but
there is a need to understand consumer perceptions of added fibres and brans in
comparison to whole grains, to consider the effectiveness of promotion of high-fibre
grain foods as a supplement to whole grain choices and an alternative to refined grain
choices. Previous studies show conflicting acceptability of added-fibre grain foods (173;
, and some consumer wariness of modified foods in general has been suggested (175).

174)

Notably, a large portion of research into acceptability of such foods was conducted over
a decade ago and overseas, and consumption habits of grain foods within Australia (164),
as well as interest in health-conscious food choices (176), appears to be shifting.
Additionally, other barriers to whole grain intake such as anti-grain sentiments likely
remain an important barrier to all grain foods choices, so an understanding of the extent
to which these influence choices is also important. Therefore, an updated understanding
of perceptions and attitudes surrounding both whole grain and added-fibre grain foods
within Australia is warranted.
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1.7 Summary of evidence and gaps in the literature
Cardiovascular disease is one of the largest public health burdens affecting Australians.
Evidence suggests that high fibre grain foods are beneficial for cardiovascular health
and as part of a balanced diet, may help to reduce the prevalence of CVD. This includes
whole grain foods, but may also include bran foods and foods with added cereal fibres,
as it is possible that the high cereal fibre content of whole grains is largely responsible
for their benefits. Alternatively, it may be that the effects of the whole grain food are
greater than those of cereal fibre, as a result of additional constituents and synergistic
actions between constituents. Even if this is the case, if cereal fibre foods are more
readily consumed by individuals, then their development may be an important tool in
promoting improved dietary patterns.

Currently, methodological issues, namely the wide variation in measurement of whole
grain intake historically used in the evidence, make it difficult to separate the effects of
cereal fibre and bran from whole grains. Emerging evidence suggests that bran foods
and added cereal fibre foods may be beneficial, but more research is needed directly
comparing the CVD health associations of whole grain intake (defined using current
definitions and estimated quantitatively in total grams) with cereal fibre intake.

Whole grain and fibre intakes within Australia remain consistently low. Added fibre
grain foods may present a viable solution to encourage increased intake of healthy grain
foods. However, there is a paucity of research on consumer acceptability and
perceptions of functional fibres, particularly in an Australian context and compared to
that of whole grain foods, which is necessary to evaluate the potential effectiveness of
promotional strategies.
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1.8 Significance of research
Research into the diet-disease relationship between CVD and grains foods is of value,
given the prevalence of the disease globally, and the staple role grains play within the
Australian diet. Insights into the health associations of whole grain and cereal fibre
intake are useful to guide the effective promotion of healthful grain food products in
public health initiatives and dietetic practice, and contribute to reducing the significant
burden of CVD. Promotion of whole grain foods as an integral part of a balanced diet
should remain important, as emphasis on whole foods is better understood by the public
than singular nutrients, and may be particularly important to directly combat the
misleading negative image that appears to exist around grain foods. However, an overly
restricted focus on whole grain foods within public health recommendations and dietetic
practice may deter or under-promote consumption of high-fibre non-whole grain foods
such as bran-based or added-fibre cereal foods, which may not only be similarly
beneficial for cardiovascular health, but potentially more appealing for consumers, and
thus more likely to be consumed in greater amounts.

If high intakes of cereal fibre were found to be similarly associated with lower risk of
CVD, this research would raise the question of whether current initiatives and health
policies regarding grain recommendations and labelling should be reviewed to ensure
adequate focus on all high-fibre grain foods. On the other hand, if it was found that high
cereal fibre intake was not associated with the same benefits as high whole grain intake,
suggestive that the additional constituents of whole grains are necessary for the full
health benefits, this may call into question whether national recommendations and
promotion of whole grain intake is sufficient in its current form. Further initiatives, such
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as an Adequate Intake (AI) value similar to the current AI for dietary fibre (160), may be
of benefit, or changes to product labelling policies to permit a whole grain health claim
may be warranted.

As described, exploring the health benefits of cereal fibre outside of whole grain foods
may also be a valuable step in functional food innovations, thereby of value to the food
industry. If non-whole grain cereal fibre and bran are similarly associated with the
health benefits of whole grain foods, and added-fibre grain products are more accepted
by the population due to improved palatability, industry may benefit from focusing
efforts on development of innovative products that meet these standards. Alternatively,
it may be more important for the industry to focus on increasing the availability and
variety of naturally high-whole grain products, whereby whole grain ingredients are
incorporated at level sufficient to make a significant contribution to intake without
compromising desired sensory properties.

1.9 Thesis aims and hypotheses
The central aim of this thesis is therefore to explore the importance of whole grain
intake in comparison to cereal fibre intake in the context of cardiovascular health,
considering both their comparative benefits, as well as feasibility in achieving adequate
intakes necessary to attain these benefits. This thesis hypothesises that high cereal fibre
intake and high whole grain intake are likely both similarly associated with favourable
cardiovascular health outcomes, but research clearly separating the two, using careful
decisions and precise categorisation, is required to fully elucidate the importance of
these two components of foods. This is particularly relevant as the current evidence base
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for whole grains relies on inconsistent definitions and is prone to confounding by bran
and cereal fibre.

While perceived health value of a food may influence consumer choices, this is in
combination with sensory perceptions, which may be a barrier to whole grain
consumption explaining why Australian intakes are low. We therefore hypothesise that
while whole grain foods should continue to be recommended and promoted, high fibre
grain foods that are not whole grain may present a viable alternative where sensory
barriers to whole grain foods exist that do not exist for these foods.

The research aims of this thesis were:

1. To critically review the existing evidence base comparing whole grain intake with
individual components bran and cereal fibre, to determine their comparative efficacy in
lowering CVD risk and shed light on the relative contribution of the cereal fibre
component to the CVD benefits associated with whole grain intake.

2. To determine the associations of whole grain and cereal fibre intakes, estimated
quantitatively using food composition databases and accepted definitions, to CVDrelated health outcomes within two population representative adult survey samples, with
use of the National Nutrition and Diet Survey Rolling Programme (NDNS RP) 2008-14
and the 2011-13 AHS.

3. To explore factors dictating grain food choices, particularly the perceptions,
knowledge and attitudes of consumers surrounding whole grain and added-fibre grain
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foods, with the intent of enhancing grain-based dietary recommendations and
encouraging increased intake of healthy grains.

1.10 Thesis overview and structure
Chapter 1 has provided an overview of the current evidence base for whole grains,
cereal fibre and CVD, and the issues that exist in separating the effects of cereal fibre.

Chapter 2 outlines the methodological framework applied within this thesis including an
in-depth discussion of the methods utilised within each research study. This covers
strengths and weaknesses of each method and justification for their use in investigating
the research questions.

Chapter 3 summarises and critiques the current evidence base comparing intakes of
whole grain with intakes of cereal fibre and/or bran to risk of CVD-related health
outcomes, using systematic review methods.

Chapter 4 and 5 describe the cross-sectional associations between whole grain and
cereal fibre intake and markers of CVD risk in adult participants of the UK NDNS RP
2008-14 (Chapter 4) and the 2011-13 AHS (Chapter 5).

Chapter 6 describes focus group studies of Australian consumers to provide an in-depth
exploration of factors that affect current grain food choices, focusing on whole grain
and added-fibre grain foods.
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Chapter 7 summarises the findings from the previous chapters in relation to the overall
aim and hypothesis of the thesis. This chapter includes a discussion of the limitations of
the research, and provides recommendations for future research within this field.
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Chapter 2:
Methodology
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2.1 Overview of methodological framework
As described (Chapter 1), it is difficult to ascertain to what extent the various
constituents of grain foods, particularly the cereal fibre content, may be protective
against CVD, in comparison to the grain in its whole form (whole grain). Further
knowledge in this area may help to enhance the effectiveness of future grain-based
dietary recommendations and promotion strategies.

Existing evidence comparing whole grain intake and cereal fibre intake to CVD risk
needs to be synthesised and critiqued, filtering by whole grain definition used, to
examine the quality of evidence currently available when whole grain intake is not
confounded by mixed grain and bran intake. Analysis of population survey data
comparing associations between diets high in whole grains (defined as containing the
correct proportion of endosperm, bran, and germ) and diets high in cereal fibre, to
markers of cardiovascular health will provide further evidence of their potential
differential significance, while also allowing insight into the population’s current
intakes, an important consideration for translation of findings into achievable
recommendations. Beyond this, exploration of consumer perceptions influencing grain
food choices will help to determine potential approaches to improve the effectiveness of
grain promotion and messaging. In order to explore factors that influence choice of
grain foods, a qualitative research approach is needed.

The aims of this thesis (Chapter 1) will be explored using a mix of research methods,
including critical review of current evidence, secondary analysis of population data and
qualitative focus groups. Each method will be discussed in detail below, including the
strengths and limitations of each approach, and their specific role within this thesis. An
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overview of the methodological framework applied in this thesis is depicted in Figure
2.1.

Hypothesis 1: High whole grain and cereal fibre
intakes are similarly associated with favourable
cardiovascular health

Study 1: Critical review
of current evidence

Study 2 & 3: Secondary analysis
of population survey data

Factors affecting
grain food
choices

Whole
grain Cereal
fibre

Risk factors
of CVD

CVD

Study 4: Qualitative exploration of
grain food choices

Hypothesis 2: Knowledge, perceptions
and attitudes affect grain food choices

Figure 2.1 Methodological framework of studies
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2.2 Study designs
2.2.1 Systematic review as an approach to evaluate existing evidence
A systematic literature review (SLR) is used to collect and critique the entire body of
evidence on a clearly defined topic of interest in a rigorous and transparent manner.
When conducting systematic research, standardised methodology must be adhered to in
the searching, filtering, reviewing, critiquing, interpreting, synthesising, and reporting
of findings from multiple publications, to avoid bias and allow an accurate assessment
of the quality and magnitude of existing evidence on the topic of interest (177).
Systematic reviews often also include meta-analyses. Meta-analysis is a formal research
design used to systematically synthesise evidence of single studies into an overall or
‘absolute’ effect, using statistical methods (178). In this sense, meta-analyses are a
specific subset of systematic review. Because meta-analyses pool data from multiple
studies, the evidence they produce is statistically stronger than the analysis of any single
study. Depending on the specific research question and the characteristics of studies
available, it may not always be possible or suitable for systematic reviews to include
meta-analysis. Owing to their strict methodology, well-conducted systematic reviews
and meta-analyses provide robust high-level evidence available on a topic of interest.

Systematic review methods are often consulted in the development of national nutrition
policy and guidelines, including the ADG. Based on a series of SLRs on the topic, the
ADG working group have developed two evidence statements regarding grain intake
and cardiovascular health (179):
1) Consumption of cereal foods (especially wholegrains and those with fibre from
oats or barley) is associated with a reduced risk of cardiovascular disease in
adults
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2) Consumption of one to three serves per day of wholegrain cereals is associated
with a reduced risk of cardiovascular disease.

The evidence underpinning these statements was determined as Grade B, indicating
good strength (180), and suggesting that it is likely that grain foods, particularly those
high in cereal fibre such as whole grain varieties, are protective against cardiovascular
disease. However, within the evidence report for the ADG, it is acknowledged that
much of the evidence within these SLRs came from studies defining whole grain intake
to include intake of bran-based foods, or from studies examining cereal fibre rather than
whole grains (179). Hence, it is difficult to differentiate the evidence for whole grains
from the evidence for cereal fibre and brans, components which potentially contributed
to the protective associations found.

Therefore while the literature regarding grain intake and CVD has been synthesised
previously, there is a paucity of evidence accurately separating the effects attributed to
whole grain intake, from those attributed to intake of related components such as total
cereal fibre or bran. Further clarity in this area would be beneficial to improve specific
recommendations and policy regarding grain foods within Australia, and to add to a
global knowledge base. As the first step in this thesis, we sought to examine the body of
evidence available which directly compares whole grain, bran and cereal fibre intake to
CVD risk, through use of systematic review.

We chose to separate studies based on design, with intervention studies (Chapter 3a)
and observational studies (Chapter 3b) reviewed as separate bodies of evidence. This
was due to the inherent differences between designs making outcomes difficult to
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compare meaningfully, as intervention studies tended to assess acute effects of grain
intake on intermediate markers of CVD risk and observational studies assessed longer
term association to mortality and morbidity of CVD. This method also creates a distinct
separation of strength of interventional evidence compared to observational evidence,
rather than strength of evidence combined. It is recommended that evidence from both
study designs is assessed separately to evaluate agreement or disparity between the two
types, with agreement between the two indicating the most robust evidence (181).

Review of intervention evidence
Systematic reviews within this thesis were completed in accordance with the PRISMA
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement (182).
The PRISMA statement (formerly the QUOROM statement) was developed to improve
the consistency and quality of reporting within systematic reviews. The statement
consists of a 27-item checklist detailing the minimum set of items to be reported within
reviews and a four-phase flow diagram outlining the study selection process (182).

In order to explore the effects of the various components of grains, especially whole
grain and cereal fibre, we needed to consider intervention studies which included whole
grain intake compared to cereal fibre and/or bran intake from the same grain, in
association to anthropometric measures (body mass index (BMI), body weight, waist
circumference or central adiposity), lipid profile constituents (total cholesterol, high
density lipoprotein (HDL)-cholesterol, LDL-cholesterol or triglycerides), blood pressure
measures (systolic or diastolic), blood glucose measures (fasting, postprandial or
haemoglobin A1c (HbA1c)) and/or C-reactive protein (CRP) levels. The rationale for
choosing these markers is outlined in section 2.2.3.
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Studies could use a cross-over or parallel design, however treatment phase of studies
was for a minimum of 2 weeks, therefore excluding short-term meal test studies. A two
week window was chosen as this time frame has been shown to be sufficient to see
effects in markers such as cholesterol in previous meta-analyses (122; 183).
Part of best practice in collation of evidence includes an assessment of study quality and
risk of bias. A number of tools exist to assess study quality, and most have been
developed to assess specific study designs such as intervention trials, cohort studies, or
cross-sectional studies. The Cochrane Collaboration’s risk-of-bias tool (184) is the most
commonly used and widely accepted tool for assessing intervention studies (185), and
was therefore used to evaluate the quality of individual studies within the review. The
tool considers biases likely to arise at all stages of a trial, covered within six bias
domains. The six bias domains include selection, performance, attrition, reporting, and
other (184). It should be noted that a revised tool was released in 2019 (185), but at the time
of research, version 1 was still in use.

Review of observational evidence
Similarly, in a review of observational studies, the same considerations of whole grain
intake and cereal fibre and/or bran intake in association to CVD-related health outcomes
in humans, including disease biomarkers, anthropometric measures, morbidity and
mortality need to be included within a single study. The National Health and Medical
Research Council (NHMRC) levels of evidence criteria (186) were used to assign a level
of evidence to each study based on design. These levels of evidence reflect the potential
of each study design to adequately answer the research question. The highest level of
evidence available (Level I) is assigned to systematic literature review of Level II
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studies, which in most cases are randomised controlled trials (RCTs). Observational
studies therefore usually range from level III-2 to level IV. Again, a tool for critical
appraisal of individual studies was also required to consider the quality of evidence. In
observational designs, questions required to assess quality often differ from those
required in intervention designs. For example, in observational designs it is crucial that
potential confounding variables are measured and adjusted for to reduce bias of results.
The National Institute of Health (NIH) Quality Assessment Tool for Observational
Cohort and Cross-Sectional Studies (187) was considered most appropriate for assessing
the quality of evidence as it is specific to observational designs but can be applied to
both prospective and cross-sectional studies included here.

The great variation in whole grain definition and categorisation used in existing
literature (Table 1.1) presents a challenge in comparing and synthesising evidence
through systematic review methods. In order to do this effectively, included studies
must comply with a robust and accepted standard definition, one which ensures all
whole grain ingredient intake has been captured and confounding from mixed grains or
bran has been minimised. The AACCI definition of whole grain states that:

“Whole grains shall consist of the intact, ground, cracked or flaked caryopsis, whose
principal anatomical components—the starchy endosperm, germ, and bran—are present
in the same relative proportions as they exist in the intact caryopsis.” (23)

At the time of the review, it was likely the most widely accepted whole grain ingredient
definition in use, and more recently released definitions such as the WGI definition (22)
only differ marginally, for example, by providing additional detail that small,
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unavoidable losses through processing are allowed. Importantly, the AACCI definition
specifies that the endosperm, germ and bran components of the whole grain must be
present in relatively natural proportions. Therefore, for a valuable whole grain review,
initial exclusion criteria must state that studies must define whole grain in accordance
with the AACCI definition (23), or essentially, as containing the endosperm, germ and
bran components. In research within this thesis, initial scoping found a limited number
of studies meeting this criteria. Consequently, a second review was conducted,
expanding the criteria to include studies with a broader definition of whole grains. This
meant that studies which categorised added bran as a whole grain source, or employed
percentage cut-offs of whole grain content (e.g. 25%) to define whole grain foods, were
included within this expanded analysis. The separation of studies within the initial and
expanded analysis also worked to further demonstrate how the quality and magnitude of
evidence differs when restricted to studies using the accepted definition of whole grains.

Systematically reviewing the literature provides an indication of the current evidence
comparing the relationships between whole grain and cereal fibre intakes to CVDrelated health outcomes. The next step is to explore this question in the specific
populations of interest. To do this, quantification of whole grain and cereal fibre intakes
using population dietary data is needed, which can then be analysed for associations
between whole grain and cereal fibre intakes to CVD-related health outcomes.
Examining diets at the population level, using national nutrition data, is particularly
useful when planning to translate findings into suitable and relevant population
recommendations, as it allows insight into current intakes within the population/s of
interest. Furthermore, it ensures that findings are based on the diets and foods consumed
within the specific context, with consideration that different whole grains or cereal
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fibres may have varied effects and health benefits. Different populations may have
varied sources of whole grain and cereal fibre.

2.2.2 Secondary analysis of population-representative national nutrition and health
data
National nutrition and health surveys are used by many countries as the main form of
population nutrition monitoring. Their use is explicitly encouraged within the WHO
European Food and Nutrition Action Plan 2015-2020, urging member states to
‘strengthen and expand nationally representative diet and nutrition surveys’(188). For
policy-makers, the data obtained from these surveys is fundamental to identify
nutritional problems affecting the population or specific sub-populations, which can
then be used to guide the planning of programs and allocation of resources, or even
inform the need for food fortification (189). Ideally, these surveys are conducted at
regular intervals, allowing for monitoring of trends in dietary intakes and nutritional
status over time, and determine the effectiveness of any interventions implemented (190).
Beyond use at the government level, stakeholders within the food industry may also use
data from national surveys to understand consumption trends and guide product
development and reformulation based on predicted consumer demand, and nongovernment organisations (NGOs) and consumer groups may use the data to create
social mobilisation and advocate to government for change (189).

National nutrition and health surveys are also useful for researchers, to explore crosssectional associations between dietary factors and risk of health-related outcomes such
as chronic disease in the population at a particular point in time. Secondary analysis of
national survey data is a time-efficient and inexpensive research method. As the data
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has already been collected and stored, the researcher is able to spend the majority of
their time analysing the data rather than collecting and preparing the data for analysis
(191)

. Similarly, any costs associated with planning and implementing the survey are

avoided. As most national nutrition surveys collect data on multiple outcomes and
exposures, there is often a multitude of analyses that could be performed using the data,
beyond what was used or explored in original output from the survey (191). Such breadth
of data, particularly from a large, population-representative sample, would be difficult
to achieve if the researcher were to collect primary data themselves.

As with any study design, there are limitations to survey data that need to be considered
prior to use. While random sampling, as used within national surveys, ensures that the
selected sample is likely to be representative of the population, this does not necessarily
mean the responders will be (192). Non-response bias can be an issue which limits the
representativeness of the sample, particularly problematic when there is considerable
difference in characteristics between responders and non-responders (193). Methods may
be implemented at data collection to reduce non-response, including using face-to-face
interviews with respondents, using interviewers who can speak languages other than
English, and conducting follow-up of non-responders. Weighting the sample using
population benchmarks can also be used to reduce non-response bias (194). If a researcher
wishes to conduct secondary analysis on survey data, and therefore was not involved in
the dietary collection phase, it is imperative that they familiarise themselves with the
dataset. This includes a thorough understanding of the collection methods, assessment
tools, response levels, sampling strategy and any weighting used (191). Not only will this
provide sufficient information needed to determine if the data can be used to generate

69

meaningful findings on the topic of interest, it ensures that analysis on the sample is
conducted correctly and errors are minimised, in turn ensuring the validity of results.

Due to the nature of the data, whereby risk factors and outcomes are measured
simultaneously at one point in time, cross-sectional studies of any kind are unable to
deduce whether the dietary exposure or the health-related risk factor came first, and
therefore cannot infer causation between exposure and outcome (195). For these reasons,
researchers using these methods must always use caution in their interpretation of
findings. However, if cross-sectional analysis of population-representative survey data
is conducted carefully and correctly, it is an efficient method for shedding light on
potential associations and generating hypotheses, which can then be used to justify the
need for future, causal research to confirm findings (192). Within this thesis, cross
sectional, secondary analyses of two national dietary surveys, the NDNS RP 2008-14
conducted within the UK and the 2011-13 AHS conducted within Australia, were
performed to explore associations between diets high in whole grain and diets high in
cereal fibre and CVD risk factors. The two studies provided opportunities for two very
similar but slightly different methods to be utilised to examine populations expected to
have similar dietary patterns but varying food supplies, thereby adding further weight to
findings.

National Diet and Nutrition Survey Rolling Programme 2008-14
The NDNS RP is a continuous, cross-sectional survey designed to collect information
on the dietary intake and nutritional status of privately dwelling people within the UK
aged 18 months and over, covering a nationally representative sample of approximately
1000 people (minimum of 500 adults and 500 children) per year (196). The NDNS is
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jointly funded by Public Health England (PHE) and the UK Food Standards Agency.
Prior to the continuous, rolling programme design, the NDNS comprised a series of
cross-sectional surveys, each covering a different age group. The rolling programme
design was first introduced in 2008 (Year 1), and results from the most recent survey
(2018/19; Year 10) are due to be released early in 2020. The rolling programme design
also allows the survey to be used to monitor these changes in dietary intakes and
nutrition status continuously over time (time trend analysis), which can be useful for
policy planning and evaluation, such as evaluating the effect of food fortification
programs. The survey consists of an initial face-to-face, computer-assisted personal
interview (CAPI) stage followed by a nurse visit approximately 8-12 weeks later. The
initial interview collected data from participants on demographic and socio-economic
characteristics, health and lifestyle habits, dietary intakes, physical measurements and
oral health. The subsequent nurse visit collected further anthropometric measurements,
blood pressure measurements and blood and urine samples for analysis of nutritional
status. Detailed methodology for the NDNS surveys has been published by PHE in
previous reports (196; 197).

At the time of analyses for this thesis, data from Years 1-6 of the NDNS RP (2008/092013/14) were available. Within this thesis, analyses were performed using data from
adult participants (18 years and older), and sampling weighting provided was applied to
the data. Sampling weights are needed in order to infer results for the in-scope adult
population of the UK at the time. They are used to adjust the sample to correct for
imperfections such as unequal probabilities of selection and non-response bias, and
ensure that particular characteristics (e.g. age, sex) are not over or underrepresented in
the sample, thereby deviating from the population distribution (198). Despite the
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relatively small sample of 1000 participants, the annual frequency of the surveys means
that the weighted sample is representative of the contemporary population, and thereby
less limited by the fast-changing nature of the food supply and dietary changes. As used
here, the yearly datasets can also be combined to produce a greater sample size.

The 2011-13 Australian Health Survey
The 2011-13 AHS is the most recent nationally representative survey within Australia,
and the largest to date. The AHS was conducted by the Australian Bureau of Statistics
(ABS), and was funded by the ABS health survey program, the Australian government
Department of Health, and the National Heart Foundation of Australia (199). The core
content of the survey collected extensive demographic and health-related information
from over 32,000 Australians. The 2011-13 AHS also composed of two separate arms:
the National Health Survey (NHS) and the National Nutrition and Physical Activity
Survey (NNPAS), the latter obtaining detailed data on dietary intake and physical
activity of 12,153 of the AHS participants, aged between two years and 85 years (Figure
2.2). Data was collected face-to-face via CAPI, which can reduce interviewer error and
streamlines the administration process (193). Where possible, participants were also
contacted at least 8 days later to participate in a second dietary data collection via
Computer Assisted Telephone Interview (CATI). All participants within the NNPAS
aged five years and over were also invited to participate in the National Health
Measures Survey (NHMS), which involved collection of blood and/or urine to examine
nutrient biomarkers and biomarkers of chronic disease. Extensive detail on the AHS has
been published online previously (194).
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Figure 2.2 Structure of the 2011-13 Australian Health Survey 3

In consistency with the NDNS RP, analyses were performed using data from adult
participants (18 years and older) of the NNPAS and the NHMS. Sampling weights, as
determine and provided by the ABS, were allocated to each participant to infer results
for the Australian population at the time. Although the total sample from the AHS is

3

Australian Bureau of Statistics, The structure of the Australian Health Survey, 2015,
https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4364.0.55.007~201112~Main%20Features~The%20Structure%20of%20the%20Australian%20Health%20Survey~7
32, accessed 20 December 2020
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much larger than the NDNS RP, the infrequency of updates, meaning that the most
recent one used here is from nine years ago, is a limitation in its representativeness of
the contemporary population. A second form of weighting, replica weighting, was also
applied to the survey data using jackknife resampling. Replica weights are used to more
accurately estimate standard errors in complex sample designs such as the AHS, which
can then be used to determine more precise confidence intervals and significance tests
(200)

. As with the sampling weights, the replica weights used were determined and

provided by the ABS in the survey dataset.

2.2.3 Dietary collection methods used within national dietary surveys
National dietary surveys can use a range of methods to collect information from
participants on food consumption and dietary habits. Dietary data collection can occur
retrospectively, such as within a 24-hour recall, food frequency questionnaire, or dietary
history interview, or prospectively, through estimated or weighted food records.
Methods can be qualitative and record types of foods consumed, or quantitative and
record types and amounts of food consumed (201). Quantitative methods are more
commonly used in national dietary surveys as they allow for estimation of nutrient
intake (201). Dietary methodologies are always a trade-off between the time, money and
feasibility and the accuracy required. The methods used in the NDNS RP and the 201113 AHS were the food record and the 24-hour recall.

Food records collect dietary intake data prospectively, whereby participants record all
foods and beverages consumed at the time of consumption for a predetermined number
of days. Food records vary in length, with most ranging from one to seven days (202).
Previous studies have found that food records of fewer days (<4 consecutive days) may
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result in more accurate data, likely due to increased participant burden associated with
longer collection periods (203). Food records may be weighed, requiring participants to
weigh all foods and beverages consumed, or simply estimated. Because foods are
recorded at the time of consumption, food records are less susceptible to recall bias than
methods such as 24 hour recall. However, they may be compromised by social
desirability bias, a common response bias whereby participants may alter their usual
diets or selectively record or omit certain foods over the study period, leading to
underestimation of usual intake (202). Within the NDNS RP, data was collected using a
4-day estimated food record. The NDNS previously used weighed 7-day food records to
collect dietary data, but the change in method was made for the rolling programme to
reduce burden on participants (204). Participants were asked within the initial interview to
keep a record of everything eaten or drunk over four consecutive days in a provided A5
diary. The diary contained photographs of 15 commonly consumed foods as small,
medium and large serving sizes which participants could use to estimate their own
servings. Alternatively, they were instructed to record portion sizes in household
measures (e.g. one tablespoon), or weight for packaged foods (204).

A 24-hour recall involves trained interviewer asking participants to list all of the food
and beverages they consumed over the previous 24 hours, therefore collecting data
retrospectively. Detailed information on preparation methods, mixed dish composition,
and brand name of commercial products, may also be obtained through skilled
interviewer probing (205). Such recalls can be administered relatively quickly and
without prior notice, and therefore participants are unlikely to alter their reported dietary
intake (202), minimising social desirability bias. As it is administered by a trained
interviewer, participant burden is low, and literacy skills of participants is not a limiting
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factor (202). However, 24 hour recall method does rely on participant’s ability to
remember what they have previously eaten, making the method susceptible to recall
bias (205). Furthermore, because it only records information about a single 24-hour
period, it is unable to accurate reflect a participants usual diet and also may miss foods
eaten regularly but infrequently (205). Notably, this is most problematic when attempting
to measure diet at the individual level, and poses less issue when estimating mean
intakes of large samples (206). Repeated 24-hour recalls are recommended to increase
accuracy of data, although this also increases associated costs (205; 206). The 2011-13
AHS used an innovative 24-hour recall method developed by the Agriculture Research
Service of the United States Department of Agriculture (USDA) called the Automated
Multiple Pass Method (AMPM) (207), modified and adapted to reflect the Australian
food supply (194). This method intends to improve validity and minimise recall bias of
24-hour recall through a five-phase system (Table 2.1) whereby participants receive
cues at each step by a trained interviewer to prompt the participants’ memory. Once a
food is reported by the participant, systematic questions follow to capture precise detail
on the food, cooking methods and amount consumed. In addition to use of this initial
interview, participants within the survey were contacted at least 8 days after the initial
24-hour hour recall and were invited to participate in a second 24-hour recall via CATI,
in an attempt to further improve the accuracy of the data (194). Approximately 64% of
participants (n=7735) completed the second 24-hour recall.
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Table 2.1 Five phases of the modified Automated Multiple Pass Method used
within the 2011-12 NNPAS (194)
Phase

Details

1. Quick list

Respondents asked to provide a quick description of foods
consumed in past 24 hours.

2. Forgotten foods

Questions asked to prompt recall of omitted foods, specific food
groups targeted include beverages, alcohol, sweets, savoury
snacks, fruit, vegetables, cheese and bread/bread rolls.

3. Time and
occasion

Respondents asked the time and name of each eating occasion
e.g. 8am, breakfast.

4. Detail cycle

Respondents asked for details including the amount consumed,
source (e.g. homemade), preparation method, type of fat, brand
names, additions to food (e.g. salt).

5. Final probe

Final opportunity for respondents to remember previously
forgotten foods.

Estimating habitual intake from short-term data: Multiple Source Method
Multiple Source Method (MSM) is an online programme used to estimate usual dietary
intakes based on dietary data collected from two or more short-term measurements such
as 24 hour recalls or food records (208). The method uses two logistic regression models;
the first to estimate the individual’s probability of intake of the nutrient on any day, and
the second to estimate the individual’s actual intake on consumption days. The two
models are then multiplied to give an estimation of usual intake. The method allows
users to add covariates assumed to be predictive of consumption such as age and gender
to the model. Further details of the method have been described elsewhere (209).

The usefulness of MSM has been established previously, where it proved to be a
reliable tool for estimating habitual intakes of episodically-consumed foods (210). Intake
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of such foods or nutrients may be underestimated if a more simple measure such as a
mean value is used. The MSM program was utilised within this thesis to estimate
habitual dietary intakes within the NDNS RP 2008-14, based on the estimated 4-day
food records. This was deemed the most robust method of establishing an estimate of
habitual intake for the purposes of analyses, particularly as there was a sizeable
percentage of non-consumers of whole grains over the 4-day period. Unfortunately,
MSM could not be used for the analysis of the AHS 2011-13, as access to this data was
only granted to the candidate for use on-site at the ABS DataLab. The ABS prohibits
internet access within the DataLab as part of data confidentiality protection, meaning
the candidate was unable to access the MSM program for use with the data.

2.2.4 Food composition databases
In order to gain insight into the nutritional composition of diets, dietary intake data
needs to be readily converted into nutrient intake data. Food composition databases
(FCDBs) are widely used for this purpose, as they contain data on the energy, nutrient
composition and in some cases even bioactive substances, additives and contaminants
of foods consumed by a specific population. In combination with dietary intake data,
they may be used in clinical practice to analyse an individual’s dietary intake and
prescribe a therapeutic diet, or in a public health setting to assess the nutritional
adequacy of a target group (211). Other uses of FCDBs include to develop food-based
guidelines, formulate health policy, estimate adequacy of the food supply, and to plan
institutional diets (212; 213).

Nutrient data within FCDBs can be sourced in a few ways: using the direct method, the
indirect method, or a combination method (212). The direct method is used when all
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nutrient values have been obtained from analyses performed specifically for the
database being compiled. In contrast, the indirect method does not use chemical
analyses but rather obtains data from published literature or laboratory report, whereby
values may be imputed, calculated or borrowed. Imputed values are estimates derived
from a similar food or another form of the same food that have been chemically
analysed (e.g. values for boiled used for steamed) or from partial analyses of a food
(e.g. chloride values imputed from sodium values). Calculated values are estimated
from standard recipes, taking into account ingredient proportions and corrected for
preparation factors such as water loss. Borrowed values may have been taken from other
databases or tables, sometimes internationally. Most FCDBs are compiled using a
combination of direct and indirect methods, known as a combination method. The
combination method may be the most effective compromise between quality and cost as
staple foods may be analysed directly, while less frequently consumed foods can be
estimated using indirect methods (212).

FCDBs are a valuable and relatively cost-effective tool for estimating nutrient intakes,
particularly of a population or group. However, it is important for users to understand
their limitations. Firstly, there is some within-food variation in nutrient composition that
cannot be accounted for in FCDBs, which can only provide a single set of nutrients for
each food item. This is particularly true for plant foods in which seasonal variation can
considerably affect micronutrient and bioactive substance content (213). It is therefore
important that values obtained from FCDBs are always treated as estimates of nutrient
content. In situations where exact measures are required, such as metabolic studies, a
direct analysis of the food being consumed is recommended (212).
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Another limitation of FCDBs relates to their use over time. Given the enormity of the
food industry and the increased consumption of processed foods globally (214), products
are almost constantly undergoing reformulation, which is difficult for FCDBs to keep
up with, and could present some inaccuracies when applying a database that is even just
a few years old to current dietary intakes. For nutrients such as dietary fibre this may be
especially relevant, as fibre is commonly added to the increasing variety of functional
foods available (215). Similarly, new products are constantly being added into the food
supply, which may be missed by dated databases. While it is recommended that if
FCDBs are intended for ongoing use, they are managed and updated over time to reflect
these changes, the speed at which this can be done is often not fast enough to capture all
changes, which may further hinder the accuracy of estimations (212).

It is also important that researchers, clinicians or anyone intending to use FCDBs are
adequately trained in how to properly do so, particularly in selecting appropriate foods
within databases. Users may not be aware of the considerable difference in nutrient
values between two identical foods cooked or prepared in different ways. For example,
if a user were to consult the nutrient values for a raw food rather than a cooked food, the
resulting nutrient information obtained would be inaccurate and may result in findings
that are unrepresentative of the diet studied (212).

Lastly, FCDBs are not easily adaptable across countries, not only due to variation in
manufactured foods available, but even due to variation in cultivars, soils, climates and
agricultural practices, as well as different technological practices and fortification levels
used (211). Therefore, it is ideal that nations prioritise development of their own national
FCDB, and have in place an established programme to manage this data (188). While the
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limitations listed above mean that development of a complete FCDB that covers all
foods eaten within a population is not possible, the usefulness of the database can be
maximised if it accurately reflects the main foods consumed by the specific population
(215)

. Within this thesis, two FCDBs have been utilised, the UK Nutrient Databank and

the AUSNUT 2011-13, designed for estimation of nutrient intakes within the NDNS RP
and the 2011-13 AHS, respectively. Expansions of these databases, detailing the whole
grain and cereal fibre content of all foods consumed within the surveys, were used to
explore how diets containing varying amounts of these grain food components may be
associated with CVD risk factors. The two databases will be discussed in more detail
below.

UK Nutrient Databank
The UK Nutrient Databank is a FCDB containing information on the content of 59
nutrients in foods frequently consumed within the UK, enabling calculation of nutrient
intakes from consumption data. The databank was initially developed for the 1990
Dietary and Nutritional Survey of British Adults, and has been updated over time for
additional national dietary surveys including the NDNS RP, most recently updated for
the latest survey, the NDNS RP 2015-16 (216). The databanks are archived within the UK
Data Service alongside the NDNS RP surveys (217), where access to both can be
requested.

Nutrient data included in the databank is similar to that found in published UK FCDBs
such as McCance and Widdowson’s The Composition of Foods (218) but includes a
larger and up to date range of processed foods and mixed dishes. Data within the
database is sourced predominately in three ways; nutrient analyses, food manufacturers
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and label information, and recipe calculations for mixed dishes. Similarly to the
AUSNUT database, if reliable data could not be sourced in any of these ways, it were
estimated from similar foods (216). As the NDNS RP is a continuous survey conducted
yearly, it is imperative that the databank is able to accurately reflect the composition of
the foods reported within each new survey, within the inherent limits discussed earlier
in this section. To ensure this, yearly updates of the databank to add new foods and
revise existing foods are carried out by PHE (216).

As there were no previously published food composition data describing the whole
grain and cereal fibre content of foods within the UK Nutrient Databank, this data
needed to be created by the thesis candidate before analysis of the NDNS UK RP could
commence. Whole grain and cereal fibre content of each food item listed within the UK
Nutrient Databank was estimated based on standard recipes held within the Food
Standards Agency Standard Recipe Database (219), and then applied to intakes over the
six years of the NDNS RP included in analysis. The Recipe Database is compatible with
the Nutrient Databank as they both use the same food identification codes.

At the time of data development, the candidate was placed at the University of
Cambridge as a visiting student, based at the MRC Elsie Widdowson Laboratory (EWL)
(formerly MRC Human Nutrition Research). The MRC EWL was the largest research
institution in the UK for human nutrition, with responsibility at the time of placement to
manage and update the UK Nutrient Databank (216). The candidate was able to receive
direct support and assistance from the food composition team in development of the
whole grain and cereal fibre food composition data, as well as applying the data to
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estimate participant intakes. Detailed information on the development of the whole
grain and cereal fibre food composition data has been described in Chapter 4.

AUSNUT 2011-13
The AUSNUT 2011-13 is a FCDB containing data for 53 nutrients in 5740 foods
consumed within the 2011-13 AHS, developed for estimating food, supplement and
nutrient intakes within the survey (220). The database, developed by FSANZ, is publicly
accessible online (220). AUSNUT 2011–13 uses a combination method, incorporating
data from a range of sources. Analytical data, taken directly from the Australian
reference FCDB at the time, NUTTAB 2010, were available for the majority of nutrient
values for 1342 food items within the initial database (215). Beyond this, nutrient values
for food items reported within the survey were derived using recipe calculations,
imputation based on similar food items, taken from label data or manufacturer
information or borrowed from international FCDBs or the previous survey database
AUSNUT 1999, with amendments made where necessary (220). To ensure transparency
and help users identify how nutrient data was sourced, each item listed in the AUSNUT
2011-13 is coded as to indicate how the majority of nutrient data were derived.

As the AUSNUT 2011-13 was developed solely for the 2011-13 AHS, it is the most
appropriate database to use for estimating intakes within this survey. It includes all
analytical data contained within NUTTAB 2010, as well as additional nutrient profiles
that were developed for new foods reported within the survey (221). Unlike the reference
database, it contains complete nutrient data for all foods items included.
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While the AUSNUT 2011-13 is not typically updated or intended for use beyond the
2011-13 AHS, it was recently updated in 2016, highlighting the continued use of the
survey data for secondary analysis purposes. This update saw the inclusion of data on
added sugars and free sugars in all listed foods to allow analyses of these nutrients,
likely reflecting increased attention to sugar intake. In brief, to obtain these values
estimations were made using analytical data for total sugars and known ingredients in
food products, as well as recipes where required. Further details on the method used is
provided by FSANZ (222).

Unlike the NDNS RP, expansions of the AUSNUT 2011-13 database estimating whole
grain and cereal fibre contents of all 5740 included foods, the latter of which was
developed previously by the thesis candidate, were already available, and used within
this thesis to estimate whole grain and cereal fibre intakes, respectively, of participants
within the 2011-13 AHS (215; 223). In brief, whole grain and cereal fibre content of all
foods was estimated to the nearest 0.1g per 100g using a systematic approach. In the
first instance, the AUSNUT 2011-13 Food Recipe File (224) was used to disaggregate
mixed foods into their individual ingredients. Whole grain and cereal fibre content of
individual ingredients could then be estimated and applied proportionately to mixed
foods. In the absence of a recipe contained within the Food Recipe File, nutrition labels,
input from manufacturers, or standardised recipes were utilised to estimate contents.

2.2.5 Outcome measures for CVD: use of intermediate level risk factors and related
conditions
It is often difficult to accurately measure relationships between diet and disease
morbidity or mortality due to insufficient study duration and cost, particularly in young,
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healthy populations. However, there are usually several related characteristics or
conditions that have been established as predictive of risk of the disease of interest,
known as risk factors, which may demonstrate a diet-disease relationship independently.
Exploration of diet-affected risk factors in place of the disease of interest is therefore
useful as a more cost-effective alternative, requiring shorter study duration and smaller
sample size (225).

Analysing dietary associations through risk factors may offer additional benefits beyond
efficiency. Diet-disease relationships occur through mechanisms involving causal
intermediate-level risk factors. For example, oats may be protective against CVD
through the effect of β-glucan soluble fibre on lowering LDL and total cholesterol (122).
Exploring the associations to these risk factors is therefore important to provide insight
into the potential myriad of pathways comprising the diet-disease relationship.
Traditional diet-affected risk factors for CVD include hyperlipidaemia (total cholesterol,
HDL-cholesterol, LDL-cholesterol and triglycerides), high blood pressure, glucose
intolerance and diabetes status, and obesity (BMI, waist circumference)(7; 8; 226). Beyond
this, additional risk factors are continuing to be explored for their potential significance
to CVD risk, with varying strength of evidence currently available. A non-exhaustive
list of CVD risk factors is provided in Table 2.2.
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Table 2.2 Selected diet-related risk factors/biomarkers of CVD. Adapted from
Stampfer (2004) (226).
Risk factor
/biomarker

Example

Traditional risk
factors

High blood pressure/hypertension, glucose intolerance/T2DM,
hyperlipidaemia (total cholesterol, LDL-c, HDL-c,
triglycerides), obesity (BMI, waist circumference, body fat %)

Non-traditional
lipid markers

Lipoprotein(a), apolipoprotein-A, apolipoprotein-B

Markers of
inflammation

High-sensitivity C-reactive protein, interleukin-6

Markers of
haemostasis

Homocysteine, fibrinogen

Markers of
oxidation

Glutathione

Within this thesis, CVD risk factors were utilised to explore CVD risk in both the SLRs
and the secondary analysis of national survey data. Inclusion criteria within the SLRs
allowed for studies assessing whole grain and cereal fibre/bran intake in association to
CVD risk factors to support available observational evidence examining CVD mortality
and morbidity. Additionally, studies reporting morbidity of related conditions, Type 2
diabetes and hypertension, were also included in the inclusion criteria.

Pertaining to the nature of secondary data, analyses was limited to what were measured
within the initial survey, so not all potentially valuable CVD risk factors could be
explored within our studies. The two survey analyses explored here include a range of
CVD risk factors, including some more novel factors. Both surveys recorded blood
pressure, lipid profile, blood glucose levels, measures of obesity, and high sensitivity
CRP. Within the NDNS RP, data were available on serum homocysteine levels, found
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to be independently associated with lower risk of CVD (227), although it is currently
unclear whether this is causal (100). Conversely, within the AHS, data were also available
on apolipoprotein-B, a lipoprotein biomarker found to significantly improve risk
prediction for CVD events when controlling traditional lipid markers (228).

Analysis of risk factors can reveal valuable insight into the diet-disease relationship of a
disease that is difficult to directly examine, usually due to impractical study duration
and cost required. They are particularly important in CVD, which is a collective term
encompassing multiple conditions and relevant pathways. However, there are
limitations that need to be considered. While a risk factor may independently predict
CVD risk, this does not inherently imply that it is a direct causal factor in the protection
against CVD, as instead, it may be a marker for the actual causal factor. Therefore
associations between dietary exposures and CVD risk factors, particularly novel risk
factors that are continuing to be explored, need to be interpreted with caution in relaying
any implication for risk of CVD event. Moreover, risk of CVD event is best predicted
by multiple risk factors (229), and so use of a combined risk factor score, as utilised
within Chapter 4 of this thesis, may be more useful at evaluating the most impactful
associations, rather than only singular risk factors .

2.2.6 Qualitative methods: exploring factors affecting consumption
The research methods discussed so far can explore how higher whole grain and cereal
fibre intake may be beneficial, as well as how much populations are currently
consuming. However, irrespective of research on health outcomes, or risk factors, these
studies do not inform researchers, policy makers and health professionals why current
consumption levels are low or, or how these may be improved. In order to consider the
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most impactful strategies to encourage consumer intake of healthful grain foods (to
improve intake and assist in improving health outcomes), a deeper understanding of the
factors influencing grain food choice is required. To explore this, qualitative research is
a valuable tool. Within this thesis, focus groups were utilised to explore factors
affecting grain food intake, including perceptions, understanding and acceptability of
whole grains and high-fibre grain foods (added-fibre refined grain products).

Within healthcare research, utilisation of focus groups is one of the most common
qualitative data collection methods used (230). A focus group is a form of group
interview, with importance placed on participant interaction and engagement. The idea
is that group discussion facilitates participant communication and assists in exploration
of attitudes and perceptions, resulting in information obtained that is greater than the
sum of what is individually expressed by each group member (230). There are several
factors to consider when designing focus groups, including the sample size and
composition of groups, the discussion questions, and the method of data analysis.

There is no formula to specify the necessary number of participants or groups in focus
group research. Instead, ongoing analysis of data from groups will reveal the
appropriate endpoint, at which repeated ideas are being expressed in new groups, and no
new information is emerging (230). This point is known as saturation of data, and new
groups should continue to be created until this point is reached, as occurred within this
thesis. When attempting to gain insight into the perceptions of broad populations using
relatively small samples, it is important that the total sample reflects the diversity of this
population and the multiple viewpoints that may be held. A maximum variation
sampling technique can aid in efforts to increase heterogeneity of a small sample. This
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technique is a form of purposive sampling which involves deliberately targeting cases
that are as different as possible, including underrepresented or ‘extreme’ demographics
(231)

. For example, in the case of grain choices, people from differing socioeconomic

backgrounds and of different ages may have diverse determinants that need to be
captured. Although this technique is helpful to capture a diverse overall sample, it is
suggested that individual focus groups are kept relatively homogeneous and small,
containing within 4-8 participants, recommended for facilitating open discussion and
engagement (230; 232).

Discussion questions used within focus groups should be open-ended but directed, and
encourage participant involvement, such as through use of reflection, choices, and rating
scales (233). The questions should proceed logically, and generally flow from general
questions to more specific questions (234). Within this thesis, use of open-ended, semistructured discussion questions provided a basic framework while allowing flexibility to
explore themes that were introduced by focus group participants.

Qualitative data can be analysed using a variety of methods. Thematic analysis was used
within this thesis to analyse focus group data. Thematic analysis is the process of
identifying and interpreting themes within qualitative data. Unlike many qualitative
analysis methods (e.g. grounded theory), it is not tied to one specific theoretical
perspective, and can be applied in several ways using a variety of approaches (235). This
also makes thematic analysis a more accessible method for researchers who are less
familiar with qualitative research, and do not have the detailed theoretical knowledge
required for other qualitative approaches (236). While this flexibility can be advantageous
for researchers, it can also result in some confusion regarding analysis and how to
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ensure theme generation is consistent and methodologically sound, particularly for
novice researchers (237). Therefore, to aid thematic analysis conducted within the current
thesis, Braun and Clarke’s six phases of thematic analysis (235) was followed, as outlined
in Table 2.3.

Table 1.3 Six phases of thematic analysis. Adapted from Braun & Clarke (2006)
(235)

Phase
1. Familiarise
yourself with the
data

Description

2. Generate initial
coding

Code interesting features of data systematically across the
entire data set.

3. Search coding for
themes

Collate codes into potential themes, gathering all data relevant
to each potential theme.

4. Review themes

Cross-check the themes are cohesive with the coded extracts
(step 1) and the entire data set (step 2), generating a thematic
‘map’ of the analysis

5. Define and name
themes

Refine the specific themes through ongoing analysis and name
and define each theme.

6. Produce final
report

Select compelling extract examples, analyse final extracts in
relation to the research question and literature, and report the
final findings.

Read and re-read transcribed data, noting initial ideas.

Focus group research is useful for a richer understanding of attitudes, perceptions and
beliefs of a target population. However, there are some limitations that must be
addressed. While sampling techniques can be utilised to enhance the diversity of views
represented, participation in focus groups is voluntary, and in the current thesis no
monetary incentive was provided. It is possible that people with a greater personal
interest in the specific topic of the focus group are therefore more likely to participate, a
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challenge to the representativeness of the sample that must be considered in
interpretation of findings. Focus group discussions may also be susceptible to social
desirability bias, whereby participant’s opinions may be influenced by dominant
participants or presence of the moderator (234), so it is imperative that moderators
employ techniques to overcome this through both the nature of the questions posed and
moderation of resulting discussion.

2.3 Conclusion
Through the methods described, this thesis aims to explore the cardiovascular health
associations of diets high in whole grain and high in cereal fibre, and consider the most
effective strategies to encourage consumption of healthful grain foods, taking into
account potential health benefit in combination with consumer perceptions and
attitudes. Each method included within this thesis serves a fundamental role in
addressing the overarching hypothesis that although whole grain foods may provide
some additional CVD protection beyond cereal fibre, high cereal fibre is independently
associated with favourable CVD outcomes, and added fibre grain foods may be received
more openly by consumers than whole grain foods, particularly when an aversion to
whole grain sensory properties exist. An overview of each method has been detailed
within this chapter to outline and justify the overall methodological framework used
within this thesis. Beyond this, individual study chapters (Chapters 3-7) will provide
further detail of the specific methods used for each study.
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Chapter 3a:
Effects of whole grains, bran and cereal fibre on CVD
risk factors: a systematic review of interventional trials
&
Chapter 3b:
Whole grain, bran and cereal fibre consumption and
cardiovascular disease: a systematic review

A major component of this chapter (3b) is the substantive content of the published article:

Barrett, EM, Batterham, MJ, Ray, S, and Beck, EJ. (2019) Whole grain, bran and cereal fibre
consumption and CVD: a systematic review. British Journal of Nutrition, 121: 914-937.

92

3.1 Introduction
As described in Chapter 1, whole grain intake is associated with reduced risk of CVD
(28)

, the leading cause of death worldwide (1), and evidence suggests this amelioration is

likely through modulation of dietary related risk factors including hyperlipidaemia,
hypertension, diabetes and obesity. Whole grains are a rich source of cereal fibre, and
also contain an abundance of other healthful constituents including vitamins, minerals
and phenolic compounds. Their high cereal fibre content may be particularly valuable
for cardiovascular health, although it is currently unclear to what extent cereal fibre
alone is responsible for the reduced risk of CVD found for whole grains.

As the bran component of the grain, removed within the refining process, contains the
overwhelming majority of cereal fibre as well as these other constituents within the
aleurone layer, comparing whole grain to refined grain intake does not provide clear
evidence to address this question. Instead, research needs to compare the effects of
whole grain intake with those of cereal fibre intake specifically. There is value in
examining bran intake as a third comparison in addition to cereal fibre, as there is
further question as to whether the constituents confined within the bran component,
including but not limited to cereal fibre, are responsible for the CVD protective effects
attributed to the whole grain.

The first step in exploring this question is to evaluate the current body of evidence
comparing whole grain, bran and cereal fibre intakes and CVD risk. Therefore, the aim
of Chapter 3 was to systematically review the evidence directly comparing whole grain
intake to bran or cereal fibre intake and risk of CVD and CVD related outcomes,
including dietary related risk factors such as hyperlipidaemia, hypertension, impaired
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glucose metabolism and obesity. Chapter 3a reviews the interventional evidence and
Chapter 3b reviews the observational evidence.

3a.1 Interventional evidence
In order to determine differential effects between whole grain, bran and cereal fibre
intakes and CVD risk, it is imperative to consider interventional evidence, particularly
that from RCTs. RCTs are regarded as the ‘gold standard’ of study designs (238), and are
able to draw causal inferences regarding relationships between dietary exposures and
health outcomes. For this reason, an examination of interventional evidence was the
starting point for this thesis.

3a.2 Methods
This systematic literature review was completed in accordance with the PRISMA
guidelines (182). The details of the review were recorded and registered with PROSPERO
(International Prospective Register of Systematic Reviews,
http://www.crd.york.ac.uk/PROSPERO), registration number CRD42017069226, prior
to commencement. It should be noted that this PROSPERO registration also covers a
systematic literature review of observational studies (Chapter 3b). The decision was
made to separate the two reviews due to wide disparity between short-term and longterm exposure.

3a.2.1 Inclusion and exclusion criteria
To be included within this review, studies must have considered whole grain intake
compared to cereal fibre and/or bran intake, in association to specific CVD related
outcomes in humans. CVD related outcomes included anthropometric measures (body
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mass index, body weight, waist circumference or central adiposity), lipid profile
constituents (total cholesterol, HDL-cholesterol, LDL-cholesterol or triglycerides),
blood pressure measures (systolic or diastolic), blood glucose measures (fasting,
postprandial or HbA1c) and C-reactive protein levels. Results were limited to full texts
published in English and contained within peer-reviewed journals. There were no
restrictions on time of publication.

3a.2.2 Exposure and comparison
At least one group of participants must have been consuming whole grains as part of the
study. Whole grain intake could have been in intact, native form (e.g. barley grains) or
processed form (e.g. oatmeal, whole grain rye bread). The pseudo cereals quinoa,
buckwheat and amaranth were included as acceptable whole grain sources.
Interventions that included a range of foods other than whole grains (e.g. dietary pattern
studies) were excluded, unless the effect of the whole grains could be separated.

At least one alternative group of participants must have been consuming bran or added
cereal fibre from the same grain variety as the whole grain exposure. For example, if the
whole grain exposure was oatmeal, the study must also have included oat bran or added
oat fibre as a comparison arm. Studies that only included a different grain variety
comparison (e.g. oatmeal vs. wheat bran) were excluded. Studies that included only a
refined grain comparison (e.g. whole grain wheat bread vs. white wheat bread) were
also excluded.
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3a.2.3 Study design
Only intervention trials were included within this review. Studies could use a cross-over
or parallel design. Treatment phase of studies must have continued for a minimum of 2
weeks, therefore excluding short-term meal test studies. A summary of participants,
exposure, comparisons, outcomes and study design is presented in Table 3.1.

Table 3.1 PICOS criteria for inclusion and exclusion of interventional studies
Parameter

Description

Population

Males and female humans of any age, health status,
socioeconomic status or geographical location

Intervention

Whole grain intake, whether in intact, ground or processed form.

Comparison

Bran or added cereal fibre from the same grain variety as
intervention

Outcomes

Effects on any lipid constituent, blood glucose, blood pressure,
anthropometric measurements or C reactive protein

Study Design

Intervention studies

PICOS, population, intervention, comparison, outcomes, study design

3a.2.4 Search terms and strategy
Relevant journal articles published before December 2018 were identified from four
medical databases: PubMed, MEDLINE, CINAHL plus and CENTRAIL in Cochrane
Library. The following keywords were used: “whole grain” OR wholegrain OR oat* OR
rice OR wheat OR barley OR millet OR quinoa OR buckwheat OR amaranth OR maize
OR sorghum OR rye OR corn AND bran OR fibre OR fiber AND cholesterol OR
dyslipid* OR hyperlipid* OR lipid* OR triglycerides OR weight OR “body mass
index” OR BMI OR “waist circumference” OR adiposity OR obes* OR “blood
pressure” OR hypertension OR systolic OR diastolic OR “blood glucose” OR HbA1c
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OR CRP OR “c-reactive protein” OR cardiovascular. The full search strategy
(MEDLINE) has been presented in Appendix 1.

Potentially relevant studies were screened by title and abstract by one author (E.M.B).
After exclusions by title and abstract, the full text of remaining articles were reviewed
by one author (E.M.B) and confirmed by a second author (E.J.B). The reference lists of
included articles were hand-searched for additional relevant studies, and grey literature
was searched.

3a.2.5 Data extraction
Data was extracted and summarised in table format by one author (E.M.B) and
reviewed by a second author (E.J.B, PhD supervisor). The summary table (Appendix 3)
includes first author’s last name and publication year, population and country of study,
mean age of participants, any baseline conditions of participants, study design and
duration, diet of participants, whole grain exposure characteristics, comparison
characteristics, measurement of effect, outcomes tested and results including statistical
significance.

3a.2.6 Quality assessment
Study quality was assessed using the Cochrane Collaboration’s tool for assessing risk of
bias (184). Three investigators (E.M.B, E.J.B and K.K, research assistant) independently
assessed whether each of the following domains would present low risk, high risk or
unclear risk of bias: random sequence generation and allocation concealment; blinding
of participants and personnel and blinding of outcome assessment; incomplete outcome
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data; and selecting reporting. Differences in assessment were resolved and consensus
was reached.

A meta-analysis was performed on studies comparing the effects on total cholesterol
levels and initially included within this systematic review. However, due to the
heterogeneous nature and limited number of total studies, the meta-analysis component
was not considered an impactful addition to the results presented here, where data has
been examined and synthesised qualitatively by CVD-related outcome assessed.
Instead, further details of the meta-analysis performed, including methods and results,
has been included in Appendix 2.

3a.3 Results
Our search strategy returned 2369 articles (Figure 3.1). Duplicates were removed,
leaving 1587 articles for title and abstract screening. After screening by title and
abstract, 37 articles remained for full text review. Of these, 22 articles were excluded as
meal test studies with insufficient treatment period length (<2 weeks), six articles did
not include a whole grain exposure and two articles included a whole grain exposure
that could not be separated from other dietary exposures (bran; general low glycaemic
index meal plan). One full text was not published in English, and one article was a
conference abstract only. Five studies, all RCTs, remained for analysis. A full summary
of these studies is presented in Appendix 3.
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2369 records identified through
database searching
PubMed n=1205
MEDLINE n= 255
CINAHL plus n= 107
CENTRAL in Cochrane library n= 802

782 duplicates removed

1587 records screened by
title/abstract

1552 records excluded

37 full-text articles assessed for
eligibility
32 full-text articles excluded
•
•
•
•
•

< 2 week treatment period (n=22)
Conference abstract (n=1)
No full text available (n=1)
No whole grain exposure (n=6)
Whole grain cannot be separated from
other dietary exposures (n=2)

5 studies remained for inclusion
in review

Figure 3.1 Flow diagram of interventional study selection process
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3a.3.1 Study characteristics and design
Characteristics of studies have been outlined in Table 3.2. Of these five articles, four
described RCTs comparing whole grain with bran (115; 239; 240; 241). While the first three
studies tested bran in its natural form as oat bran (115; 241) and wheat bran cereal (239), the
fourth study tested whole grain rye bread compared to white wheat bread with added
bioprocessed rye bran (bioprocessed with enzymes and yeast to enhance nutrient
availability) (240). As the bran comparison was from the same grain as the whole grain
exposure (rye), this was considered acceptable. The fifth RCT described a study
comparing a 50% whole grain wheat product with a 50% whole grain wheat with added
arabinoxylan-rich (AX) wheat fibre (123). Three of five studies also included an
additional comparison or control group, which were a farina wheat control (115); a white
wheat bread control (240) and a no oat product control (241).

In three studies, both whole grain intake and bran intake was prescribed as between 24g
and 84g per day (115; 239; 241), with one study assessing effects at 28g, 56g and 84g in a
dose-response analysis (115). Two studies determined prescribed intake based on
participants individual energy requirements (123; 240). Participants were advised to
consume 6-10 slices of whole grain rye bread or added rye bran bread (25-30g/slice;
10% dietary fibre for both breads) each day in one study (240), and 4-5 slices of bread
and 1-2 muffins made from 50% whole grain wheat with or without added wheatderived AX fibre per day (123).

All five included studies measured total cholesterol and triglycerides as a study outcome
(115; 123; 239; 240; 241)

. HDL-cholesterol was measured in four studies (115; 123; 239; 241), while

LDL-cholesterol was measured in three studies (115; 123; 241). Three studies measured
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fasting glucose (123; 239; 240), and only one also measured 2-hour post prandial glucose
(123)

. Body weight and fat mass were measured in two studies (123; 240). Systolic and

diastolic blood pressure were only measured within one study (123) .
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Table 3.2 Characteristics of included interventional studies
CVD-related outcomes examined
Study

Comparison

Grain

TC

TAG

HDL

LDL

Costabile 2008 (239)

Bran

Wheat







Davidson 1991 (115)

Bran

Oat







Lappi 2014 (240)

Bran

Rye





Van Horn 1986 (241)

Bran

Oat









Lu 2004 (123)

Cereal fibre

Wheat









Fasting
glucose

2hr PP
glucose

Adiposity
BP
measures















TC, Total Cholesterol; TAG, triglycerides; PP, post-prandial; BP, blood pressure.
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Total study length ranged from ten to twenty weeks, while treatment phase ranged from
three to six weeks. Three studies were of cross-over design, and therefore had two
treatment phases each (123; 239; 240), while two were of parallel design (115; 241). Two
studies compared treatments in a low-fat diet background, beginning with either a six
week (241) or eight week (115) low-fat dietary phase which continued into treatment.

Sample size within studies ranged from 15 to 208 participants, and all studies included
participants of both sexes. Two studies were conducted in the United States (115; 241), one
in the UK (239), one in Australia (123) and one in Finland (240). Two studies were
conducted with healthy participants (239; 241), while the other three studies had a specific
selection criteria (impaired lipid profile (115), self-reported gastrointestinal issues after
grain consumption (240), and type-2 diabetes (123)). Overall, data from 415 participants
were included in this synthesis.

3a.3.2 Quality assessment
Quality assessments showed some potential for bias in the studies (Figure 3.2) Only one
study specified the randomisation technique used (240), and no studies provided
sufficient information regarding any concealment of allocation sequencing. Only one
study, which performed double blinding (239), was deemed low risk of performance bias.
Two studies that performed single blinding (participant-blinded) (115; 123) were deemed
unclear risk of performance bias. One study did not specify whether any blinding had
occurred (240), while another implied no blinding occurred, as participants were provided
recipes and dietary counselling to incorporate the treatment food into their diets (241).
Both studies were considered a high risk of performance bias. Three of the five studies
(115; 123; 240)

did not report whether blinding of outcome assessors had occurred, however
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as all outcomes examined were objective, detection bias was considered unclear risk for
these studies rather than high. Three studies (123; 239; 240) were considered low risk for
attrition bias, while two were unclear (115; 241) due to limited information regarding
missing data provided. Four studies presented unclear risk for reporting bias (115; 123; 239;
241)

, due predominantly to unavailability of study protocols. One study was deemed high

Low risk
Selective reporting

Incomplete outcome data

Blinding outcome assessment

Blinding participants/personnel

Allocation concealment

Random sequencing

Study

risk due to missing outcome data based on protocol (240).

Unclear risk
High risk

Costabile 2008 (236)
Davidson 1991 (112)
Lappi 2014 (237)
Van Horn 1986 (238)
Lu 2004 (120)

Figure 3.2 Quality assessments using Cochrane Risk of Bias tool

3a.3.3 Intervention effects
Blood lipids
Of the five studies assessing the total cholesterol response to the intervention, four
studies found statistically significant results (115; 239; 240; 241). Higher intakes of oatmeal
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(whole grain food) (84g/d) resulted in a 7.7% reduction (P=0.02) in total cholesterol
compared to non-oat, non-whole grain controls in one six week study (115). Higher
intakes of oat bran (56-84g/d) also significantly reduced total cholesterol from 7.3 to
10.0%, with the 56g/d dose proving the most effective (115). At lower intakes (28-56g/d
oatmeal, 28-39g/d oat bran) there were reductions ranging from 2.8 to 4.1%, although
only one of these reductions was statistically significant, after a 6 week treatment of
35g/d oatmeal (P=0.038) (241). Reductions were more pronounced for both oatmeal and
oat bran in the sample of hyperlipidaemic participants compared to healthy participants.
Similarly, in a shorter study (3 weeks) of healthy participants there were significant
differences in total cholesterol after whole grain wheat and wheat bran breakfast cereal
treatments at 48g/day doses, but only among participants in the highest quartile of total
cholesterol concentrations (n=8). Here, reductions in total cholesterol of 24.4% and
21.4% were observed after whole grain and bran breakfast cereal consumption,
respectively (239). While not significantly different to white wheat control bread, whole
grain sourdough rye bread consumption resulted in significantly lower total cholesterol
compared to white wheat bread with added rye bran in a 4 week crossover trial
(P=0.006) (240). No difference in total cholesterol was found after treatment with whole
grain wheat products with and without added wheat fibre in a 5 week trial of
participants with T2DM.

Only one of three studies showed significant reductions in LDL-cholesterol following a
whole grain, bran or added cereal fibre treatment (115). In the six week study of 140
hyperlipidaemic participants, oatmeal supplementation of 84g/day reduced LDL
cholesterol levels by 10.9%. Oat bran supplementation of 56g/day and 84g/day reduced
LDL cholesterol by 16.4% and 11.9%, respectively. In the same study, similar effects to
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those seen for total cholesterol were found, whereby lower intakes of oatmeal and oat
bran (28-56g/d) showed modest reductions in LDL-cholesterol (4.3-6.5%), but these
were not significantly different from the non-oat control group. There were no
significant differences in LDL-cholesterol reductions between oatmeal and oat bran
treatments (35g and 39g/d, respectively) or no-oat control in a 6 week trial of 208
healthy participants (241), nor after intervention with whole grain wheat products with
and without added wheat fibre in a smaller study of 15 participants with T2DM (123).

None of the five studies included within this review found a significant difference
between whole grain treatments and bran or added fibre treatments on HDL-cholesterol
or triglycerides levels.

Blood pressure
Only one included study, of fifteen participants with T2DM, measured response in
systolic and diastolic blood pressure after treatment (123). No differences were found in a
5 week trial after intervention of whole grain wheat products with and without added
wheat fibre.

Blood glucose
One of three studies assessing blood glucose measurements post-treatment found
significant effects. The study of 15 participants with T2DM found a 7.9% reduction in
fasting glucose and an 11.8% reduction in 2-hour postprandial glucose following daily
consumption of whole grain wheat products with added wheat fibre for five weeks (123).
Daily consumption of whole grain wheat products without added wheat fibre did not
significantly affect either blood glucose measurement within this study. There were no
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differences in blood glucose levels in metabolically healthy participants found after a 3
week trial of whole grain wheat or wheat bran breakfast cereal treatments (239), nor a 4
week trial of whole grain rye or added rye bran breads (240).

Body weight measures
Two included studies assessed the effects of whole grain and bran or added cereal fibre
on body weight measures over four and five week periods (123; 240), but neither study
found any differences after treatments on body weight or fat mass.

3a.4 Discussion
The present systematic review of five intervention studies involving 415 participants
assessed the evidence for whole grain intake compared to bran or cereal fibre intake on
risk factors of CVD. Here, a similar effect was observed between whole grain and bran
intake and total cholesterol and LDL-levels. It is thought that β-glucan, a
predominantly-soluble fibre in high amounts within the bran component of grains such
as oats and barley, plays a major role in reducing blood cholesterol. As a soluble fibre,
β-glucan might reduce cholesterol concentrations by inhibiting intestinal uptake of
dietary cholesterol, as well as preventing reabsorption of bile acid (58). This causes the
body to utilise circulating cholesterol to produce new bile acid, resulting in reduced
levels of cholesterol in the blood. It was therefore not unexpected that reductions in total
cholesterol and LDL-cholesterol were found in both oat studies. While the LDLcholesterol reductions did not always reach significance, this may have been due to
insufficient statistical power to detect smaller differences. Further, oat products were
provided partly through baked products such as muffins within included studies, which
have been found to lower the molecular weight (MW) of the β-glucan (through β107

glucanase activity from flours) which lowers viscosity of the fibres thereby blunting the
effects (242).

As β–glucan is contained in the bran component of oats, and oat bran is therefore richer
in β–glucan than whole grain oatmeal, this could suggest that a greater reduction in
blood cholesterol might be expected after oat bran intake compared with the same
amount of whole grain oatmeal intake. However, this was not consistently evident
within the two studies with oat-based interventions. In one of these studies, greater
reductions in total and LDL cholesterol were found with bran intake than whole grain
intake (115). While 56g per day of oatmeal (2.4g β –glucan) did not have a significant
effect on total cholesterol, 56g per day of oat bran (4.0g β –glucan) did, and as did 84g
per day of oatmeal, providing 3.6g β –glucan. However, interestingly, bran intakes at
56g (4.0g β –glucan) per day resulted in greater decreases in total and LDL cholesterol
than bran intakes at 84g (6.0g β –glucan) per day, suggesting a non-linear response.

Within the second oat study, fibre content did not appear to explain the effect. Within
this study, participants consumed an average of 35g per day of oatmeal and 39g per day
of oat bran, providing 4.9g and 10.8g of fibre, respectively (241). Despite the oat bran
treatment providing more than double the fibre of the oatmeal, the reductions to total
cholesterol were greater after the oatmeal treatment. This study also had arms with
wheat based cereals. Iin participants with the highest baseline total cholesterol,
significant reductions in cholesterol were found after consumption of 48g per day of
whole grain wheat and 48g per day of whole grain bran. Not only do both wheat
products provide minimal β–glucan, but the wheat bran treatment provided over double
the fibre (in this case, mainly insoluble) of the whole grain wheat treatment. Despite
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this, comparable effects were found between the treatments. So cholesterol lowering
effects of whole grain appeared equivalent to bran effects (despite fibre dose) and this
effect was not just related to mechanisms identified with β-glucan, but with wheat
products, likely to be predominantly 70% arabinoxylan, which while soluble, is
typically less viscous than β-glucan. The lower effects are shown with results only
significant in individuals with higher cholesterol.

Unexpectedly, an increase in total cholesterol was observed after consumption of rye
bran within one study, resulting in significantly higher cholesterol levels after the rye
bran treatment compared to the whole grain rye treatment (240). This was unpredicted,
and the authors suggested it may be due to a slightly higher intake of dietary fat during
the rye bran period of the cross over study, rather than any true effect from the bran
treatment, although the higher fat intake was not statistically significant.

Only one study found a significant reduction in fasting blood glucose and 2-hour post
prandial blood glucose after consumption of whole grain wheat bread and muffins with
added wheat AX fibre, compared to the same whole grain bread and muffins without the
added fibre. This effect may be because AX fibre is still somewhat viscous and soluble
in nature, with a soluble to insoluble fibre ratio of 1.6 (123). It is thought that soluble
fibres may affect plasma glucose by delaying gastric emptying (243) and nutrient
absorption (244), or by mediating increased intestinal mobility (245).

It was interesting that rye, being relatively high in AX fibre, did not affect blood
glucose, in either whole grain or bran form (240). Similarly, the second wheat study
within the review did not find an effect for whole grain wheat or wheat bran (239). In
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Lu’s study (123), participants in the added AX fibre treatment were consuming an
average of 49g per day of dietary fibre, while on the control treatment they were
consuming an average of 34g per day, a more similar amount to that consumed from
whole grain or bran products in the rye or other wheat study. It is therefore possible that
fibre intakes within the other studies were not high enough to produce an effect as seen
with the added AX fibre. However, due to the few studies examining fasting glucose,
the evidence of differential effects between whole grains, bran and cereal fibre is
limited. No effect for either whole grain, bran or cereal fibre was found for any other
CVD risk factors tested within included studies, potentially due to the small number of
studies examining each effect.

Findings from this review are limited due to the small number of heterogeneous studies,
each testing the effects of different varieties of grain on different CVD risk factors. This
was the result of broad inclusion criteria in an attempt to address the various ways
whole grain, bran or cereal fibre may be protective, as there are likely multiple
mechanisms involving different risk factors. Still, only five studies met these criteria
and were included in the review, ultimately limiting any wider interpretation of
findings.

3a.5 Conclusion
Although there is too little evidence to draw wider interpretation from this synthesis
alone, this review does suggest that there may be merit in further exploring the health
effects of bran and cereal fibre, particularly in mediating cholesterol responses, where
included studies tended to find similar effect between bran and whole grains. Perhaps
more crucially, this review makes evident that well-designed, longer term intervention
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studies which directly compare whole grain intake with bran and cereal fibre intake to
determine differential effects are lacking, and future research in this area is necessary.

It is also important not to underestimate the value of observational studies within
nutrition science, where good quality intervention studies can often be lacking,
particular of longer time frames which may be required to demonstrate dietary effects.
For this reason, interventional evidence cannot be considered alone, and should be
supplemented with an evaluation of observational evidence, as outlined in the following
chapter.

3b.1 Observational evidence
As described (Chapter 3a), limited interventional evidence exists exploring the
comparative effects of whole grain, cereal fibre and/or bran intakes on CVD related
outcomes. Observational evidence is needed to adequately evaluate the full body of
evidence determining the role of the cereal fibre component in the CVD protection
attributed to whole grains, to supplement findings from interventional studies (Chapter
3a).

3b.2 Methods
The systematic literature review was completed in accordance with the PRISMA
guidelines (182). The details of the review were recorded and registered with PROSPERO
(International Prospective Register of Systematic Reviews,
http://www.crd.york.ac.uk/PROSPERO), registration number CRD42017069226 prior
to commencement.
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3b.2.1 Inclusion and exclusion criteria
Articles were required to have considered both whole grain intake and cereal fibre
and/or bran intake in association to CVD-related health outcomes in humans. As there
were limited articles identified as meeting this criterion, no restrictions were placed on
the CVD-related health outcomes examined and included. These could include, but
were not limited to disease biomarkers, anthropometric measures, morbidity and
mortality. Results were restricted to those published in English and contained within
peer-reviewed journals, and there were no restrictions based on time of publication.
Editorials, reviews, meta-analyses and conference abstracts were excluded.

Exposure – initial analysis
Articles must have reported on total whole grain intake, and those examining intake of
only a defined set of whole grain foods or dietary patterns including whole grains, were
excluded. The definition of whole grains used was in accordance with the American
Association of Cereal Chemists International (AACCI) definition: ‘the intact, ground,
cracked or flaked caryopsis, whose principal anatomical components - the starchy
endosperm, germ and bran - are present in the same relative proportions as they exist in
the intact caryopsis’(23). This definition is similar to those used in Europe and
Australasia but critically defines whole grains, not whole grain foods. Also, it means
that articles that included added bran or germ as a source of whole grain were excluded
from the initial analysis.
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Exposure – expanded analysis
Initial scoping found a limited number of studies meeting the described inclusion
criteria. Consequently, a second review of the evidence was conducted, expanding the
criteria to include studies with a broader definition of whole grains. This expanded
analysis includes studies that may not have defined whole grains as per the AACCI
definition, but may have utilised whole grain food definitions. For example, several
articles that utilised a categorisation system of whole grain and refined grain foods,
which categorised added bran and germ as a whole grain food, were included in an
expanded analysis. Similarly, articles that met all other selection criteria but did not
clearly explain how whole grain intake was defined or categorised were included in this
expanded analysis.

Comparison
To be considered for inclusion, studies must have made a comparison of whole grain
intake to cereal fibre and/or bran intake. This may have been completed through
assessment of cereal fibre/bran intakes separately, adjustment of whole grain intake for
cereal fibre/bran, or by matching whole grain and refined grain intake based on cereal
fibre/bran content. Bran was included as an alternative comparison as it is the portion of
the grain containing the majority of the cereal fibre.

Study Design
This chapter reports only the results of observational studies, as interventional studies
were reviewed in Chapter 3a. A summary of the participants, exposure, comparisons,
outcomes and study design (PICOS) criteria is presented in Table 3.3.
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Table 3.3 PICOS criteria for inclusion and exclusion of observational studies
Parameter
Population
Exposure

Description
Males and female humans of any age, health status, socioeconomic
status and geographical location
Whole grain intake, whole grain defined according to the AACCI
definitiona

Comparison

Cereal fibre intake or bran intake

Outcomes

Association to any CVD-related health outcome

Study Design

Observational studies

PICOS, population, intervention (exposure), comparator, outcomes, study design;
AACCI, American Association of Cereal Chemists International.
a.
Expanded to include studies not meeting this definition in expanded analysis

3b.2.2 Search term and strategy
Relevant human journal articles were identified in medical databases Scopus, Web of
Science, CINAHL plus, CENTRAL in Cochrane Library and PubMed published before
March 2018 using the following keywords: “cardiovascular”, “coronary”, “stroke”,
“cholesterol”, “triglycerides”, “lipids”, “obes*”, “overweight”, “glucose” and “diabetes”
in combination with “wholegrain*” or “grain*”, as well as “cereal*” or “bran” and
“fibre” or “fiber”. The full search strategy (SCOPUS) has been presented in Appendix
1.

The titles of the articles were screened for inclusion by one author. The abstracts of
remaining articles were then reviewed. After exclusion based on abstract, the full text of
each potentially eligible article was retrieved. Two authors (E.M.B & E.J.B) separately
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assessed the full text studies for inclusion in the review. The reference lists of included
articles were hand-searched for additional studies that met the criteria.

3b.2.3 Data extraction
One author (E.M.B) extracted the required information and summarised the data in table
format, which was reviewed by a second author (E.J.B). Studies meeting the correct
definition of whole grains (initial analysis) were summarised separately to those in the
expanded analysis. Within both groups, whole grain, cereal fibre and bran intake data
were extracted in separate tables. Each summary table included first author’s last name,
publication year, country in which study was performed, study design, cohort,
participants, CVD-related outcomes examined, median intake range, covariate
adjustments, main results and statistical significance. When bran intake data was
extracted, the table also included whether the bran was total bran (naturally occurring
plus added) or added bran.

3b.2.4 Quality assessment
The design of each included study was identified and recorded. The National Health and
Medical Research Council levels of evidence criteria (186) were used to assign a level of
evidence to each study based on design. Additionally, the National Institute of Health
(NIH) Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies
(187)

was used to guide critical appraisal of articles. The NIH quality assessment tool

provides a checklist of 14 criteria that can be applied to cohort and cross-sectional
studies to evaluate internal validity. Studies were assessed on the basis of research
objective, study population specification, participation rate, inclusion/exclusion criteria,
sample size justification, timeframe, exposure and outcome measurement, blinding,
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attrition and confounders. The NIH tool then includes a subjective quality rating (good,
fair or poor) that the reviewer decides on based on their overall evaluation, rather than a
direct numerical ranking.

3b.2.5 Method of analysis
Due to the wide range of CVD-related outcomes assessed within limited studies, a
meta-analysis was not undertaken. Instead, studies were grouped based on comparison
measure (cereal fibre or bran intake) and where possible, on health outcome assessed,
and data were examined and synthesised qualitatively. The separation of articles within
the initial and expanded analysis allows an examination of how the quality of evidence
differs when restricted to articles using the current accepted definition of whole grains.
The quality assessment process was also used to inform the synthesis of results, with
studies of higher quality guiding the interpretation of findings and subsequent
discussion.

3b.3 Results
Our search strategy identified 1909 articles (Figure 3.3). Duplicates were removed and
titles were screened for relevance, with 671 articles selected for screening of abstract.
After screening for both title and abstracts, 96 full-text citations remained with a further
73 articles excluded because they did not analyse both whole grain and cereal fibre or
bran intake. One article was excluded as it measured only non-CVD related outcomes,
and two articles were excluded because they defined cereal fibre as the fibre sourced
from breakfast cereals only. A further twelve articles were excluded from the initial
analysis because they did not use the AACCI definition of whole grain and one article
excluded based on no clear description of how whole grain foods were defined (later
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included within the expanded analysis). Seven articles (based on three studies) remained
in the initial analysis.

When the expanded criterion was applied to include the articles that did not use the
AACCI definition of whole grain, thirteen previously-excluded articles (eight additional
studies) were included (Figure 3.3). They were previously excluded as eleven of these
articles included added bran and/or germ as a source of whole grain, one article did not
include whole grain bread as a source of whole grain intake, and one article did not
provide sufficient detail as to how whole grain intake was defined.

A brief outline of the characteristics of articles exploring the associations between
whole grain, cereal fibre and bran intake are presented in Table 3.4. Appendices 4 and 5
present a more extensive summary of articles within the initial analysis and expanded
analysis, respectively.
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1909 records identified through
database searching
PubMed n=528
Scopus n=487
Web of Science n=598
CINAHL plus n=157
CENTRAL in Cochrane library n=139
1238 records removed
by title screening and
removing duplicates
671 records abstract screened
PubMed n= 127
Scopus n= 196
Web of Science n= 177
CINAHL plus n= 116
Cochrane CENTRAL n= 55
575 records removed
after abstract screening
96 full-text articles assessed
for eligibility
89 full-text articles were excluded
•
•
•
•
•

7 articles (3 studies) remained
for inclusion in initial analysis

Did not report on both cereal fibre or
bran and whole grain intake (n=73)
Irrelevant study outcomes (n=1)
Calculated cereal fibre as fibre from
breakfast cereal only (n=2)
Incorrect definition of whole grain used
(n=12)
Whole grain categorisation not defined
(n=1)

13 articles (8 additional studies)
included in expanded analysis

Figure 3.3 Flow diagram of observational study selection process
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3b.3.1 Data extraction
Within the initial analysis, seven articles, which were based on three primary studies,
investigated various associations between whole grain, bran and cereal fibre intake and
CVD-related outcomes. The primary studies were the Nurses Health Study (NHS) I & II
and the Health Professionals Follow up Study (HPFS).

The following CVD-related health outcomes were assessed in relation to whole grain
and cereal fibre and/or bran intake within the initial analysis, each within single articles:
incidence of T2DM; CVD mortality and all-cause mortality in healthy participants and
those with diabetes; hypertension; CHD; long-term weight gain and various
inflammatory markers (Table 3.4).

Within the expanded analysis (13 articles reporting on eight new studies), three articles
directly compared outcomes between whole grain intake and bran intake and eight
articles directly compared outcomes between whole grain intake and cereal fibre intake.
One article adjusted whole grain intake for cereal fibre intake, and one article compared
associations between whole grain and non-whole grain intake matched on cereal fibre
content. The expanded analysis investigated: incidence of T2DM (3 articles), CVD
mortality and all-cause mortality in healthy participants (2 articles), incidence of CHD
(1 article), metabolic syndrome (1 article) and stroke (1 article): and markers of CVD
risk, anthropometric measures (3 articles), blood lipid profile (2 articles), blood glucose
measures (3 articles), inflammatory markers (1 article) and change in coronary artery
diameter and per cent stenosis (1 article) (Table 3.4).
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3b.3.2 Quality assessment
The level of evidence among the articles according to the NHMRC guidelines ranged
from level II (12 prospective cohort studies observing mortality or morbidity endpoints) to level IV (6 cross sectional analysis studies) (Table 3.4). Five of the seven
articles within the initial analysis were assigned level II, while seven of the thirteen
articles within the expanded analysis were assigned level II.

While the majority of articles (10/19) were of good quality as determined using the
NIH quality assessment tool, the ratio of good to fair quality was better in the initial
analysis (6:1 vs 4:9 in the expanded analysis) (Table 3.4). The study design used often
limited the quality that could be attained, with cross-sectional design unable to measure
exposure prior to outcome, and unable to assess associations over a sufficient
timeframe. Additionally, articles that only assessed exposure once over the study
period, and articles that relied on self-reported outcome measures were often assessed as
lower quality than those that assessed exposure multiple times and used validated
measures.
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Table 3.4 Characteristics of included observational studies
NIH Quality
assessment
tool rating

Design

Comparator

Outcomes

NHMRC level
of evidence

He 2010 (110)

PCS

Bran
Cereal fibre

CVD death, All cause death

II

Good

Jensen 2004 (142)

PCS

Bran

CHD

II

Good

Qi 2006 (246)

CS

Bran
Cereal fibre

CRP, ICAM-1, E-selectin, TNF-R2

IV

Fair

Wu 2015 (247)

PCS

Bran

CVD death

II

Good

de Munter 2007 (143)

PCS

Bran

T2DM

II

Good

Flint 2009 (112)

PCS

Bran

Hypertension

III-2

Good

Koh Banerjee 2004 (113)

PCS

Bran
Cereal fibre

8-year weight change

II

Good

Jensen 2006 (111)

CS

Bran

TC, HDL, LDL, HbA1c, Insulin, C-peptide,
Leptin, CRP, Fibrinogen, IL-6, Homocysteine

IV

Fair

Liu 1999 (248)

PCS

Bran

CHD

II

Good

Juan 2017 (139)

PCS

Bran

Stroke

II

Good

Fung 2002 (114)

PCS

Cereal fibre

T2DM

II

Good

Study
Initial analysis

Expanded analysis
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Montonen 2003 (51)

PCS

Cereal fibre

T2DM

II

Fair

Meyer 2000 (50)

PCS

Cereal fibre

T2DM

II

Fair

McKeown 2004 (249)

CS

Cereal fibre

HOMA-IR, metabolic syndrome

IV

Fair

Huang 2015 (108)

PCS

Cereal fibre

CVD death, All cause death

II

Good

Jacobs 2000 (250)

PCS

Cereal fibre

CHD death, Other CVD death, All cause death

II

Fair

Erkkila 2005 (251)

PCS

Cereal fibre

Minimum coronary arterial diameter change,
stenosis change

III-2

Fair

CS

Cereal fibre

Diastolic BP, Systolic BP, TC, HDL, LDL,
TAG, Fasting glucose, 2-hr PP glucose, Fasting
insulin, BMI, weight, waist circumference

IV

Fair

McKeown 2009 (137)

CS

Cereal fibre

BMI, Body fat %, Trunk fat mass

IV

Fair

Van de Vijver 2009 (252)

CS

Cereal fibre

BMI, Overweight risk, Obesity risk

IV

Fair

Newby 2007

(147)

PCS, prospective cohort study; CS, cross-sectional study; ICAM-1, intercellular adhesion molecule 1; TNF-R2, Tumour necrosis factor receptor
2; TC; total cholesterol; IL-6, interleukin 6; HOMA-IR, homoeostatic model assessment of insulin resistance; BP, blood pressure; TAG,
triglycerides; PP, post-prandial.
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3b.3.3 Initial analysis
Of the seven articles that assessed whole grain intake in the initial analysis, six found a
significant inverse association to CVD-related outcomes (112; 113; 142; 143; 246; 247) ,
however, two of these found the association attenuated when adjusting for cereal fibre
and whole grain constituents (112; 142). All six articles investigating bran intake found a
significant inverse association to CVD-related outcomes (110; 112; 113; 142; 143; 246; 247),
although one of these articles investigated two separate cohorts, and found a nonsignificant inverse association in one cohort (143). There were mixed results on the
associations to cereal fibre, with two articles showing a significant inverse association
(113; 143; 246)

between intake and CVD-related outcomes, and a third article showing no

association (110).

Whole grain intake compared to bran intake
The highest intakes of whole grain were associated with 12% lower risk of CVD
mortality (hazard ratio (HR) 0.88, 95% CI 0.82-0.96, P=0.001) and an 8% lower risk of
all-cause mortality (HR 0.92, 95% CI 0.89-0.96, P<0.001) compared to lowest intakes
in a large combined cohort of the NHS I and the HPFS (247). Within the same cohort, the
association of high bran intake to lower risk of CVD mortality was slightly greater. A
20% lower risk for the highest intake of total bran (HR 0.80, 95% CI 0.73-0.87,
P<0.001) and 24% lower risk for the highest intake of added bran (HR 0.76, 95% CI
0.70-0.83, P<0.001) compared to lowest intakes was observed. Similarly, high whole
grain and total bran intake were both associated with lower risk of T2DM among
healthy participants within the NHS I (relative risk (RR) 0.75, 95% CI 0.68-0.83,
P<0.001 and RR 0.72, 95% CI 0.65-0.80, P<0.001, respectively) and the NHS II (RR
0.86, 95% CI 0.72-1.02, P=0.03 and RR 0.84, 95% CI 0.71-1.00, respectively) (143),
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however, the inverse association with total bran intake within the NHS II only reached
borderline significance (P=0.07).

Whole grain intake was associated with a 19% lower risk of hypertension (112) (RR 0.81,
95% CI 0.75-0.87, P<0.0001) and a 16% lower risk of CHD (142) (HR 0.84, 95% CI
0.71-0.98, P=0.01) in the HPFS, when comparing the highest quartile of intake to
lowest. However, after adjusting for cereal fibre intake (112) and whole grain constituents
including dietary fibre (142), both of these associations were attenuated (P=0.23 and
P=0.06, respectively), suggesting some significance of the cereal fibre component
towards the whole grain associations. Bran intake was also inversely associated to risk
of both hypertension and CHD (RR 0.85, 95% CI 0.78-0.92, P=0.002 and HR 0.72,
95% CI 0.61-0.84, P<0.0001, respectively), and the association to lower risk of CHD
remained significant after adjusting for constituents (P<0.001).

Whole grain intake compared to bran and cereal fibre intake
Within the HPFS, whole grain, bran and cereal fibre intake were associated with better
weight management over time (113). The association was stronger for whole grain intake
than for cereal fibre or bran intake. For every 40g/d increase in whole grain intake, 8year weight gain was 1.1kg lower (P<0.0001), while for every 20g/d increase in cereal
fibre or bran intake, 8-year weight gain was 0.81kg (P=0.0004) and 0.36kg (P=0.01)
lower respectively, indicating a slightly stronger, although still modest, association for
whole grain intake.

Lower risks of CVD mortality and all-cause mortality were found for high whole grain,
cereal fibre and bran (total and added) intakes in a cohort of 7822 women with existing
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T2DM (110). However, after adjustment for lifestyle and dietary factors, only the
associations for total and added bran intake remained significant for both outcomes. A
64% lower risk of CVD mortality (RR 0.36, 95% CI 0.24-0.54, P<0.001) and a 55%
lower risk of all-cause mortality (RR 0.45, 95% CI 0.36-0.57, P<0.001) was observed
for those consuming the highest intake of added bran compared to non-consumers.

Whole grain, bran and cereal fibre were significantly inversely related to CRP and
Tumour necrosis factor receptor 2 levels in a fair-quality analysis of women with T2DM
within the NHS I (246), but no associations were found to E-selectin or Intercellular
Adhesion Molecule 1 levels. Notably, within this study no adjustment was made for
overall diet quality or other singular dietary factors that may be correlated with whole
grain intake and influence inflammation, such as polyunsaturated fatty acid intake.

3b.3.4 Expanded analysis
Eleven of thirteen articles within the expanded analysis found a significant inverse
association between whole grain intake and at least one CVD-related outcome analysed
(50; 51; 108; 111; 114; 137; 147; 248; 249; 251; 252)

, though six of these found the association no longer

significant after adjustment for cereal fibre intake (50; 51; 108; 114; 248; 249), indicating cereal
fibre as a key component in the association. All eight articles that analysed cereal fibre
intake separately found a significant inverse association to at least one CVD- related
outcome (50; 51; 108; 137; 147; 249; 251; 252). One article investigating bran intake found mixed
associations (111), while the other two found significant inverse associations (139; 248).

Whole grain intake compared to bran intake
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One fair-quality analysis (111) considered associations of whole grain and bran intake to
lipid profile, markers of glycaemic control and inflammation. The highest consumers of
whole grains (Q5) had 2.9% lower total cholesterol (P=0.02), 5.3% lower HDLcholesterol (P=0.05) and 2.1% lower LDL-cholesterol than the lowest consumers (Q1),
although the association to LDL-cholesterol did not reach significance (P=0.10).
Highest whole grain intake (Q5) was also associated with 17.4% lower levels of
homocysteine, as well as lower concentrations of C-peptide (-13.6%, P=0.03) and leptin
(-11.0%, P=0.03). Other markers examined, including HbA1c, were not associated with
whole grain intake. Similar associations were seen when examining bran intake
separately but were only borderline statistically significant with the exception of
homocysteine concentrations (-10.9%, P=0.02). Leptin was not associated with higher
bran intake (-2.0%, P=0.88).

Whole grain and bran intake were both associated with lower incidence of CHD in a
good-quality prospective cohort study (248) (RR 0.74, 95% CI 0.58-0.94, P=0.01 and RR
0.63, 95% CI 0.42-0.95, P=0.001, respectively), with participants consuming one
serving of added bran per day having a 37% lower risk of CHD compared to nonconsumers. These significant associations were found after adjustment for several
related lifestyle and diet covariates including smoking status, physical activity and fatty
acid composition of diet, however, the association to whole grain intake was attenuated
after further adjustment for grain constituents including dietary fibre (P=0.07). High
total bran intake was associated with 11% lower risk of stroke (HR 0.89, 95% CI 0.791.0, P=0.004) in a separate good-quality pooled cohort study, whereas whole grain
intake showed no association (139).
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Whole grain intake compared to cereal fibre intake
Whole grain intake was associated with a 21% (95% CI 0.65-0.96, P=0.0089) to 35%
(95% CI 0.36-1.18, P=0.02) lower risk of T2DM comparing the highest intake to the
lowest intake in three studies (one good quality, two fair-quality) (50; 51; 114). Importantly,
the two fair quality studies failed to adjust for potentially important covariates including
physical activity (51) and related dietary factors such as fruit and vegetable intake (50). A
fourth study of fair-quality found a 33% lower risk (95% CI 0.48-0.91, P=0.01) of
metabolic syndrome (249). The associations completely disappeared when adjusting for
cereal fibre in all four cases. The three fair-quality studies also examined risk
reductions for cereal fibre intake separately and found that the highest intakes were
associated with a 36% (95% CI 0.53-0.79, P=0.0001) to 61% (95% CI 0.20-0.77,
P=0.01) lower risk of T2DM, and a 38% (95% CI 0.45-0.86, P=0.002) lower risk of
metabolic syndrome. Meyer et al. (2000) adjusted this result for whole grain intake, and
the lower risk was only slightly reduced to 34% (95% CI 0.53-0.83, P=0.0001).

The associations of whole grain and cereal fibre intake to all-cause mortality and CVDmortality were explored in a large, good-quality analysis of 367,442 US participants
(108)

. High whole grain intake was associated with a 17% lower risk of both outcomes

(95% CI 0.81-0.86, P<0.0001 and 95% CI 0.78-0.88, P<0.001, respectively). Once
adjusted for cereal fibre, the association to all-cause mortality was attenuated to 6%
(95% CI 0.90-0.97, P=0.002), and the association to CVD-mortality completely
disappeared (HR 0.95, 95% CI 0.88-1.03, P=0.188). High cereal fibre intake, analysed
separately within the same study, was associated very similar lower risk of all-cause and
CVD mortality. In a smaller, fair quality study (250), whole grain consumers tended to
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have lower risk of all-cause mortality (HR 0.83, 95% CI 0.73-0.94, P<0.05) than
refined-grain consumers.

The associations of whole grain and cereal fibre intake to progression of coronary
atherosclerosis among 229 women were analysed within a fair-quality study (251).
Women consuming above the median intake of whole grains (>6 serves/wk) and cereal
fibre intake (>3g/1000 kcal) had a significantly smaller change in minimum coronary
artery diameter over the 3-year period compared to those consuming under the median
(-0.06mm v. -0.10mm, P=0.04 and -0.04mm v. -0.09mm, P=0.03, respectively).

Two fair-quality cross sectional articles examined whole grain and cereal fibre intake in
relation to glycaemic control. In the Framingham Offspring Study, mean homeostasis
model assessment-estimated insulin resistance (HOMA-IR) was borderline significantly
lower in the highest quintile of whole grain intake (Q5) compared to the lowest (Q1)
(Q1 6.8 v. Q5 6.6, P=0.05), however, this association disappeared once adjusted for
cereal fibre (249). In contrast, the association between high cereal fibre intake and lower
mean HOMA-IR remained after adjusting for whole grain intake (Q1 6.9 v. Q5 6.5,
P=0.003). Within the Baltimore Longitudinal Study of Aging, higher whole grain and
cereal fibre intake were similarly associated with lower postprandial glucose (Q1 8.24
mmol/L v. Q5 7.23 mmol/L, P=0.006 and Q1 8.05 mmol/L v. Q5 6.48 mmol/L, P=0.02,
respectively), however no associations were found to fasting glucose, fasting insulin or
postprandial insulin (147).

Within the same study, the highest consumers of whole grain and cereal fibre had
significantly lower total cholesterol than the lowest consumers (Q1 5.79 mmol/L v. Q5
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5.49 mmol/L, P=0.02 and Q1 5.73 mmol/L v. Q5 5.44 mmol/L, P=0.005, respectively).
The highest consumers of both intakes also had lower LDL-cholesterol than the lowest
consumers, although this was borderline significant for cereal fibre intake (Q1 3.13
mmol/L v. Q5 2.9 mmol/L, P=0.07), and somewhat negatively, the highest consumers
of whole grain intake had lower HDL-cholesterol, although not significantly (Q1 1.27
mmol/L v. Q5 1.22 mmol/L, P=0.07).

Participants consuming the highest intake of whole grain and cereal fibre had
significantly lower anthropometric body measurements compared to those consuming
the lowest intakes in three cross sectional analyses (137; 147; 252), although notably two of
the three studies did not perform an adjustment for physical activity within their
multivariate models (147; 252). Within the Netherlands Cohort Study, it was estimated that
every 1g/day higher intake of whole grain was associated with a 0.03kg/m2 and
0.04kg/m2 lower BMI in men and women, respectively (P<0.01 for both). This meant
that a decrease of 1kg/m2 BMI corresponded to a 33g and 25g increase in whole grain
intake. Every 1g of cereal fibre intake was similarly associated with a 0.04kg/m2 lower
BMI in men (P<0.01), but no association was found for women. Within the same
cohort, a high intake of whole grain was associated with a slightly lower risk of being
overweight and obese in both men (OR 0.98, 95% CI 0.96-0.99, P<0.01 and OR 0.90,
95% CI 0.84-0.98, P<0.05, respectively) and women (OR 0.98, 95% CI 0.96-0.99,
P<0.01 and OR 0.96, 95% CI 0.93-0.99, P<0.05, respectively), while a high intake of
cereal fibre was only associated with a lower risk of being overweight in men (OR 0.98,
95% CI 0.96-0.99, P<0.01). Van de Vijver et al. (2009) also conducted a prospective
analysis of a smaller cohort of 1257 participants of the Netherlands Cohort Study, with
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follow-up ranging 1-5 years, but no association was found between baseline intake and
anthropometric measures.

3b.4 Discussion
This review provides an up to date summary of the observational evidence comparing
whole grain, bran and cereal fibre intake and their associations to CVD. Further, it
highlights the discrepancy in the definition and categorisation of whole grain intake
applied within studies, and the issues this can create when attempting to synthesise
evidence.

Within the review, the association between whole grains, bran, and cereal fibre and
lower risk of CVD-related outcomes were evident. In the expanded analysis, cereal fibre
and whole grain (including added bran) intake were similarly associated with lower risk
of CVD mortality, and the fibre component tended to explain the association (108),
whereas fibre-rich bran was strongly associated with lower risk of stroke incidence (139).
The inverse associations between risk of CVD-related outcomes and cereal fibre intake
may be due to favourable effects on factors likely to influence the development of the
disease such as serum lipids (253), glucose and insulin metabolism (254), blood pressure
(255)

and inflammation (256). These factors may also play a role in slowing progression of

CVD, as higher intakes of cereal fibre and whole grain products were both associated
with less progression of coronary atherosclerosis in postmenopausal women with
established CHD (251). The differences in progression (0.04mm less progression in high
whole grain consumers; 0.05mm less progression in high cereal fibre consumers) were
somewhat comparable to treatment effects reported in statin trials (0.06-0.08mm) (257).
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Interestingly when studies assessed added bran intake, (bran added to food during
processing), some of the strongest inverse associations to CVD-related outcomes were
found. As added bran, as opposed to total bran, does not include bran intake consumed
as part of whole grain foods, there is less chance of it being simply a surrogate marker
for whole grain intake, providing a more precise insight into the benefits of bran alone.
In the study by He et al. (2010) of women with T2DM, only added bran was
significantly associated with lower CVD-related and all-cause mortality after
adjustment for lifestyle and dietary factors (110). While this study was underpowered to
detect modest associations, and therefore the non-significant associations found for
whole grain and cereal fibre may be due to limited power, the same strong inverse
association to CVD-mortality and all cause-mortality was found for added bran intake
in healthy participants (247). Furthermore, added bran had the strongest inverse
association with CHD (142; 248). One possible explanation for the consistently strong
inverse associations found for added bran is that within these populations, bran is
sourced mainly from only two sources, wheat bran and oat bran (142). Oat bran is one of
the highest sources of the soluble fibre β-glucan, which is consistently associated with
reduced serum total LDL-cholesterol in clinical trials (117; 258).

However, the direct associations within the cross-sectional studies of whole grain,
cereal fibre and total bran intake to serum cholesterol levels were less consistent (111; 147).
Again, associations may have been stronger if specifically analysing intake of high
soluble-fibre grains. Cross-sectional studies are inherently unable to capture impact of
long term trends in intake and sample sizes were relatively small within both studies.
For example, while a 4.7% lower LDL-cholesterol level, as found in one study
comparing highest consumers of cereal fibre to lowest consumers (147), may appear
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clinically relevant to reduced CVD risk (55), it did not quite reach statistical significance
(P=0.07). In a similar way, a significantly lower risk of hypertension was found with
high whole grain intake within the HPFS, which was attenuated to non-significance
after adjustment for cereal fibre (112). However, neither whole grain intake nor cereal
fibre intake was associated with lower blood pressure in the cross-sectional study by
Newby et al (2007) (147).

It is thought that whole grains may contribute to weight loss through the effect of fibre
on satiation and satiety (259), leading to lower energy intake. Additionally, the secretion
of particular gut hormones such as CCK may contribute to satiety or alter glucose
homeostasis (260), and soluble fibre may improve insulin sensitivity by slowing the
absorption of macronutrients, indirect affecting body weight (259). While the inverse
associations within the HPFS between whole grain, added bran and cereal fibre intakes
and weight gain over an 8-year period were statistically significant, the weight change
differences between the highest and lowest intakes were modest

(113)

. Similarly, within

several cross sectional studies, higher intakes of all three dietary variables were
associated with small but statistically significant differences in anthropometric markers.
Considering the findings for whole grains and fibre intake effect on weight regulation in
clinical trials tend to be inconsistent (261; 262; 263), further research investigating this
relationship is needed. Certainly current advice would be that increased intake of whole
grains is positive for weight control, but cereal fibre sourced from non-whole grain
foods or from bran may also be a suitable alternative.

Within this review, whole grain intake tended to be associated with lower incidence of
T2DM and metabolic syndrome, but this association consistently disappeared after
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adjustments for cereal fibre intake. The one study that did not perform adjustments for
cereal fibre intake found similar lowered risk between whole grain and bran (143). High
soluble fibre foods have been found to reduce post-prandial glucose and insulin
response (264) and high-fibre diets may improve insulin sensitivity and lower insulin
secretion (265). Interestingly, two studies within the review found that insoluble fibre but
not soluble fibre was associated with lower risk of T2DM (50; 51). Insoluble fibre may
also slow the absorption of foods (266), but it is also suggested that a quicker transit time,
achieved with high insoluble fibre intake, allows less time for carbohydrates to be
absorbed in the upper jejunum, thus relieving insulin demand (267). Both whole grain and
cereal fibre intake were associated with significantly lower HOMA-IR, a measure of
insulin resistance, in the Framingham cohort, with the whole grain association
disappearing after adjustment for cereal fibre (249).

In addition to the fibre content, micronutrients within whole grains such as magnesium
may also play a role in insulin sensitivity and reduced risk of T2DM. In a small study of
elderly participants, 4.5g of magnesium daily for 4 weeks improved glucose and insulin
responses (268). Within our review, the importance of magnesium intake was
inconclusive. Some studies found that magnesium intake could not explain the whole
grain associations (51; 143), while another found magnesium was independently associated
with lower risk of T2DM, even after adjustment for cereal fibre (50). Importantly, this
study did not adjust for any other related dietary factors that may confound these
associations. Overall, the findings suggest that the fibre component of whole grains and
bran may play the major role in the inverse associations to T2DM. Other nutrients such
as magnesium may also contribute.
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Concentrations of C-peptide, a marker of insulin production, were significantly lower
for both high whole grain (including bran) and total bran intake in one study (111),
suggesting lower insulin production among high consumers. High whole grain intake
(including bran) was significantly associated with lower fasting insulin, but this was
attenuated once adjusted for lifestyle and dietary factors. Participants in the highest
quintile of bran intake did have 14% lower average fasting serum insulin concentrations
than those in quintile 1, but this was not statistically significant. Given the small sample
size and the single measure of outcome used, it is not surprising that few associations
reached significance.

However, it was interesting that high whole grain intake (including bran) was
significantly associated with lower plasma leptin concentrations, while total bran intake
alone was not at all associated (111). Leptin, a hormone secreted by adipocytes, is
correlated with obesity (269), and high levels have been shown to predict increased
weight gain among overweight men within the HPFS (270). High serum leptin
concentrations have also previously been linked with higher fasting insulin, even when
controlling for BMI (271), and it is suggested that there is a relationship between
insensitivity to leptin and insulin resistance (272). A high-fibre diet has been found to
reduce leptin in animal studies (273; 274), mainly due to a reduction in adipose tissue, but
this does not explain why the association was so strong for whole grain and non-existent
for bran within this study, suggesting more research may be warranted in this area.

Associations of whole grain, bran and cereal fibre to numerous markers of inflammation
associated with CVD were examined within this review. However, all markers except
for CRP were not assessed in more than one fair-quality, cross-sectional study, making
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it difficult to draw conclusive findings. Elevated CRP concentrations, a marker of
inflammation, have been found to independently predict CVD in the general population
(275)

and people with T2DM (276), and the American Heart Association has concluded

that the risk of CVD is lower when the CRP level is below 1 mg/L (277). Here, high
whole grain, bran and cereal fibre intake were significantly associated with lower CRP
concentrations in the same cohort of women with T2DM (246). Within a healthy
population, high whole grain and bran intake tended to be associated with lower CRP
concentrations however after adjustment for dietary and lifestyle factors the association
completely disappeared for whole grain, and became non-significant for bran (111).
Hyperglycaemia may, in part, influence production of pro-inflammatory cytokines (278;
279)

, so whole grain and cereal fibre intake may assist in inhibiting inflammation through

their effect on blood glucose control. Potentially, the associations are more pronounced
in a population prone to hyperglycaemia, however, an inverse relationship between
dietary fibre and CRP in healthy populations has been found in previous studies (256; 280).

The findings of this review suggest that fibre may play a significant role in the cardioprotective associations of whole grains. Whole grain, bran and cereal fibre intake were
associated with similarly lowered risks of most outcomes assessed, and when tested,
cereal fibre often accounted considerably for whole grain associations, particularly for
T2DM. When bran was separated from whole grains as in the initial analysis, intakes of
bran, particularly added bran, had equal or stronger inverse associations to various
CVD-related outcomes to that of whole grains. As bran contains the majority of cereal
fibre within grains, this may further support the notion that fibre contributes
considerably to the protective associations of grains. Of course, it is important to note
that bran cannot be interpreted simply as a direct measure of cereal fibre, due to the
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abundance of minerals, phytochemicals and phytoestrogens contained within the
aleurone layer, often extracted with bran in the milling process (54). In the HPFS cohort,
adjusting for fibre and micronutrient constituents attenuated the inverse association
between whole grains and CHD, but did not have an appreciable effect on the strong
inverse association for added bran (142). Further, Jacobs et al. (2000) found that
consumers of fibre from whole grain sources (which included bran) compared to fibre
from refined grain sources tended to have lower risk of all-cause mortality, but not
specifically CVD-mortality (250). We cannot disregard the possibility that these bioactive
compounds within the aleurone layer, botanically linked to fibre, may contribute to the
protective effects found (250).

Another important consideration in examining associations between whole grains and
CVD-related outcomes is the diet and lifestyle of whole grain consumers, beyond whole
grain consumption. Whole grain intake may be associated with an overall healthier
lifestyle and better diet quality (15), and some of these associated factors such higher
physical activity levels, lower incidence of smoking and higher fruit and vegetable
intake may confound or contribute to any associations attributed to whole grain intake.
Within the initial analysis, all seven of the good-quality articles included careful
adjustment for multiple lifestyle and dietary factors in their multivariate models.
However, the fair-quality article (246) observing associations to markers of inflammation,
included lifestyle factors within the multivariate model, without inclusion of potentially
relevant dietary factors such as polyunsaturated fat intake (281). Similarly, several of the
articles included within the expanded analysis failed to adjust for factors such as
physical activity (51; 137; 147; 251; 252), alcohol intake (51) and other dietary factors (50). In
some cases, articles reporting on the same study cohorts adjusted for considerably
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different factors within their multivariate models. As causation cannot be determined
from observational studies, it is crucial that careful adjustment is made for all
potentially confounding factors, as even then, residual confounding may still impact
findings. The inconsistency among several articles within the review, particularly within
the expanded analysis, may limit the quality of the overall evidence.

Many of the articles within this review also went on to adjust for constituents within the
whole grain, including cereal fibre. It was interesting that associations found within the
initial analysis were less prone to attenuation after adjustment for cereal fibre than in the
expanded analysis. Using an accepted definition of whole grain (including all fractions
in natural proportions), and methodical calculation of whole grain, bran, and cereal fibre
intakes, results are less likely to be confounded by imprecise categorisation. We can
therefore be more confident that the abundance of nutrients expected to be found within
whole grains and the separate bran component were accurately captured in estimated
intakes. Beyond the incorrect inclusion of added bran, it is possible that the presence of
non-whole grain, and therefore potentially nutrient-poorer grain intake incorrectly
captured as whole grain intake within the expanded analysis diluted the overall quality
of intakes and therefore blunted the contribution of any whole grain nutrients beyond
cereal fibre. The noticeable difference in results between initial and expanded analysis
suggests that while it is evident that cereal fibre is an important component of whole
grain and bran, we cannot disregard contribution from nutrients beyond this.

The inconsistency in definitions and categorisation systems used, and therefore limited
amount of evidence based on the correct definition of whole grains, is a considerable
limitation of this review. Only three major study cohorts (the NHS I&II and the HPFS)
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were analysed using the correct definition of whole grains. Additionally, while the wide
variety of CVD-related outcomes assessed shed light on the various ways whole grain
intake may be protective, we were limited in our ability to draw sound conclusions
about any one risk factor or outcome, as most outcomes were assessed in few studies, in
diverse populations, or using different definitions of whole grain, making a more indepth study of results by way of a meta-analysis not possible.

3b.5 Conclusion
Observational evidence suggests that intakes of whole grain, cereal fibre and bran (total
and added) appeared to be similarly associated to lower risk of various CVD-related
outcomes within this review, suggesting that the fibre component of whole grains,
located primarily within the bran fraction, may play an important role in the cardio
protective associations observed with whole grain intake. Notably, however, when the
accepted definition and precise categorisation of whole grain and bran intakes were
used, associations found were stronger and less prone to attenuation after adjustment for
cereal fibre, potentially indicating a role of whole grain nutrients beyond fibre.

The findings from this review are interesting in consideration of the promotion of grain
foods in public health initiatives and dietetic practice. Potentially, an overly restricted
focus on whole grain cereal foods may deter consumption of high-fibre non-whole grain
foods such as bran-based cereals and some refined cereals. The similar lower risks
observed for added bran separate to whole grain across both analyses raises the question
of whether current initiatives and health policies should include mention of whole grain
and/or bran foods.
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Furthermore, considering that cereal fibre was also associated with lower risk of CVD,
it is important not to entirely deter consumption of refined grain foods, which although
may be lower in nutritional value than whole grains, still contribute to cereal fibre
intakes and, alongside some whole grain choices, can introduce variety and remain a
valuable component of a balanced diet.

While these are exciting speculations, the frequent inconsistencies in the literature
highlighted by this review make it difficult to determine any sound conclusions or
recommendations using the currently available evidence at this point. Future
adequately-powered studies, including intervention studies comparing the effects of
whole grain intake with fibre-matched bran or added-cereal fibre intake on CVD-related
risk factors and outcomes, are needed to establish the mechanisms behind the protective
effects of whole grains and their components, as well as the dose-response relationships,
where there is currently paucity of data and lack of agreement. These studies are needed
before findings can be translated into practical application. Most importantly, there is a
crucial need for future research to utilise a consistent, methodical and quantified
approach when calculating whole grain intakes. This will ensure future evidence in this
area is consistent, accurate and reflects the current definition of whole grain, and
estimations are not based on a “proxy measure” of whole grains based on varied and
sometimes misdirected definitions of whole grain foods.
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Chapter 4:
Whole grain intake compared with cereal fibre intake in
association to cardiovascular disease risk factors – a cross
sectional analysis of the National Diet and Nutrition
Survey (UK)

A major component of this chapter is the substantive content of the accepted article:

Barrett, EM, Amoutzopoulos, B, Batterham, MJ, Ray, S, and Beck, EJ. (2020) Whole grain
intake compared with cereal fibre intake in association to cardiovascular disease risk factors – a
cross sectional analysis of the National Diet and Nutrition Survey (UK). Public Health
Nutrition. (Accepted 1 October 2019).
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4.1 Introduction
It is well established that higher intakes of whole grains is associated with lower risk of
CVD (131; 247; 248), and consequently, whole grain intake is now widely encouraged
within national dietary guidelines across the globe, including the Eatwell Guide in the
UK (282). The association may manifest through several pathways, as whole grain intake
has been linked to management of various CVD-mediators including glycaemic control
(283)

, plasma lipids (284) and inflammation (246). The specific components of whole grains

that may be responsible are unclear. Whole grains are a rich source of dietary fibre, and
cereal fibre specifically has been found to be particularly protective against CVD (27; 29;
32)

. In addition, whole grains contain constituents such as vitamin E, magnesium, folate

and phenolic compounds, all of which may contribute to their benefits (285).

In the previous chapters, we reviewed existing evidence exploring whole grains, bran
and cereal fibre and risk of CVD and CVD-related outcomes. We found that when
observational studies defined whole grains as including the germ, endosperm and bran
in their natural proportions, associations appeared stronger and less likely to be
attenuated after adjustment for individual components such as cereal fibre intake,
potentially due to poorer-quality non-whole grain foods weakening any associations.
Although this is an interesting finding, there is currently not enough consistent evidence
available to ascertain to what extent the cereal fibre or bran components of whole grains
are responsible for their cardiovascular health benefits. Further research, using
consistent definitions and systematic methods to estimate whole grain intake, is needed
in this area.
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In order to contribute to this evidence base, here, associations between intakes of whole
grain and cereal fibre and CVD risk factors within adult participants of the UK NDNS
RP 2008-14 are examined and compared. The NDNS RP is a survey collecting dietary
intake and health related data from 1000 participants across the UK each year. Whole
grain and cereal fibre intakes of participants were estimated using nutrient composition
data for all foods reported within the surveys, contained within the UK NDNS Nutrient
Databank (217). Whole grain and cereal fibre content of all foods was estimated using
accepted definitions and as grams per-100g of the food item, ensuring all whole grain
and cereal fibre intake was captured, including from food items contributing small
amounts.

Using population representative survey data is also useful because it can provide insight
into the food choices of the population, to provide an overall picture of what a freeliving high whole grain or high cereal fibre diet might comprise of within the population
of interest. This is helpful for messaging purposes, as consumers better understand
food-based messaging, but also to compare the overall food choices and adequacy of the
differing diets. Within this chapter, we also aimed to explore the composition of diets
containing varied amounts of whole grain and cereal fibre, particularly those diets that
may be high in whole grain but low in cereal fibre or high in cereal fibre but low in
whole grain.

4.2 Methods
4.2.1 Study population
This study was a secondary analysis of data from the NDNS RP 2008-14, collected
between February 2008 and August 2014 and archived within the UK Data Service (217).
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The NDNS RP is a continuous, cross- sectional survey designed to collect information
on the dietary intake and nutritional status of privately dwelling people within the UK
aged 18 months and over, covering a nationally representative sample of approximately
1000 people (minimum of 500 adults and 500 children) per year. The detailed
methodology of the NDNS RP survey has been described elsewhere (197). The survey is
carried out under the UK Research Ethics Service Research Ethics Committee approval.
All participants or legal guardians of participants provided informed consent.

A total of 9374 participants were included in the NDNS RP 2008-14. For the purpose of
our analysis, we excluded participants who were under 18 years old (n=4427).
Additionally, we excluded under-reporters of energy intake (n=1956) using the
Goldberg cut off method (286). As body weight was needed for this method, participants
that did not have a valid body weight recorded were also excluded (n=302). After
exclusions, 2689 participants remained for analysis. However, among these participants
there was further missing data for particular risk factors included in our analyses. Thus,
the available sample size varied somewhat between risk factors, as follows: body mass
index (BMI) (n=2658), waist-hip ratio (n=2107), systolic blood pressure (n=1673), total
cholesterol and HDL cholesterol (n=1481), LDL cholesterol (n=1465), triglycerides
(n=1477), fasting glucose (n=1416), HbA1c (n=1445), C-reactive protein (n=1481) and
homocysteine (n=1250). CVD relative risk score, determined using Systematic
Coronary Risk Evaluation (SCORE) charts(287) developed by the European Society of
Cardiology, was also included as a risk factor in analyses, conducted with smokers
included (n=1182) and without smokers included (n=1023).
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4.2.2 Dietary intake assessment
Dietary intake data were collected via a four-day estimated food diary, completed by
participants on consecutive days with the assistance of the survey interviewers.
Participant nutrient intakes were estimated from the diaries using food composition data
from the UK NDNS Nutrient Databank (217). The Nutrient Databank includes
approximately 5900 food codes. The nutrient values are generated based on nutrient
analysis (analytical and indirect analysis) of foods. Values are regularly updated based
on manufacturers’ data and food label data. Further details on the dietary collection and
analysis process are published elsewhere (204).

4.2.3 Estimation of whole grain and cereal fibre content/intakes
Whole grain and cereal fibre content of each food item reported by participants within
the survey was estimated using the Nutrient Databank and the Food Standards Agency
Standard Recipes Database (219). The Recipes Database consists of approximately 9,200
foods of which 7,044 are recipes reported in UK national nutrition surveys, including
the NDNS. The Recipes Database provides information on the gram amount of each
ingredient in 100g of each recipe (i.e. proportion of ingredients). The Recipe Database
is compatible with the Nutrient Databank, as they both use the same food identification
code.

For this study, whole grain and cereal fibre databases were built from the Recipe
Database. In order to do this, each elementary ingredient (i.e. ingredients within the
database that are not broken down into further ingredients) was assessed by the
candidate (EMB) to identify if it was a whole grain and/or a source of cereal fibre. To
be considered a whole grain, an ingredient was required to be a grain containing the
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endosperm, germ and bran components, whether in intact, ground, flaked or otherwise
processed form. This matches the recently released definition of a whole grain food
ingredient by the WGI (22). Use of this classification meant that bran ingredients (e.g. oat
bran) were not considered a whole grain. Examples of whole grain ingredients included
rolled oats, brown rice, 100% wholemeal flour, and popcorn with no added fat or sugar.
Cereal fibre was interpreted as all fibre that is derived from a cereal grain source,
whether whole grain or refined. Therefore, all cereal grain-sourced ingredients,
including items such as 100% wholemeal flour, cornflour, oat bran and white rice, were
cereal-fibre containing ingredients. Two pseudo cereal grains, buckwheat and quinoa,
were also contained within the database as ingredients. Both pseudo cereal grains were
considered a whole grain ingredient and a source of cereal fibre for this analysis due to
their similar nutritional composition, preparation and use to cereal grains (288), which is
also consistent with the WGI definition (22).

If the ingredient was determined as a whole grain, for example 100% wholemeal flour,
it would be assigned a whole grain value equal to its dry weight per 100g (100g-water
content/100g). Similarly, if an ingredient was determined as a source of cereal fibre, for
example cornflour, it would be assigned a cereal fibre value (g/100g) equal to its total
dietary fibre content (g/100g) reported within the database. If the ingredient was a nongrain food, such as red apple, it would be assigned a cereal fibre value of 0g/100g and a
whole grain value of 0g/100g.

An automated background calculation, a feature of the database, then generated a gram
value for whole grain and cereal fibre per 100g of all recipes (foods with multiple
ingredients) based on the proportion of ingredients. For example, for a cereal bar
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containing 20% raw oatmeal and no other cereal based ingredients, if the whole grain
content of oatmeal is 90g/100g, the gram whole grain content of the cereal bar was
calculated as in Equation 4.1:

20% 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑥𝑥 90𝑔𝑔 𝑤𝑤ℎ𝑜𝑜𝑜𝑜𝑜𝑜 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 𝑖𝑖𝑖𝑖 100𝑔𝑔 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 = 18𝑔𝑔 𝑤𝑤ℎ𝑜𝑜𝑜𝑜𝑜𝑜 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 𝑖𝑖𝑖𝑖 100𝑔𝑔 𝑜𝑜𝑜𝑜 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑏𝑏𝑏𝑏𝑏𝑏

Equation 4.1

This step enabled the Recipes Database to be populated with whole grain and cereal
fibre values of all foods including ingredients (e.g. 100% wholemeal flour) and complex
foods (e.g. cereal bar). Each value was examined and compared to previously developed
estimations (289), and issues were resolved by manual correction using product labels and
manufacturer information. After manual examination and corrections, final whole grain
values estimated within the Recipe Database were applied to all food data within the
Nutrient Databank.

Final cereal fibre values were determined using the same method as described above,
with an additional step. To account for slight variation in nutrient composition recorded
for each mixed recipe food within the Nutrient Databank compared to disaggregated
nutrient composition within the Recipe database, the cereal fibre values of each food
calculated from the Recipe database method was applied as a proportion of total dietary
fibre recorded within the Recipe database. This ratio was then applied to total dietary
fibre as recorded within the Nutrient Databank to determine final cereal fibre values
(Equation 4.2).
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Dietary fibre values of foods recorded within the six years of the Nutrient Databank
varied slightly across years due to various reasons such as product reformulation.
Therefore, we applied the above approach separately and retrospectively for all survey
years, dating back to NDNS Year 1 (2008/09).

𝑔𝑔
�
100𝑔𝑔
𝑔𝑔
�
�
100𝑔𝑔

𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑙𝑙 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 �
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 �

Equation 4.2

𝑔𝑔

100𝑔𝑔

𝑥𝑥 𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 �

𝑔𝑔

100𝑔𝑔

� =

�

The final estimated values of whole grain and cereal fibre content of each food and the
total amount of foods consumed by each participant were used to estimate total whole
grain and cereal fibre intake of each participant. Intake of respondents for each day of
the survey (day 1-4) was calculated by multiplying the percentage whole grain or cereal
fibre content of each consumed food (g/100g) by the total amount of that food
consumed that day (g).

MSM was utilised to estimate usual whole grain and cereal fibre intakes based on all
four days of data from the food diaries (208). MSM employs regression modelling to
consider the probability of consumption, usual intake on consumption days and usual
intake on all days. Age and gender were included in the regression models as covariates
assumed predictive for consumption. Further details of the process have been described
elsewhere (209). MSM was also applied to all dietary data included within analyses as
descriptive data or covariates.
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4.2.4 Outcome assessment
Height (cm) and weight (kg) of participants were measured using stadiometer and
digital scales, respectively, and BMI was calculated from these measurements. Waist
and hip circumference (cm) were taken by a nurse during the follow up visit with use of
an insertion tape, from which waist-hip ratio was calculated.

An automated blood pressure monitor (Omron HEM 907) was used to measure blood
pressure three times at one-minute intervals. If at least one of the three readings were
not valid, the participant’s blood pressure measurements were excluded. LDL
cholesterol, triglycerides and fasting glucose results data were only included where
fasted blood samples were taken. All risk factors analysed within this study were
collected from participants of all 6 years of the NDNS RP, except for homocysteine,
which was not collected in the sixth year. More information on the collection and
analysis of blood samples has been published previously (290).

Current recommendations for prevention of CVD emphasise the need to assess the
individual’s total burden of risk rather than singular risk factors (229). CVD relative risk
was determined for participants through use of the SCORE risk chart (287). The chart
was derived using combined data from 12 European cohort studies comprising over
200,000 persons representing 2.7 million person years of follow-up with 7934
cardiovascular deaths recorded (291). The chart predicts relative risk of fatal
cardiovascular event by age and sex using the predictors smoking status, systolic blood
pressure, and total cholesterol. To explore the significance that the potential confounder
smoking status had on overall risk score, we performed the analysis both including and
excluding current smokers. Further details of the SCORE chart have been published
148

previously (291). Unlike all other outcomes analysed, which were measured and collected
by NDNS personnel at the time of the survey, CVD relative risk score was calculated by
the authors prior to analyses.

4.2.5 Lifestyle factors and demographics assessment
Participants completed a Face-to-face CAPI to record information on ethnicity,
employment status, educational background, household income, smoking and alcohol
intake. Participants were also asked about current medications, including prescription
and/or use of lipid-lowering or blood pressure-lowering medications.

As there was considerable missing data on physical activity, it was not included as a
variable in analysis of the total dataset. Instead, physical activity as recorded using the
Recent Physical Activity Questionnaire (RPAQ) within the NDNS years 2-6 (year 1
used a bespoke method) was included in a post-hoc sensitivity analysis of available
data. The RPAQ is a validated self-completion questionnaire designed to capture
physical activity undertaken at home, at work, while commuting, and during leisure
activities (292). For each reported activity, metabolic equivalent of task (MET) scores (293)
were assigned. The time (hours per day) participants reported performing moderate to
vigorous activity (MET ≥3.0) was used to indicate physical activity levels.

4.2.6 Statistical analysis
Statistical analyses were conducted using Stata software version 14.0 (StataCorp LP,
College Station, Tx.). Weighting was applied to all data to adjust for sampling and nonresponse error. Full details of the weighting process have been published previously
(294)

. For the purpose of analyses, participants were divided into quartiles of both
149

energy-adjusted (g/10MJ/day) whole grain and cereal fibre intake to be analysed
separately. Energy-adjusted intakes were used for analyses to better reflect whole
grain/cereal fibre density of the diet. For both dietary variables, lowest energy-adjusted
intakes were categorised in quartile 1 (Q1) and highest intakes were categorised in
quartile 4 (Q4).

Characteristics and dietary intakes of participants within each quartile of whole grain
and cereal fibre intake were examined. Associations across quartiles with continuous
variables (e.g. age) were tested with linear regression analysis and a test for trend,
whereas associations with categorical variables (e.g. sex) were tested with a chi-squared
analysis. Separate linear regression models were then used to determine associations
between whole grain and cereal fibre and each risk factor examined. CVD risk factors
that were not normally distributed (triglycerides and homocysteine levels) were log
transformed prior to analysis. Tobit regression was used for the analysis of CRP, as the
data were left-censored. Adjusted mean values of each CVD risk factor were predicted
for each quartile of whole grain and cereal fibre intake, and a test for linear trend was
then used to examine significance of associations. Statistical significance for all tests
was set at P<0.05.

In the simple models, adjustments were made for age and sex. The multivariate models
were adjusted for relevant covariates, specific to each CVD risk factor. Dietary
covariates included intake of total energy, saturated fat, trans fat, sodium and non-milk
extrinsic sugars (sugars not contained within the cellular structure of a food except
lactose in milk and milk products (196)). Ethnicity, smoking status and alcohol intake
were also included as covariates within the multivariate models. Beyond the
150

multivariate model, adjustments for BMI and blood pressure or cholesterol-lowering
medication were also made where relevant, and whole grain associations were further
adjusted for cereal fibre intake.

4.2.7 High whole grain/low cereal fibre and low whole grain/high cereal fibre diets
Diets of participants in the lowest quartile of whole grain intake (Q1) and the highest
quartile of cereal fibre intake (Q4) (low WG/high CF), and diets of participants in the
highest quartile of whole grain intake (Q4) and the lowest quartile of cereal fibre intake
(Q1) (high WG/low CF) were examined. As there were few participants meeting these
criteria, statistical analysis comparing these diets would not be meaningful. Instead,
foods making up these meal patterns were reviewed descriptively to provide insight into
the composition of these diets.

4.3 Results
There were 5860 foods in the databank recorded from the NDNS RP 2008-14. Of these,
454 foods (7.7%) were estimated to contain at least 0.1g whole grain/100g and 2088
foods (35.6%) were estimated to contain at least 0.1g cereal fibre/100g, meaning
approximately 21.7% of cereal-fibre containing foods contained some whole grain
ingredients. The highest sources of whole grain were 100% whole grain foods with
relatively low water content, including popcorn (plain with no added fat, sugar or salt)
(95.9g/100g), corn cakes (100% corn) (95.4g/100g), raw wild rice (91.7g/100g) and raw
oatmeal (91.1g/100g). The highest sources of cereal fibre in the database were bran
wheat (33g/100g), All Bran™ cereal (Kellogg’s® brand only) (25.1g/100g) and all bran
cereal (other brands) (23.6-24.3g/100g), which notably all contained no whole grain, but
were instead high sources of bran.
151

Descriptive characteristics and dietary intakes of participants are outlined in Tables 4.14.2. Age was positively associated with whole grain (P<0.0001) and cereal fibre intake
(P=0.017). Participants within Q4 of energy-adjusted whole grain intake reported lower
consumption of total energy (P<0.0001), total fat (P=0.003), saturated fat (P=0.01),
monounsaturated fat (P=0.0001) and sodium (P=0.05). They reported consuming more
cereal fibre, total dietary fibre, carbohydrate (P<0.0001 for all) and protein (P=0.04).
They were more likely to have graduated from university (within the UK) (P<0.0001),
had a significantly higher equivalised household income (P=0.0001), and were less
likely to smoke (P<0.0001).

Review of the key characteristics of participants in the highest quartile of energyadjusted cereal fibre intake (Q4) showed similar patterns, reporting lower amounts of
total energy (P<0.0001), total fat (P=0.04), saturated fat (P=0.05), trans fat (P=0.02),
monounsaturated fat (P=0.003) and added (non-milk extrinsic) sugar (P=0.02). They
reported consuming more whole grain, total dietary fibre, carbohydrate (all P<0.0001)
and polyunsaturated fat (P=0.01). Significantly fewer participants in Q4 were current
smokers or daily alcohol consumers (both P<0.0001), and they were significantly more
likely to have graduated from university (within the UK) (P=0.0001).
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Table 4.1 Characteristics and nutrient intakes according to quartiles of energy-adjusted whole grain intake among participants of the
NDNS RP 2008-14

Age (y)3
Sex (% female)
Energy (kj/d)4
Cereal fibre (g/d)5
Total fibre (g/d)5
Carbohydrate (g/d)5
Protein (g/d)5
Total fat (g/d)5
Non-milk extrinsic sugar (g/d)5
Saturated fat (g/d)5
Mono-unsaturated fat (g/d)5
Poly-unsaturated fat (g/d)5
Trans fat (g/d)5
Sodium (mg/d)5
Equivalised household income
(GBP)4
UK university graduate (%)
Not working or studying (%)
White ethnicity (%)
Current smoker (%)
Daily alcohol consumer (%)
Blood pressure-lowering medication
use (%)6

Q1 (n=673)1
x̅ or %
SE
43.1
1.0
42.0
8632
82.4
3.9
0.1
13.4
0.2
239.3
1.7
78.7
0.7
77.3
0.5
61.7
1.7
29.1
0.3
28.2
0.2
12.8
0.1
1.4
0.03
2436
22.5

Q2 (n=672)
x̅ or %
SE
46.4
1.0
49.0
8798
79.3
4.9
0.1
14.1
0.2
240.4
1.8
78.5
0.7
77.8
0.6
65.6
1.8
29.5
0.3
28.0
0.2
12.9
0.1
1.4
0.03
2417
20.0

Q3 (n=673)
x̅ or %
SE
51.3
0.9
56.3
8538
68.3
6.0
0.1
15.3
0.2
244.8
1.5
79.2
0.5
76.3
0.5
63.0
1.4
28.9
0.3
27.4
0.2
12.9
0.1
1.4
0.03
2413
19.0

Q4 (n=671)
x̅ or %
SE
51.9
1.0
50.3
8188
78.4
8.2
0.1
16.5
0.2
249.5
1.5
80.6
0.7
75.1
0.6
62.1
1.5
28.1
0.3
26.9
0.2
13.0
0.1
1.4
0.03
2372
22.6

27880

1207

33645

1263

35299

1238

34371

1212

0.0001

16.0
35.7
87.9
37.1
11.1

-

27.8
33.3
92.3
21.0
13.1

-

30.0
38.4
91.4
12.1
10.8

-

36.3
41.9
91.3
8.8
8.4

-

<0.0001
0.16
0.10
<0.0001
0.36

8.6

-

9.4

-

13.7

-

11.4

-

0.13

P value2
<0.0001
0.001
<0.0001
<0.0001
<0.0001
<0.0001
0.04
0.003
0.86
0.01
0.0001
0.45
0.19
0.05
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Lipid-lowering medication use (%)6

13.4

-

15.7

-

18.0

-

17.8

-

0.35

1

Median whole grain intake (g/10MJ/d): Q1 3.0, Q2 20.1, Q3 38.9g, Q4 68.8
Associations with continuous variables were tested with linear regression analysis and a test for trend, associations with categorical variables
were tested with a chi-square analysis
3
Adjusted for sex
4
Adjusted for age and sex
5
Adjusted for age, sex and total energy intake (kJ/d)
6
Based on data available from smaller sample of participants (n=2128)
2
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Table 4.2 Characteristics and nutrient intakes according to quartiles of energy-adjusted cereal fibre intake among participants of the
NDNS RP 2008-14

Age (y)3
Sex (% female)
Energy (kj/d)4
Whole grain (g/d)5
Total fibre (g/d)5
Carbohydrate (g/d)5
Protein (g/d)5
Total fat (g/d)5
Saturated fat (g/d)5
Mono-unsaturated fat (g/d)5
Poly-unsaturated fat (g/d)5
Trans fat (g/d)5
Non-milk extrinsic sugar (g/d)5
Sodium (mg/d)5
Equivalised household income (GBP)4
UK university graduate (%)
Not working or studying (%)
White ethnicity (%)
Current smoker (%)
Daily alcohol consumer (%)
Blood pressure-lowering medication use
(%)6
Lipid-lowering medication use (%)6

Q1 (n=673)1
x̅ or %
47.0
48.5
9157
7.7
13.2
234.6
79.0
77.3
29.1
28.1
12.7
1.4
65.8
2394
31032
20.0
37.1
90.5
31.8
18.5
11.0
15.8

Q3 (n=672)
x̅ or % SE
48.6
1.0
50.7
8328
62.0
31.7
0.8
15.3
0.2
246.4
1.6
79.9
0.7
76.4
0.5
28.7
0.3
27.6
0.2
13.1
0.1
1.4
0.03
62.7
1.5
2411
18.9
32877
1261
29.0
37.4
91.4
13.6
9.6
11.5
-

Q4 (n=672)
x̅ or % SE
50.0
0.9
45.4
7964
80.3
55.8
1.5
16.4
0.2
249.8
1.5
79.8
0.6
75.8
0.5
28.4
0.3
27.1
0.2
13.1
0.1
1.3
0.02
59.8
1.3
2412
22.6
33886
1195
34.7
36.9
89.1
10.7
6.9
10.3
-

P value2

SE
1.0
82.5
0.6
0.2
1.8
0.7
0.6
0.3
0.2
0.1
0.03
2.2
23.5
1151
-

Q2 (n=672)
x̅ or % SE
47.2
1.0
52.9
8705
65.9
20.3
0.7
14.4
0.2
243.3
1.5
78.3
0.6
76.9
0.6
29.3
0.3
27.7
0.2
12.7
0.1
1.4
0.03
64.1
1.5
2422
19.5
33405
1317
26.4
37.9
91.9
22.8
8.4
10.2
-

-

17.1

15.5

16.6

0.94

-

-

-

0.02
0.19
<0.0001
<0.0001
<0.0001
<0.0001
0.23
0.04
0.05
0.003
0.01
0.02
0.02
0.67
0.13
0.0001
0.95
0.25
<0.0001
<0.0001
0.95
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1

Median cereal fibre intake (g/10MJ/d): Q1 4.0, Q2 5.7, Q3 7.4, Q4 9.8
Associations with continuous variables were tested with linear regression analysis and a test for trend, associations with categorical variables
were tested with a chi-square analysis
3
Adjusted for sex
4
Adjusted for age and sex
5
Adjusted for age, sex and total energy intake (kJ/d)
6
Based on data available from smaller sample of participants (n=2128)
2
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Associations between whole grain and cereal fibre intake and assessed risk factors are
shown in Table 4.3 and 4.4, respectively. Compared to participants in the lowest
quartile of whole grain intake, participants in the highest quartile had lower waist-hip
ratios (Q1: 0.872; Q4: 0.856; P=0.006). These results remained significant after
adjustment for cereal fibre (P=0.04), as well as further adjustment for physical activity
in the sensitivity analysis (P=0.03, data not shown). Comparable results were found for
cereal fibre intake (Q1: 0.872; Q4: 0.867; P=0.03), however this disappeared when
examining the smaller sample within the sensitivity analysis (P=0.14).

Whole grain intake was inversely associated with CRP levels (Q1 3.50 mg/L; Q4 1.78
mg/L; P=0.008), and these associations remained after adjusting for BMI and use of
lipid-lowering medications (P=0.02). Upon adjusting for cereal fibre, the association
was no longer significant (P=0.11). A borderline significant inverse association was also
found for CRP and cereal fibre intake, which remained after adjustment for BMI and
use of lipid-lowering medication (P=0.05).

Both whole grain and cereal fibre intake were associated with significantly lower
homocysteine levels, even after further adjustment for BMI (Q1: 10.14 µmol/L, Q4:
8.52 µmol/L; P<0.0001 and Q1: 9.62 µmol/L, Q4: 8.49 µmol/L; P=0.002, respectively).
Whole grain intake remained significant after adjustment for cereal fibre intake
(P=0.01). Both associations remained significant within the sensitivity analysis (P=0.03
for whole grain; P=0.003 for cereal fibre), where there was a much smaller sample size
of 990 participants.
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HbA1c values were relatively consistent across quartiles of energy-adjusted whole grain
intake, however, unexpectedly, after adjustment for cereal fibre intake, a small but
statistically significant inverse association was seen (Q1: 5.66%, Q4: 5.47%; P=0.01),
which remained in the sensitivity analysis (P=0.008). Interestingly there was a slight
positive but non-significant association between cereal fibre intake and HbA1c.

When smokers were included in the analysis, higher whole grain and cereal fibre intakes
were both associated with significantly lower CVD risk SCORE (Q1: 1.85, Q4: 1.56;
P=0.002 and Q1: 1.78, Q4: 1.52; P=0.003, respectively). After adjustment for cereal
fibre, the whole grain association was no longer significant (P=0.26). When smokers
were excluded from the analysis, whole grain intake was associated with lower relative
risk SCORE after adjustment for cereal fibre intake with borderline significance
(P=0.05), which was attenuated slightly in the sensitivity analysis (P=0.07).

No other risk factors assessed were significantly associated with whole grain or cereal
fibre intakes (P>0.05 for all).
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Table 4.3 Cardiovascular disease risk factors according to quartiles of energy-adjusted whole grain intake among participants of the
NDNS RP 2008-14
Q1
x̅

SE

Q2
x̅

SE

Q3
x̅

SE

Q4
x̅

SE

P for
trend

0.24
0.24
0.27

26.37
26.34
26.42

0.26
0.25
0.26

26.05
26.04
26.02

0.20
0.20
0.20

25.60
25.64
25.40

0.21
0.21
0.26

0.31
0.42
0.09

0.004
0.004
0.004

0.867
0.866
0.866

0.004
0.004
0.004

0.868
0.868
0.868

0.003
0.003
0.003

0.856
0.856
0.857

0.003
0.003
0.004

0.004
0.006
0.04

1.02
1.02
1.01
1.10

125.32
125.22
125.19
125.41

0.76
0.79
0.76
0.79

126.06
126.16
125.96
125.89

0.83
0.84
0.79
0.79

125.91
125.97
126.38
125.73

0.89
0.91
0.88
1.12

0.47
0.56
0.92
0.46

0.07
0.07
0.07
0.08

5.08
5.05
5.04
5.03

0.07
0.07
0.06
0.07

5.06
5.06
5.05
5.05

0.07
0.07
0.06
0.06

5.04
5.05
5.07
5.09

0.06
0.07
0.06
0.08

0.91
0.84
0.71
0.94

2

BMI (kg/m ) (n=2658)
Simple adjusted1
25.83
+ Total energy intake
25.82
+ Cereal fibre intake
26.00
Waist-hip ratio (n=2107)
Simple adjusted1
0.872
+ Total energy intake
0.872
+ Cereal fibre intake
0.872
Systolic blood pressure (mmHg) (n=1673)
Simple adjusted1
127.17
2
Multivariate adjusted
127.12
+ BMI and BP-lowering medication
126.78
+ Cereal fibre intake
127.26
Total cholesterol (mmol/L) (n=1481)
Simple adjusted1
5.05
3
Multivariate adjusted
5.08
+ BMI and lipid-lowering medication 5.11
+ Cereal fibre intake
5.09
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HDL-cholesterol (mmol/L) (n=1481)
Simple adjusted1
Multivariate adjusted3
+ BMI and lipid-lowering medication
+ Cereal fibre intake
LDL-cholesterol (mmol/L) (n=1465)
Simple adjusted1
Multivariate adjusted3
+ BMI and lipid-lowering medication
+ Cereal fibre intake
CRP (mg/L) (n=1481)
Simple adjusted1
Multivariate adjusted3
+ BMI and lipid-lowering medication
+ Cereal fibre intake
Triglycerides (mmol/L) (n=1477)
Simple adjusted1
Multivariate adjusted4
+ BMI and lipid-lowering medication
+Cereal fibre intake
Fasting glucose (mmol/L) (n=1416)
Simple adjusted1
+ Energy intake
+ BMI
+ Cereal fibre intake

1.49
1.50
1.50
1.51

0.03
0.03
0.03
0.03

1.47
1.47
148
1.48

0.03
0.03
0.02
0.02

1.51
1.51
1.51
1.51

0.03
0.03
0.02
0.02

1.53
1.53
1.51
1.49

0.02
0.03
0.02
0.03

0.21
0.28
0.71
0.81

3.02
3.04
3.07
3.05

0.06
0.06
0.05
0.07

3.08
3.05
3.03
3.02

0.07
0.07
0.06
0.06

3.04
3.04
3.03
3.04

0.07
0.07
0.06
0.06

3.02
3.03
3.05
3.07

0.06
0.06
0.06
0.07

0.92
0.84
0.77
0.82

3.58
3.50
3.44
3.31

0.45
0.44
0.44
0.45

2.74
2.72
2.60
2.55

0.30
0.31
0.32
0.31

2.63
2.67
2.64
2.66

0.46
0.44
0.44
0.43

1.74
1.78
1.91
2.09

0.24
0.27
0.28
0.36

0.003
0.008
0.02
0.11

1.09
1.09
1.09
1.06

0.04
0.04
0.03
0.04

1.12
1.11
1.09
1.08

0.04
0.04
0.03
0.04

1.05
1.06
1.06
1.06

0.03
0.03
0.03
0.03

1.02
1.02
1.05
1.09

0.03
0.04
0.03
0.04

0.09
0.15
0.41
0.83

5.22
5.22
5.22
5.21

0.08
0.08
0.08
0.10

5.25
5.25
5.24
5.23

0.06
0.06
0.06
0.06

5.23
5.23
5.22
5.23

0.07
0.07
0.06
0.06

5.18
5.17
5.20
5.22

0.06
0.06
0.06
0.07

0.61
0.60
0.82
0.98
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HbA1c (%) (n=1445)
Simple adjusted1
5.59
0.05
+ Energy intake
5.59
0.05
+ BMI
5.59
0.05
+ Cereal fibre intake
5.66
0.05
Homocysteine (µmol/L) (n=1250)
Simple adjusted1
10.22
0.31
5
Multivariate adjusted
10.17
0.31
+ BMI
10.14
0.30
+ Cereal fibre intake
9.95
0.30
Relative risk SCORE (n=1182)
Simple adjusted1
1.83
0.07
+ Total energy intake
1.83
0.07
+ Cereal fibre intake
1.79
0.08
Relative risk SCORE (n=1023) (smokers excluded)
Simple adjusted1
1.58
0.05
+ Total energy intake
1.57
0.05
+ Cereal fibre intake
1.62
0.06

5.59
5.59
5.58
5.60

0.04
0.04
0.04
0.05

5.54
5.54
5.53
5.53

0.03
0.03
0.03
0.03

5.54
5.54
5.55
5.47

0.03
0.03
0.03
0.04

0.23
0.25
0.34
0.01

9.25
9.25
9.25
9.15

0.28
0.28
0.28
0.27

9.08
9.12
9.12
9.14

0.18
0.18
0.18
0.18

8.52
8.52
8.52
8.76

0.17
0.17
0.17
0.26

<0.0001
<0.0001
<0.0001
0.01

1.63
1.63
1.61

0.08
0.08
0.08

1.54
1.54
1.53

0.06
0.06
0.06

1.56
1.56
1.64

0.06
0.06
0.10

0.004
0.004
0.26

1.42
1.42
1.44

0.04
0.04
0.04

1.42
1.42
1.40

0.05
0.05
0.05

1.46
1.47
1.43

0.05
0.05
0.07

0.15
0.19
0.05

1

Adjusted for age and sex
Adjusted for age, sex, total energy, ethnicity, smoking status, sodium
3
Adjusted for age, sex, total energy, ethnicity, smoking status, alcohol, sat fat, trans fat
4
Adjusted for age, sex, total energy, ethnicity, smoking status, alcohol, sat fat, trans fat, non-milk extrinsic sugar
5
Adjusted for age, sex, total energy, ethnicity, smoking status, alcohol
2
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Table 4.4 Cardiovascular disease risk factors according to quartiles of energy-adjusted cereal fibre intake among participants of the
NDNS RP 2008-14
Q1
x̅
BMI (kg/m2) (n=2658)
Simple adjusted1
25.95
+ Total energy intake
25.85
Waist-hip ratio (n=2107)
Simple adjusted1
0.872
+ Total energy intake
0.872
Systolic blood pressure (mmHg) (n=1673)
Simple adjusted1
126.73
2
Multivariate
126.50
+ BMI and BP-lowering medication
126.35
Total cholesterol (mmol/L) (n=1481)
Simple adjusted1
5.09
3
Multivariate adjusted
5.07
+ BMI and lipid-lowering medication
5.12
HDL-cholesterol (mmol/L) (n=1481)
Simple adjusted1
1.52
3
Multivariate adjusted
1.51
+ BMI and lipid-lowering medication
1.50

SE

Q2
x̅

SE

Q3
x̅

SE

Q4
x̅

SE

P for
trend

0.24
0.25

26.09
26.06

0.24
0.24

25.92
25.95

0.21
0.21

25.89
25.98

0.22
0.23

0.74
0.78

0.004
0.004

0.867
0.867

0.004
0.004

0.862
0.862

0.004
0.004

0.861
0.862

0.003
0.004

0.02
0.03

0.89
0.93
0.93

124.85
124.93
124.70

0.89
0.89
0.86

126.26
126.24
126.28

0.90
0.91
0.89

126.62
126.79
126.98

0.82
0.88
0.86

0.78
0.61
0.42

0.07
0.07
0.06

5.06
5.04
5.05

0.07
0.07
0.06

5.03
5.03
5.01

0.08
0.08
0.07

5.05
5.09
5.08

0.06
0.06
0.06

0.65
0.93
0.63

0.03
0.03
0.03

1.50
1.50
1.51

0.03
0.03
0.03

1.47
1.46
1.47

0.02
0.02
0.02

1.51
1.52
1.51

0.03
0.03
0.02

0.70
0.99
0.97
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LDL-cholesterol (mmol/L) (n=1465)
Simple adjusted1
Multivariate adjusted3
+ BMI and lipid-lowering medication
CRP (mg/L) (n=1481)
Simple adjusted1
Multivariate adjusted3
+ BMI and lipid-lowering medication
Triglycerides (mmol/L) (n=1477)
Simple adjusted1
Multivariate adjusted4
+ BMI and lipid-lowering medication
Fasting glucose (mmol/L) (n=1416)
Simple adjusted1
+ Total energy intake
+ BMI
HbA1c (%) (n=1445)
Simple adjusted1
+ Total energy intake
+ BMI
Homocysteine (µmol/L) (n=1250)
Simple adjusted1
Multivariate adjusted5
+ BMI

3.05
3.05
3.08

0.06
0.06
0.06

3.02
3.00
3.01

0.06
0.06
0.05

3.07
3.07
3.06

0.07
0.07
0.07

3.02
3.04
3.04

0.06
0.06
0.06

0.95
0.82
0.77

2.96
3.02
3.06

0.38
0.38
0.39

2.97
2.87
2.78

0.35
0.36
0.36

2.87
2.91
2.90

0.45
0.43
0.43

1.91
1.88
1.87

0.18
0.22
0.23

0.03
0.05
0.05

1.11
1.10
1.11

0.03
0.03
0.03

1.11
1.09
1.08

0.04
0.04
0.03

1.02
1.04
1.04

0.04
0.03
0.03

1.04
1.05
1.06

0.04
0.04
0.03

0.08
0.27
0.31

5.19
5.19
5.21

0.06
0.06
0.06

5.16
5.16
5.15

0.04
0.04
0.04

5.32
5.32
5.32

0.09
0.09
0.09

5.21
5.21
5.22

0.07
0.07
0.07

0.42
0.45
0.49

5.53
5.52
5.53

0.04
0.04
0.04

5.55
5.55
5.54

0.03
0.03
0.03

5.58
5.58
5.57

0.04
0.04
0.04

5.61
5.61
5.61

0.04
0.04
0.04

0.15
0.10
0.13

9.59
9.63
9.62

0.19
0.29
0.29

9.32
9.30
9.27

0.19
0.19
0.19

9.52
9.60
9.61

0.29
0.29
0.29

8.59
8.50
8.49

0.17
0.17
0.17

0.003
0.001
0.002

163

Relative risk SCORE (n=1182) (smokers included)
Simple adjusted1
1.75
0.06
+ Total energy intake
1.76
0.07
Relative risk SCORE (n=1023) (smokers excluded)
Simple adjusted1
1.51
0.05
+ Total energy intake
1.50
0.05

1.68
1.68

0.09
0.09

1.60
1.60

0.06
0.06

1.53
1.52

0.05
0.05

0.004
0.003

1.47
1.47

0.05
0.05

1.46
1.46

0.04
0.04

1.44
1.45

0.05
0.05

0.32
0.47

1

Adjusted for age and sex
Adjusted for age, sex, total energy, ethnicity, smoking status, sodium
3
Adjusted for age, sex, total energy, ethnicity, smoking status, alcohol, sat fat, trans fat
4
Adjusted for age, sex, total energy, ethnicity, smoking status, alcohol, sat fat, trans fat, non-milk extrinsic sugar
5
Adjusted for age, sex, total energy, ethnicity, smoking status, alcohol
2
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4.3.1 Composition and quality of high whole grain/low cereal fibre and low whole
grain/high cereal fibre diets
Only two participants were categorised as consuming a high whole grain/low cereal
fibre diet based on being in both the highest quartile of whole grain intake (Q4) and the
lowest quartile of cereal fibre intake (Q1). Both participants reported consuming brown
rice (a relatively low-fibre whole grain food) daily. With the exception of brown rice,
few other cereal foods were included in the 4-day food diaries of either participant.

Two main patterns of intake could be identified within the 23 participants that were in
both the lowest quartile of whole grain intake (Q1) and the highest quartile of cereal
fibre intake (Q4) (low whole grain/high cereal fibre diet). A small number of
participants (n=5) reported consuming cereal foods that were not whole grain but were
high in cereal fibre, such as bran products and brown breads (brown bread is not
classified as a whole grain as it contains only 80% intact grain). However,
unexpectedly, the majority of participants within this group (n=18) reported diets that
were comprised of large amounts of refined grain cereal foods. While these cereal foods
were not high sources of fibre individually, these participants ate them in large enough
qualities to accumulate to higher intakes, even after adjustment for total energy intake.
Commonly eaten cereal foods within this group included white bread and bread
alternatives, white pasta and noodles, pizza, and white rice.

4.4 Discussion
Among adult participants of the NDNS RP 2008-14, some modest associations were
found between diets high in whole grain and cereal fibre, and lower waist-hip ratio,
CRP levels (borderline p=0.05 for cereal fibre), homocysteine levels, and CVD relative
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risk score. However, no associations were found for all other CVD risk factors
examined, including BMI, lipid profile constituents, blood pressure, and metabolic
markers.

In contrast to similar cross-sectional studies from the United States (137; 147; 295; 296), we
did not find a significant association for BMI within this UK population, however both
whole grain and cereal fibre intakes were inversely associated with waist-hip ratio.
Potentially, waist-hip ratio is more indicative of cardiovascular risk than overall body
weight, as it is a more direct measure of central adiposity. Commonly proposed
mechanisms explaining the association between whole grain intake and weight
management mainly refer to the fibre component and its effect on overall energy intake.
Foods high in fibre such as whole grains tend to be of lower energy density, resulting in
reduced overall energy intake (297). Soluble fibre in particular may also delay gastric
emptying and macronutrient absorption by binding with water to form a viscous matrix
trapping nutrients prior to digestion, postulated to increase satiety (297). Our findings
seem to support this pathway, as both whole grain and cereal fibre intakes were strongly
inversely associated with overall energy intake, and this was more pronounced for
cereal fibre. However, the actual differences in mean waist-hip ratios between lowest
and highest quartiles of whole grain and cereal fibre intake are minor (0.016 and 0.01,
respectively), and neither are necessarily indicative of considerable risk difference,
which limits interpretation of potential differential benefits between whole grain and
cereal fibre intakes.

Neither whole grain nor cereal fibre were associated with any lipid profile constituent.
While one cross-sectional study also found no associations (295), other similar sized
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studies have found significant inverse associations for whole grain intake (111; 147; 298) and
cereal fibre intake (147). It is likely that lipid-lowering effects of whole grains are
dependent on the type of whole grains and the fibre they contain. Whole grains high in
β-glucan soluble fibre such as oats are thought to lower LDL cholesterol through the
ability of β-glucan to inhibit bile acid reabsorption, causing the body to increase uptake
of circulating LDL-cholesterol to replenish hepatic cholesterol (58). In a previous study
of the NDNS RP 2008-11, oats accounted for only 15% of total whole grain consumed
. Given these proportions, any associations relating directly to oat or β-glucan intake

(21)

are unlikely to be captured in analysis of total whole grain and cereal fibre intake. In
controlled intervention studies targeting oat intake only, more pronounced effects on
lipid profile constituents have been shown from both oatmeal (a whole grain) and oat
bran (a high cereal fibre source), with effects related specifically to the fibre content as
β-glucan (56). Similarly, our study found no associations between whole grain and cereal
fibre to systolic blood pressure, in agreement with other cross-sectional studies (147; 295;
298)

Two reviews of controlled trials found that effects were more pronounced in

hypertensive participants rather than normotensive participants (299) (300), which may
explain lack of results in population-based studies.

Whole grain and cereal fibre intake were also not associated with fasting plasma
glucose levels in this study. Again, grains higher in soluble fibre may have a differential
effect to other whole grains, as the increased viscosity of intestinal contents created by
soluble fibre may reduce macronutrient absorption and slow gastric emptying, in turn
reducing glucose and insulin responses (264). Additionally, associations are often more
pronounced in participants with T2DM or insulin resistance (301; 302). Here, an inverse
association between whole grain intake and HbA1c did become significant only after
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adjustment for cereal fibre intake. Although the association was not significant, higher
cereal fibre intakes also tended to be associated with higher HbA1c. While it is unlikely
that this trend is genuine, other constituents of whole grains may account for the
association seen only in whole grain intake. For example, magnesium intake may also
be of benefit to glucose metabolism, as restoration of intracellular magnesium
concentrations in patients with non-insulin dependent T2DM, has been shown to
effectively improve insulin-mediated glucose uptake (91).

Whole grain intake was inversely associated with CRP, although the association
disappeared after adjustment for cereal fibre intake. In a previous cross-sectional study
of years 1-4 of the NDNS RP (2008-11), whole grain intake was not associated with
CRP levels (303). Despite the study using a similar method, it is possible that the addition
of years 5-6 of the NDNS RP within our study accounted for the difference in findings.
Within other cross-sectional studies, whole grains (111; 140) have been associated with
lower CRP levels. Similarly to results seen here, the associations were attenuated in
models adjusting for BMI. CRP is a clinical indicator of inflammation, and as obesity is
characterised by low-grade systemic inflammation (304), fibre may in part reduce CRP
levels through its effect on body weight. Although, BMI was not independently
associated with whole grain intake within our study. Additionally, fermentation of
cereal fibres within the gut, particularly arabinoxylan and β-glucan, increase production
of butyrate, a short-chain fatty acid which has been shown to inhibit inflammatory
response (305). These proposed mechanisms may explain why adjustment for cereal fibre
intake caused the association for whole grain intake to disappear within our study. That
is, the associations are primarily due to the fibre content of the whole grain foods.
However, high cereal fibre intake when analysed separately was only borderline
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inversely (P=0.05) related to CRP levels. Phenolic acids, particularly ferulic acid, have
been shown to also exhibit anti-inflammatory activity (79), suggesting additional
bioactive compounds within whole grains may also contribute to the association found.

Both whole grain and cereal fibre intake were strongly associated with lower
homocysteine levels within this study, consistent with other cross-sectional studies in
differing populations (111; 140). While the association to whole grain intake was
attenuated after adjustment for cereal fibre intake, it remained significant. This was not
unexpected, as folate and pyridoxine (vitamin B6), both contained within whole grain
foods, are key cofactors in the metabolism of homocysteine, and supplementation with
both (as well as vitamin B12) have been found to restore elevated homocysteine levels
(306)

. Therefore it is probable that these components of high whole grain intake are

contributing to the inverse association seen here. While high homocysteine levels been
proven as an independent risk factor for CVD (227), it is not yet known whether a
causative relationship exists or whether it is a marker of risk, as there is limited
evidence showing lowered CVD risk with administration of homocysteine-lowering
vitamins (100). With consideration of this, findings here should be interpreted cautiously,
and larger studies are needed to further clarify the relationship between homocysteine
and CVD.

As consumers of higher whole grain and cereal fibre were significantly less likely to
smoke in our study, and smoking status is one of the three risk factors included in
calculation of relative risk SCORE, the inverse associations found between whole grain
and cereal fibre intakes and relative risk SCORE may be highly influenced by this
confounding relationship. Therefore, analysing risk SCOREs with current smokers
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excluded is potentially more accurate for considering dietary-related associations. It was
interesting that when associations between whole grain intake and total cholesterol and
systolic blood pressure were performed separately, no results were found, but when
combined into a risk score, a borderline inverse association was found (P=0.05) after
adjustment for cereal fibre intake, despite the much smaller sample size. This finding
suggests the value in further research assessing CVD risk with a combination of risk
factors such as through risk scores.

An issue with attempting to examine the extent to which the benefits associated with
whole grain intake may be explained by their high cereal fibre content, is separating the
whole grain and cereal fibre intake. Unsurprisingly, the highest consumers of whole
grain also make up the vast majority of those consuming the highest amount of cereal
fibre. We attempted to descriptively explore the diet composition of participants that did
not fit this pattern, as there were not enough eligible participants to perform statistical
analyses. The findings were unexpected, particularly the diets of those consuming high
cereal fibre-low whole grain, which contained high amounts of poorer-quality refined
grain foods (e.g. pizza, white rice, fried breads), rather than being rich in bran-based
foods, which were the highest sources of cereal fibre recorded within the survey. This
finding highlights the difficulty in determining the individual health benefits of nonwhole grain cereal fibre outside of a controlled setting, as comparative diets may be
starkly different in overall quality. Differences in associations seen here between whole
grains and cereal fibre intakes, such as the slight positive association between cereal
fibre intake and HbA1c, may be partly a result of this, despite attempts to adjust for
other dietary confounders. However, it is difficult to speculate based on these results
only, given the very small number of participants within these separated groups. It
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would be valuable to compare CVD-associations between high whole grain consumers
and the two different high cereal fibre-low whole grain patterns (namely high bran
consumers and high refined grain consumers), if sufficient sample sizes were available.

The strengths of this study include the large sample size, the use of a 4 day-food diary
to record intakes and MSM adjustment to estimate usual intakes, and the systematic
process used to estimate whole grain and cereal fibre content within all foods consumed
by participants. Although attempts were made to adjust for relevant confounding dietary
and lifestyle factors for associations, there is the possibility of residual confounding, as
higher whole grain and cereal fibre intake may be associated with a healthier lifestyle
and better diet quality. As there are multiple risk factors that may be relevant in the
association between whole grain and cereal fibre intake and CVD risk, many tests were
performed within this study, increasing the potential for type 1 error. However,
significant associations found within our paper did tend to be consistent with findings in
previous, similar cross sectional studies, while inconsistency tended to occur when we
did not find an association. Regardless, caution needs to be taken with interpretation of
findings, particularly those of borderline significance. While many risk factors were
assessed within this study, data were restricted to that which was measured within the
NDNS RP, limiting exploration of additionally potentially relevant CVD risk factors.
Finally, as this was a cross sectional study, it lacks temporality, and it is impossible to
determine any causation between intakes and risk factors assessed.

4.5 Conclusion
In consideration of all findings, cereal fibre intake often attenuated inverse associations
to CVD risk factors found when examining whole grain intakes, although the
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associations were stronger in whole grain analyses (prior to cereal fibre adjustment),
than when cereal fibre intake was independently examined. This suggests that while
cereal fibre is likely a major component contributing to most whole grain inverse
associations, additional components present with high whole grain intake, which may
not be present with high cereal fibre intake, are also of value. Alternatively, as we found
that diets high in cereal fibre from non-whole grain sources tended to feature high
amounts of poorer quality grain foods, it may be that additional components of these
diets that were not accounted for in multivariate analyses are weakening any benefits of
the high cereal fibre consumed. Longer term intervention studies are needed to explore
this notion further, whereby participants are fed whole grain and non-whole grain diets
that are matched for cereal fibre intake and overall diet quality.

Importantly, all associations found here were modest, and there were many risk factors
assessed that were not associated with either whole grain or cereal fibre intakes. In these
cases, other dietary factors may be more relevant, highlighting that while it is valuable
to explore potential independent associations of singular foods or nutrients within the
research setting, translation of findings into efforts to prevent chronic disease should
always be placed in the context of total diet quality and composition.

The next chapter follows a similar methodology, however, with application to the most
recent Australian population-representative dietary dataset. It is of value to consider
associations in the Australian context to not only strengthen the overall evidence, in
consideration of different food supplies, but also ensure that any findings are relevant to
the dietary patterns of Australians.
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Chapter 5:
Whole grain and cereal fibre intake in the Australian
Health Survey (AHS) - associations to cardiovascular
disease risk factors

A major component of this chapter is the substantive content of the accepted article:

Barrett, EM, Batterham, MJ, and Beck, EJ. (2020) Whole grain and cereal fibre intake in the
Australian Health Survey (AHS) - associations to cardiovascular disease risk factors. Public
Health Nutrition. (Accepted 1 October 2019).
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5.1 Introduction
CVD is a major public health burden for Australia, with one in six (approximately 4
million) Australians affected by the disease (3). Diet can play a role in managing and
reducing the risk of developing these CVD related conditions, and as discussed
previously, a diet high in whole grains and whole grain foods may be particularly
protective.

The rich mix of fibre, vitamins, minerals and phenolic compounds contained in whole
grain may each play a role in different pathways (26). Cereal fibre is often found to have
the strongest association with favourable cardiovascular health compared to other
sources of fibre such as fruit or vegetable (41), which may suggest that the fibre
component of the whole grain is specifically responsible for their benefits. However, it
is also possible that high cereal fibre intake simply reflects high whole grain intake, as
whole grains are a primary source of cereal fibre, and it is difficult to separate the two
exposures. To date, there is limited research directly comparing the health associations
of cereal fibre and whole grain intakes accurately (Chapter 3).

To accurately compare associations of whole grain and cereal fibre intakes, accepted
definitions need to be used and whole grain food sources need to be examined at an
ingredient-level such as with use of food composition databases, allowing whole grain
and cereal fibre intake to be reported as total grams per day rather than food serves. In
the previous chapter, this methodology was applied to a UK dietary dataset, where
modest inverse associations were found between both whole grain and cereal fibre to
CVD-related outcomes, with slightly stronger inverse associations found for whole
grains. This chapter will follow a similar methodology and aimed to examine
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associations between whole grain and cereal fibre intakes to CVD-related outcomes but
here, within adult participants of the 2011-13 AHS, quantified systematically using food
composition databases and accepted definitions. The AHS is the most recent
population-representative dietary survey conducted in Australia, thereby providing the
most up to date representation of Australian dietary intakes.

5.2 Methods
5.2.1 Study population
This study used data from the 2011-12 NNPAS and the 2011-13 NHMS subcomponents
of the 2011-13 AHS. Core content of the AHS includes household and demographic
information from 32,000 Australians. The NNPAS was then conducted on 12,153 of
these participants, aged between 2 and 85 years old, to obtain data on nutritional intake
and physical activity. All participants within the NNPAS aged five years and over were
also invited to participate in the NHMS, which involved collection of blood and/or urine
to examine nutrient biomarkers and biomarkers of chronic disease. Further details of the
survey have been published elsewhere (194).

Within this study, we excluded participants of the AHS who were under the age of 18
years. Additionally, we excluded under-reporters of daily energy intake, based on the
Goldberg cut-off of 0.9 for one day of intake (286). Of the initial 12,153 participants,
7,665 remained for analysis. However, the available sample size varied between
outcomes due to further missing data. The available sample size for each outcome is as
follows: body mass index (BMI) (n=6206), waist circumference (n=6214), systolic and
diastolic blood pressure (n=6381), total cholesterol and HDL cholesterol (n=3116),
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LDL cholesterol (n=2614), triglycerides (n=2640), apolipoprotein-B (n=3115), Creactive protein (n=3114), fasting glucose (n=2641), and HbA1c (n=3107).

5.2.2 Food and nutrient intake assessment
Dietary intake data was collected within the survey via one 24-hour dietary recall, using
an adapted version of the AMPM (207), a five-phase questionnaire designed to maximise
food recall and minimise memory bias. Details on the questionnaire are provided in the
AHS survey user guide (194).

Participant nutrient intake was estimated from the recalled intake data using the
customised nutrient composition database developed by FSANZ, the AUSNUT 2011-13
food nutrient database (307). In 2016, free sugars were added to the existing food nutrient
database to allow estimation of free sugar intakes within the AHS. Free sugars were
defined as per the WHO, and included added forms of dextrose, fructose, sucrose,
lactose, sugar syrups, fruit syrups, the sugar component of honey, fruit juice and fruit
juice concentrates (308). In comparison to total sugars, free sugars do not include natural
sugars from intact fruits, vegetables and milk.

5.2.3 Cereal fibre and whole grain intake estimation
Whole grain and cereal fibre content of each food item reported within the survey was
estimated using published food composition databases previously developed from the
AUSNUT 2011-13 food nutrient database (215; 223).

In brief, whole grain was defined as per the FSANZ definition as:
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“the intact grain or the dehulled, ground, milled, cracked or flaked grain where the
constituents—endosperm, germ and bran—are present in such proportions that
represent the typical ratio of those fractions occurring in the whole cereal, and includes
wholemeal.” (24)

Whole grain ingredients within the database included BarleyMax™, millet, oats, rice
(brown, wild, black and red), rye and wholemeal rye flour, sorghum and wholemeal
sorghum flour, triticale, wheat (all varieties) and wholemeal wheat flour, and sprouted
whole grains. Pseudo cereal grains including amaranth, buckwheat and quinoa were also
considered whole grain due to their similar nutritional composition, preparation and use.
Whole grain content of all foods was calculated in grams per/100g of product on a dry
weight basis.

Cereal fibre was defined as fibre with cereal grains or pseudo cereal grain origin,
including cereal fibres that are both intrinsic and extrinsic to the food source. Food
sources containing >0.1g cereal fibre per 100g-food product were considered sources of
cereal fibre, based on the limitations of the analytical tests that measure fibre.

Using the databases, whole grain and cereal fibre intake for the day of the survey was
calculated as the summed amount of each whole grain or cereal fibre containing food
reported (g) by the participant, multiplied by the amount of whole grain or cereal fibre
(g/100g) within each food.
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5.2.4 Outcome assessment
Height (cm), weight (kg) and waist circumference (cm) of consenting participants were
measured in the initial AHS interviews using digital scales, stadiometer and a tape
measure, respectively. Waist circumference was measured by placing the tape measure
across the top of the umbilicus. BMI was obtained through calculation. Blood pressure
was measured using an automated blood pressure monitor by trained interviewers.
Participants were invited to sit down and extend and relax their left arm (in the case of a
prohibitive injury, the right arm was used instead), with their palm facing upwards. Two
blood pressure readings were taken, and if either the two systolic or diastolic pressure
readings differed by greater than 10 mmHg, a third reading was taken. For participants
who needed only two readings, the second reading was used for the measures of systolic
and diastolic pressure. When a third reading was needed, the second and third readings
were averaged.

Blood samples were collected at Sonic Healthcare collection clinics and analysed at
Douglass Hanly Moir Pathology (Sydney, Australia). As required for the LDL
cholesterol, triglyceride and fasting plasma glucose tests, participants providing blood
samples were asked to fast for 8 hours prior to their test. Total cholesterol and
triglycerides were measured by enzymatic method and HDL-cholesterol concentrations
were measured by enzymatic method with accelerator selective detergent (Architect
C16200). LDL-cholesterol concentrations were estimated using the Friedewald equation
(Architect Ci16200) and apolipoprotein-B levels were measured by
immunoturbidimetry method (Integra 800). C-reactive protein concentrations were
measured by ultrasensitive immunoturbimetric assay (Architect Ci16200), fasting
plasma glucose levels were measured by hexokinase method (Integra 800) and HbA1c
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was measured using Catlon-Exchange High-Performance Liquid Chromatography (Biorad Variant™ II TURBO Haemoglobin Testing System). Adult participants who
provided lipid profile blood samples in the survey were also asked if they were
currently taking lipid-lowering medication, as one means of determining dyslipidaemia
status. More information on the collection of all outcome measures has been previously
described (194).

5.2.5 Lifestyle factors assessment
Sample lifestyle characteristics including smoking status, physical activity levels
(minutes undertaken physical activity for fitness, recreation, sport or transport in last
week), alcohol intake, equivalised weekly income (household income accounting for
household size and composition), education level, and employment status were
determined within the survey via interview by trained interviewers through CAPI (194).

5.2.6 Data and statistical analysis
Sampling weights were allocated to each participant within this study in order to infer
results for the total in-scope population. To account for the survey design and sampling
process, replica weighting was also applied using jackknife resampling. All statistical
analyses were performed using Stata software version 14.0 (StataCorp LP, College
Station, Tx.).

Participants were divided into quantiles based on energy-adjusted (g/10MJ/day) whole
grain and cereal fibre intake on the day of the survey to be analysed separately. Due to
varying sample sizes available for each outcome, quantiles were created separately for
each outcome analysed. For cereal fibre analyses, participants were categorised into
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quartiles, with lowest intakes in quartile 1 and highest intakes in quartile 4. As there
were a significant number of participants that did not consume any whole grain on the
day of the survey, participants were divided into tertiles of energy-adjusted whole grain
intake (T1 lowest intake; T3 highest intake) or non-whole grain consumers (0g/d) for
whole grain analyses. As quantiles are reflective of weighted participant’s distribution,
the number of unweighted participants (n) in each quantile is not precisely equal.

Sample descriptive characteristics and dietary intakes on the day of the survey were first
examined between the quantiles of whole grain and cereal fibre intakes. Associations
between intakes and continuous variables (e.g. age) were tested with linear regression
analysis and a test for trend. Associations with categorical variables (e.g. sex) were
tested with a chi-squared analysis. Separate linear regression models were then used to
determine associations between the intakes (in quantiles) and each CVD risk factor
examined. Triglyceride concentrations, which were not normally distributed, were log
transformed prior to analysis. Tobit regression was used for the analysis of CRP, as the
data were left-censored. Covariate-adjusted means for each CVD risk factor were
predicted for each quantile of whole grain and cereal fibre intake. A test for linear trend
was then used to determine statistical significant associations between quantiles of
intakes. Statistical significance was set at P<0.05.

The simple regression model adjusted for age and sex. The multivariate models were
further adjusted for energy intake (kJ/day), physical activity (minutes of moderate to
intense activity/day), alcohol intake (g/day), smoking status (current smoker, exsmoker, never smoked) and usual fruit and vegetable intake (serves/day). Within the
dietary adjustment model, blood pressure outcomes analyse were further adjusted for
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sodium intake (mg/day); lipid constituents analyses were adjusted for saturated and
trans fat intake and polyunsaturated fat intake (% energy/day). Triglycerides analysis,
as well as fasting blood glucose and HbA1c analyses, were further adjusted for free
sugars intake (% energy/day). All outcome analyses except for BMI and waist
circumference were further adjusted for BMI, and all lipid constituents’ analyses for
current lipid-lowering medication use, within a lifestyle adjustment model. Lastly, the
final models (dietary adjustment models for BMI and waist circumference, lifestyle
adjustment models for all other outcomes) used in whole grain analyses were further
adjusted for cereal fibre intake (g/day).

5.3 Results
Descriptive characteristics and dietary intakes of participants on the day of the survey,
by quantile of whole grain and cereal fibre intakes, are shown in Tables 5.1 and 5.2,
respectively. Age was positively associated with both whole grain and cereal fibre
intake (both P<0.0001). Participants within the highest tertile of energy-adjusted whole
grain intake (T3) reported higher intake of cereal fibre, total fibre, carbohydrates and
polyunsaturated fat, as well as higher estimated daily fruit and vegetable servings (all
P<0.0001). These participants reported significantly lower intakes of total fat, free
sugars, saturated and trans fat, monounsaturated fat, sodium and alcohol intake (all
P<0.0001), reflecting an overall higher diet quality in higher whole grain consumers.
Participants that did not report consuming any whole grains on the day of the survey
were more likely to smoke (P<0.0001), less likely to have a university degree
(P=0.0019), less likely to be currently employed or studying (P=0.008), and less likely
to be meeting current Australian physical activity recommendations for more than 150
minutes of exercise per week (P<0.0001).
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Participants reporting the highest consumption of energy-adjusted cereal fibre (Q4) on
the day of the survey had similar diet and lifestyle characteristics to high whole grain
consumers. Participants in Q4 of energy-adjusted cereal fibre intake reported higher
whole grain, total fibre, carbohydrate and estimated daily fruit intakes (all P<0.0001),
while reporting lower protein, total fat, free sugars, saturated and trans fat,
monounsaturated fat, and daily alcohol intakes (P<0.0001). There were fewer smokers
in Q4 (P<0.0001), and participants were more likely to be currently employed or
studying (P=0.03).
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Table 5.1 Nutrient intakes and demographic characteristics of participants in the AHS 2011-13 by tertile of energy-adjusted whole grain
intake

Age (y)3
Sex (% female)
Energy (kJ/d)4
Cereal fibre (g/d)5
Total fibre (g/d)5
Carbohydrate (% kJ)5
Protein (% kJ)5
Total fat (% kJ)5
Free sugars (% kJ)5
Saturated and trans fat (% kJ)5
Mono-unsaturated fat (% kJ)5
Poly-unsaturated fat (% kJ)5
Sodium (mg/d)5
Fruit (serves/d)
Vegetable (serves/d)
Daily alcohol intake (std. drinks/d)4,6
Equivalised weekly income (AUD)4
University graduate (%)
Unemployed, not studying (%)

Non-consumers
(n = 2043)1
x̅ or % SE
42.0
0.5
48.7
9163.4
90.8
5.8
0.1
19.4
0.3
42.0
0.4
18.0
0.2
32.0
0.3
11.9
0.3
13.0
0.2
12.4
0.1
4.5
0.1
2769.0
44.9
1.4
0.04
2.2
0.05
1.9
0.1
946.3
25.2
22.0
3.0
-

T1
(n = 1794)
x̅ or % SE
44.1
0.4
50.3
10086.2 94.5
7.1
0.1
22.3
0.3
42.0
0.3
17.5
0.2
32.3
0.3
11.2
0.2
12.7
0.2
12.5
0.1
4.8
0.1
2692.1
34.3
1.5
0.03
2.4
0.05
2.1
0.1
1104.4
28.6
29.6
2.1
-

T2
(n = 1874)
x̅ or % SE
48.1
0.5
51.5
9878.9
90.1
10.2
0.1
26.3
0.3
42.8
0.3
18.3
0.1
31.5
0.3
10.1
0.2
12.5
0.1
11.9
0.1
4.9
0.1
2627.3
31.8
1.7
0.30
2.4
0.04
1.5
0.1
1076.4
28.0
26.1
1.0
-

T3
(n = 1954)
x̅ or % SE
49.8
0.6
49.6
9103.9
90.3
14.6
0.2
31.6
0.4
46.0
0.3
18.0
0.1
29.6
0.2
8.7
0.2
11.2
0.1
11.1
0.1
5.2
0.1
2479.9
33.0
1.8
0.04
2.5
0.04
1.0
0.1
996.5
21.4
27.0
1.4
-

P value2
<0.0001
0.65
0.33
<0.0001
<0.0001
<0.0001
0.13
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.28
0.0019
0.0078
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Current smoker (%)
Physical activity (% meeting
recommendations)7
Lipid-lowering medication use8

26.2

-

16.2

-

14.4

-

10.5

-

<0.0001

42.7

-

53.1

-

53.0

-

54.4

-

<0.0001

8.9

-

11.4

-

13.1

-

19.4

-

0.0007

1

Median whole grain intakes (g/d): non consumers 0; T1 14.0; T2 44.9; T3 95.1
Associations with continuous variables were tested with linear regression analysis and a test for trend, associations with categorical variables
were tested with a chi-square analysis
3
Adjusted for sex
4
Adjusted for age and sex
5
Adjusted for age, sex and total energy intake (kJ/d)
6
One standard drink is equivalent to 10g of alcohol
7
Australian physical activity recommendations of 150 minutes of exercise per week
8
Based on data available from smaller sample of participants (n=2608)
2
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Table 5.2 Nutrient intakes and demographic characteristics of participants in the AHS 2011-13 by quartile of energy-adjusted cereal
fibre intake

Age (y)3
Sex (% female)
Energy (kJ/d)4
Whole grain (g/d)5
Total fibre (g/d)5
Carbohydrate (% kJ)5
Protein (% kJ)5
Total fat (% kJ)5
Free sugars (% kJ)5
Saturated and trans fat (% kJ)6
Mono-unsaturated fat (% kJ)5
Poly-unsaturated fat (% kJ)5
Sodium (mg/d)5
Fruit (serves/d)5
Vegetables (serves/d)5
Daily alcohol intake (std. drinks/d)4,6
Equivalised weekly income (AUD)4
University graduate (%)
Unemployed, not studying (%)
Current smoker (%)

Q1 (n = 1940)1
x̅ or % SE
44.0
0.4
51.0
9858.9
107.5
6.0
0.5
18.8
0.3
37.3
0.3
18.6
0.2
33.6
0.3
12.3
0.3
13.2
0.2
13.3
0.1
4.8
0.1
2516.9
47.1
1.4
0.05
2.3
0.1
3.0
0.2
1068.4
24.9
25.4
2.7
25.2
-

Q2 (n = 1941)
x̅ or % SE
44.5
0.5
50.0
9840.7
111.1
20.8
0.7
22.6
0.3
42.5
0.3
18.1
0.2
31.9
0.3
11.3
0.3
12.8
0.2
12.2
0.1
4.8
0.1
2778.1
35.8
1.5
0.04
2.3
0.04
1.7
0.1
1044.0
27.8
24.9
2.4
17.9
-

Q3 (n = 1801)
x̅ or % SE
46.6
0.5
50.6
9360.4
110.0
41.8
0.9
25.3
0.3
44.9
0.3
17.7
0.2
30.9
0.3
10.0
0.2
12.3
0.1
11.6
0.1
4.9
0.1
2688.8
33.7
1.7
0.04
2.4
0.04
1.2
0.1
990.9
23.2
27.3
1.6
13.9
-

Q4 (n = 1983)
x̅ or % SE
48.4
0.6
48.2
9117.6
74.1
79.2
1.7
32.2
0.4
48.0
0.3
17.4
0.1
28.9
0.2
8.5
0.2
11.2
0.1
10.8
0.1
4.9
0.1
2601.6
32.9
1.7
0.04
2.4
0.05
0.7
0.1
1014.8
25.1
26.6
0.9
11.6
-

P value2
<0.0001
0.60
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.35
0.41
<0.0001
0.30
<0.0001
0.07
0.57
0.0277
<0.0001
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Physical activity (% meeting
recommendations)7
Lipid-lowering medication use8

47.1

-

50.0

-

53.7

-

51.4

-

0.08

11.2

-

12.4

-

12.8

-

16.8

-

0.18

1

Median cereal fibre intake (g/d): Q1 3.9; Q2 7.4; Q3 10.7; Q4 16.3.
Associations with continuous variables were tested with linear regression analysis and a test for trend, associations with categorical variables
were tested with a chi-square analysis
3
Adjusted for sex
4
Adjusted for age and sex
5
Adjusted for age, sex and total energy intake (kJ/d)
6
One standard drink is equivalent to 10g of alcohol
7
Australian physical activity recommendations of 150 minutes of moderate exercise per week
8
Based on data available from smaller sample of participants (n=2608)
2
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Table 5.3 and 5.4 report associations between whole grain and cereal fibre intakes and
CVD risk factors. Whole grain and cereal fibre intake were both inversely associated
with BMI and waist circumference within our multivariate analysis. Compared to
participants that did not consume any whole grain on the day of the survey, those in the
highest tertile of intake had lower BMI (non-consumers: 26.8 kg/m2; T3: 26.0 kg/m2,
P<0.0001) and waist circumferences (non-consumers: 92.2 cm; T3: 89.7 cm, P=0.0005).
After adjustment for cereal fibre intake, the inverse association to BMI was no longer
significant (P=0.11), while the association to waist circumference was attenuated but
remained significant (P=0.03). When cereal fibre intake was analysed separately,
comparable inverse associations were found for BMI (Q1 27.1 kg/m2; 26.1 kg/m2,
P<0.0001) and waist circumference (Q1 92.3 cm; Q4 90.1 cm, P=0.0008).

Cereal fibre intake but not whole grain intake was inversely associated with total
cholesterol, LDL-cholesterol and apolipoprotein-B concentrations within our analysis.
Participants in the highest quartile of cereal fibre intake had lower total cholesterol (Q1:
5.11 mmol/L; Q4: 4.95 mmol/L, P=0.02), LDL-cholesterol (Q1: 3.20 mmol/L; Q4: 3.05
mmol/L, P=0.02) and apolipoprotein-B concentrations (Q1: 1.02 mmol/L; Q4: 0.96
mmol/L, P=0.009) after multivariate and dietary adjustment. After further adjustment
for BMI and use of hypercholesterolaemic agents, the significance of all three
associations were attenuated to borderline significance (P=0.07, 0.07 and 0.06,
respectively), although the inverse trends were still evident.

In contrast, whole grain intake was slightly associated with fasting plasma glucose and
HbA1c, while cereal fibre showed no association. Participants in the highest tertile of
whole grain intake had marginally lower fasting plasma glucose compared to non187

consumers in the simple model (non-consumers: 5.09 mmol/L, T3: 5.00 mmol/L,
P=0.02) although statistical significance was lost after adjusting for various relevant
dietary and lifestyle factors (P=0.06). Interestingly, further adjustment for cereal fibre
intake strengthened the association to borderline significance (P=0.048). A similar
trend was found for the association to HbA1c levels, whereby an inverse association
was observed after adjustment in the multivariate and dietary adjustments model (nonconsumers: 5.47%; T3: 5.38%, P=0.03) but this was attenuated slightly after further
adjustment for BMI (P=0.05). When the model was additionally adjusted for cereal
fibre, the effect became stronger (P=0.03).

All other risk factors assessed were not significantly associated with cereal fibre or
whole grain after multivariate adjustment (P>0.05 for all).
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Table 5.3 CVD risk factors according to tertiles of energy-adjusted whole grain intake among participants of AHS 2011-13
Non consumers
x̅
SE

T1
x̅

SE

T2
x̅

SE

T3
x̅

SE

P for
trend

0.2
0.2
0.2

26.9
26.8
26.7

0.2
0.2
0.2

26.7
26.6
26.7

0.1
0.1
0.1

25.9
26.0
26.3

0.1
0.1
0.2

<0.0001
<0.0001
0.11

0.5
0.5
0.6

91.9
91.8
91.7

0.4
0.5
0.5

91.9
91.8
91.8

0.4
0.4
0.4

89.4
89.7
90.0

0.4
0.4
0.4

<0.0001
0.0005
0.03

0.5
0.5
0.5
0.6
0.6

121.8
121.7
121.6
121.8
121.7

0.6
0.7
0.7
0.7
0.6

122.1
122.1
122.1
122.2
122.2

0.5
0.5
0.5
0.5
0.5

121.6
121.9
122.0
122.4
122.4

0.6
0.6
0.6
0.6
0.8

0.51
0.87
0.97
0.69
0.71

0.4
0.4
0.4
0.4
0.4

75.9
75.7
75.6
75.4
75.3

0.4
0.4
0.4
0.4
0.4

76.0
76.1
76.1
76.0
76.1

0.3
0.4
0.4
0.3
0.3

75.2
75.5
75.6
75.8
76.1

0.4
0.4
0.4
0.4
0.5

0.004
0.07
0.09
0.33
0.91

2

BMI (kg/m ) (n=6206)
Simple adjustment1
26.9
2
Multivariate adjustment
26.8
2,9
Cereal fibre adjustment
26.7
Waist circumference (n=6214)
Simple adjustment1
92.3
2
Multivariate adjustment
92.2
2,9
Cereal fibre adjustment
92.0
Systolic blood pressure (mmHg) (n=6381)
Simple adjustment1
122.3
2
Multivariate adjustment
122.2
2,3
Dietary adjustment
122.2
2,3,7
Lifestyle adjustment
122.2
2,3,7,9
Cereal fibre adjustment
122.2
Diastolic blood pressure (mmHg) (n=6381)
Simple adjustment1
76.9
2
Multivariate adjustment
76.7
2,3
Dietary adjustment
76.7
2,3,7
Lifestyle adjustment
76.6
2,3,7,9
Cereal fibre adjustment
76.4
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Total cholesterol (mmol/L) (n=3116)
Simple adjustment1
5.10
2
Multivariate adjustment
5.07
2,4
Dietary adjustment
5.07
2,4,8
Lifestyle adjustment
5.03
2,4,8,9
Cereal fibre adjustment
5.00
HDL-cholesterol (mmol/L) (n=3116)
Simple adjustment1
1.35
2
Multivariate adjustment
1.35
2,4
Dietary adjustment
1.35
2,4,8
Lifestyle adjustment
1.35
2,4,8,9
Cereal fibre adjustment
1.36
LDL-cholesterol (mmol/L) (n=2614)
Simple adjustment1
3.17
2
Multivariate adjustment
3.16
2,4
Dietary adjustment
3.16
2,4,8
Lifestyle adjustment
3.14
2,4,8,9
Cereal fibre adjustment
3.10
Apolipoprotein-B (mmol/L) (n=3115)
Simple adjustment1
1.00
2
Multivariate adjustment
0.99
2,4
Dietary adjustment
0.99
2,4,8
Lifestyle adjustment
0.98
2,4,8,9
Cereal fibre adjustment
0.97

0.06
0.06
0.06
0.05
0.05

5.09
5.07
5.07
5.05
5.03

0.06
0.06
0.06
0.06
0.06

4.95
4.97
4.96
4.95
4.96

0.06
0.06
0.06
0.06
0.06

5.02
5.04
5.04
5.07
5.11

0.05
0.05
0.05
0.05
0.06

0.15
0.52
0.49
0.97
0.40

0.02
0.02
0.02
0.02
0.02

1.38
1.37
1.37
1.36
1.37

0.02
0.02
0.02
0.02
0.02

1.35
1.35
1.35
1.35
1.35

0.02
0.02
0.02
0.02
0.02

1.36
1.36
1.36
1.36
1.34

0.02
0.02
0.02
0.02
0.02

0.96
0.86
0.78
0.97
0.50

0.06
0.05
0.05
0.05
0.05

3.13
3.12
3.12
3.11
3.09

0.06
0.05
0.06
0.05
0.05

3.08
3.08
3.08
3.06
3.07

0.05
0.06
0.06
0.06
0.06

3.09
3.11
3.11
3.14
3.18

0.05
0.05
0.05
0.05
0.05

0.25
0.40
0.39
0.88
0.40

0.02
0.02
0.02
0.02
0.02

0.99
0.99
0.99
0.98
0.97

0.02
0.02
0.02
0.02
0.02

0.97
0.98
0.98
0.97
0.98

0.02
0.02
0.02
0.02
0.02

0.97
0.97
0.97
0.98
0.99

0.01
0.02
0.01
0.02
0.01

0.15
0.38
0.30
0.79
0.42
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CRP (mmol/L) (n=3114)
Simple adjustment1
3.19
2
Multivariate adjustment
3.17
2,4
Dietary adjustment
3.13
2,4,8
Lifestyle adjustment
3.04
2,4,8,9
Cereal fibre adjustment
3.16
Triglycerides (mmol/L) (n=2640)
Simple adjustment1
1.16
2
Multivariate adjustment
1.13
2,5
Dietary adjustment
1.12
2,5,8
Lifestyle adjustment
1.11
2,5,8,9
Cereal fibre adjustment
1.11
Fasting glucose (mmol/L) (n=2641)
Simple adjustment1
5.09
2
Multivariate adjustment
5.09
2,6
Dietary adjustment
5.09
2,6,7
Lifestyle adjustment
5.09
2,6,7,9
Cereal fibre adjustment
5.10
HbA1c (%) (n=3107)
Simple adjustment1
5.48
2
Multivariate adjustment
5.47
2,6
Dietary adjustment
5.47
2,6,7
Lifestyle adjustment
5.47
2,6,7,9
Cereal fibre adjustment
5.48

0.41
0.39
0.40
0.43
0.42

2.93
2.88
2.88
2.71
2.78

0.29
0.29
0.29
0.27
0.31

2.51
2.52
2.55
2.52
2.49

0.21
0.21
0.21
0.21
0.21

2.52
2.59
2.59
2.59
2.44

0.25
0.25
0.25
0.28
0.28

0.10
0.14
0.20
0.36
0.15

0.02
0.03
0.03
0.02
0.02

1.10
1.11
1.11
1.11
1.11

0.03
0.03
0.03
0.03
0.03

1.07
1.07
1.07
1.07
1.07

0.03
0.03
0.03
0.03
0.03

1.10
1.10
1.11
1.11
1.10

0.03
0.03
0.03
0.03
0.03

0.14
0.39
0.60
0.88
0.69

0.04
0.04
0.04
0.04
0.05

5.11
5.11
5.11
5.11
5.11

0.03
0.04
0.04
0.03
0.04

5.00
5.01
5.01
5.00
5.00

0.03
0.03
0.03
0.03
0.03

5.00
5.01
5.01
5.02
5.00

0.03
0.03
0.03
0.03
0.03

0.02
0.07
0.07
0.06
0.048

0.04
0.04
0.04
0.04
0.04

5.43
5.44
5.44
5.44
5.45

0.03
0.03
0.03
0.03
0.03

5.39
5.39
5.39
5.40
5.39

0.02
0.02
0.02
0.02
0.02

5.38
5.38
5.38
5.38
5.37

0.02
0.02
0.02
0.02
0.02

0.02
0.03
0.03
0.05
0.03
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1

Adjusted for age and sex
Adjusted for age, sex, total energy intake, alcohol intake, smoking status, physical activity, fruit and vegetable serves
3
Adjusted for sodium intake
4
Adjusted for saturated and trans fat intake and PUFA intake
5
Adjusted for saturated and trans fat intake, PUFA intake and free sugar intake
6
Adjusted for free sugar intake
7
Adjusted for BMI
8
Adjusted for BMI and lipid-lowering medication use
9
Adjusted for cereal fibre intake
2
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Table 5.4 CVD risk factors according to quartiles of energy-adjusted cereal fibre intake among participants of AHS 2011-13
Q1
x̅
BMI (kg/m2) (n=6206)
Simple adjustment1
27.1
2
Multivariate adjustment
27.1
Waist circumference (n=6214)
Simple adjustment1
92.6
2
Multivariate adjustment
92.3
Systolic blood pressure (mmHg) (n=6381)
Simple adjustment1
122.5
2
Multivariate adjustment
122.1
2,3
Dietary adjustment
122.2
2,3,7
Lifestyle adjustment
122.0
Diastolic blood pressure (mmHg) (n=6381)
Simple adjustment1
76.9
2
Multivariate adjustment
76.5
2,3
Dietary adjustment
76.5
2,3,7
Lifestyle adjustment
76.1
Total cholesterol (mmol/L) (n=3116)
Simple adjustment1
5.15
2
Multivariate adjustment
5.11
2,4
Dietary adjustment
5.11
2,4,8
Lifestyle adjustment
5.07

Q2

Q3

Q4

SE

x̅

SE

x̅

SE

x̅

SE

P for
trend

0.2
0.2

26.9
26.9

0.2
0.2

26.3
26.4

0.2
0.2

26.0
26.1

0.2
0.2

<0.0001
<0.0001

0.6
0.5

92.3
92.1

0.5
0.5

90.9
91.0

0.4
0.4

89.9
90.1

0.4
0.4

<0.0001
0.0008

0.7
0.4
0.7
0.7

121.7
123.2
121.7
121.8

0.6
0.4
0.6
0.6

122.3
123.6
122.2
122.5

0.5
0.4
0.5
0.5

121.8
122.7
121.8
122.3

0.6
0.4
0.6
0.6

0.31
0.86
0.84
0.55

0.4
0.4
0.4
0.4

76.0
75.9
75.9
75.7

0.3
0.3
0.3
0.3

76.1
76.2
76.2
76.2

0.4
0.4
0.4
0.3

75.2
75.5
75.5
75.8

0.4
0.4
0.4
0.4

0.004
0.10
0.10
0.80

0.06
0.06
0.06
0.06

5.10
5.10
5.10
5.10

0.05
0.05
0.05
0.05

4.98
4.97
4.97
4.96

0.06
0.06
0.06
0.06

4.92
4.95
4.95
4.97

0.05
0.06
0.05
0.06

0.002
0.02
0.02
0.07
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HDL-cholesterol (mmol/L) (n=3116)
Simple adjustment1
1.37
2
Multivariate adjustment
1.35
2,4
Dietary adjustment
1.34
2,4,8
Lifestyle adjustment
1.35
LDL-cholesterol (mmol/L) (n=2614)
Simple adjustment1
3.20
2
Multivariate adjustment
3.20
2,4
Dietary adjustment
3.20
2,4,8
Lifestyle adjustment
3.18
Apolipoprotein-B (mmol/L) (n=3115)
Simple adjustment1
1.02
2
Multivariate adjustment
1.01
2,4
Dietary adjustment
1.02
2,4,8
Lifestyle adjustment
1.00
CRP (mmol/L) (n=3114)
Simple adjustment1
3.10
2
Multivariate adjustment
3.09
2,4
Dietary adjustment
3.13
2,4,8
Lifestyle adjustment
2.90
Triglycerides (mmol/L) (n=2640)
Simple adjustment1
1.13
2
Multivariate adjustment
1.12
2,5
Dietary adjustment
1.11
2,5,8
Lifestyle adjustment
1.09

0.02
0.02
0.02
0.02

1.37
1.37
1.37
1.37

0.02
0.02
0.02
0.02

1.35
1.35
1.35
1.34

0.02
0.02
0.02
0.02

1.35
1.36
1.37
1.36

0.02
0.02
0.02
0.02

0.26
0.82
0.53
0.92

0.05
0.05
0.05
0.05

3.18
3.18
3.18
3.17

0.05
0.05
0.05
0.05

3.05
3.03
3.02
3.03

0.05
0.05
0.05
0.05

3.04
3.05
3.05
3.08

0.06
0.06
0.06
0.06

0.01
0.02
0.02
0.07

0.02
0.02
0.02
0.02

0.99
0.99
0.99
0.99

0.02
0.02
0.02
0.02

0.97
0.97
0.97
0.97

0.02
0.02
0.02
0.02

0.95
0.96
0.96
0.96

0.02
0.02
0.02
0.02

0.006
0.02
0.009
0.06

0.35
0.36
0.38
0.43

2.63
2.62
2.60
2.46

0.18
0.18
0.18
0.15

2.56
2.59
2.60
2.62

0.24
0.25
0.25
0.24

2.83
2.82
2.78
2.83

0.26
0.25
0.26
0.27

0.51
0.53
0.49
0.97

0.02
0.02
0.03
0.03

1.12
1.12
1.12
1.11

0.03
0.03
0.03
0.03

1.07
1.06
1.07
1.08

0.03
0.03
0.03
0.03

1.09
1.10
1.11
1.12

0.03
0.03
0.03
0.03

0.18
0.35
0.68
0.77
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Fasting glucose (mmol/L) (n=2641)
Simple adjustment1
5.08
2
Multivariate adjustment
5.07
2,6
Dietary adjustment
5.07
2,6,7
Lifestyle adjustment
5.06
HbA1c (%) (n=3107)
Simple adjustment1
5.43
2
Multivariate adjustment
5.43
2,6
Dietary adjustment
5.43
2,6,7
Lifestyle adjustment
5.41

0.03
0.03
0.03
0.03

5.04
5.04
5.04
5.03

0.03
0.04
0.04
0.04

5.05
5.06
5.06
5.07

0.04
0.03
0.04
0.04

5.03
5.04
5.04
5.05

0.04
0.04
0.04
0.04

0.35
0.65
0.62
0.99

0.03
0.03
0.03
0.03

5.43
5.43
5.43
5.44

0.03
0.03
0.03
0.03

5.42
5.42
5.42
5.42

0.03
0.03
0.03
0.03

5.41
5.41
5.41
5.41

0.02
0.02
0.02
0.02

0.51
0.62
0.47
0.84

1

Adjusted for age and sex
Adjusted for age, sex, total energy, alcohol intake, smoking status, physical activity, fruit and vegetable serves
3
Adjusted for sodium intake
4
Adjusted for saturated and trans fat intake and PUFA intake
5
Adjusted for saturated and trans fat intake, PUFA intake and free sugar intake
6
Adjusted for free sugar intake
7
Adjusted for BMI
8
Adjusted for BMI and lipid-lowering medication use
2
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5.4 Discussion
In the current study, whole grain and cereal fibre were both inversely associated with
BMI and waist circumference, and the cereal fibre appeared to, at least partially, explain
the association. These findings are in line with previous observational studies of similar
populations (113; 147), and a recent meta-analysis of intervention trials found that higher
intakes of both dietary fibre and whole grains reduced bodyweight, with pooled effect
estimates mean differences of -0.37 (-0.63, -0.11) and -0.62 (-1.19, -0.05), respectively
(28)

. Dietary fibre may play a role in body weight regulation through a few related

mechanisms, including displacement of available calories and macronutrients in the
diet, decreased gastric emptying rate, and increased satiation and satiety, therefore
reducing energy intake (309). These mechanisms may explain our findings, as energy
intake was inversely related with cereal fibre intake (although not whole grain intake)
here. Interestingly, while high whole grain and fibre intakes have been shown to
increase subjective satiety, few studies demonstrate any impact of this on subsequent
energy intake (310), suggesting the mechanisms may not be entirely clear. Additional
whole grain characteristics that could also contribute to favourable weight management
may include structure (311) and glycaemic index (312), although the findings are
inconsistent (313). To some extent these mechanisms still have some dependency on
subsequent reduced energy intake. Longer-term intervention trials, with whole grain and
high cereal-fibre products provided as part of an otherwise unrestricted diet, are needed
to explore the effects of the isolated fibre component on energy intake and subsequent
weight management.

Cereal fibre intake was inversely related to total cholesterol, LDL-cholesterol and
apolipoprotein-B, while whole grain intake was not significantly associated to any of
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these CVD risk factors. This is in contrast to previous studies, whereby either no
associations were found for either intake (Chapter 4) or the inverse associations between
the two were of similar magnitude (147) . Soluble fibre, found in grains such as oats and
barley, may play a role in lowering cholesterol levels by reducing the absorption of
cholesterol into the bloodstream, and this is supported in intervention trials (314). Given
the relevance of the fibre component, perhaps it is not surprising for the magnitude of
association to be stronger for cereal fibre specifically. Although, an inverse association
for whole grain would still be expected. Notably, the association between cereal fibre
intake and lipid constituents here was attenuated when the model was further adjusted
for use of lipid-lowering medication use and BMI. It may be that participants taking
lipid-lowering medication are more likely to have made relevant dietary changes, as
there was a significant association found between whole grain intake and lipid-lowering
medication use, and a positive linear trend between cereal fibre intake and lipidlowering medication use (P=0.18). However, more likely, BMI may have partially
mediated the association between cereal fibre and lipid constituents, as cereal fibre
showed a strong inverse association with BMI independently, and
hypercholesterolaemia is linked to obesity (315). However, no significant association was
seen between whole grains and lipid constituents despite the inverse association present
between whole grains and BMI, and the attenuation found may also be partly the result
of the reduced available sample size. The association between cereal fibre and lipid
constituents may be explained by a combination of both direct and indirect mechanisms,
including weight management.

Whole grain intake was marginally inversely associated with fasting plasma glucose and
HbA1c. This is in contrast to similar studies in US cohorts (111; 249; 298) which showed no
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relation to blood glucose measures, although these studies did tend to show an inverse
association to fasting insulin concentrations and insulin resistance. It was interesting
that in our study, after adjustment for cereal fibre intake, the inverse associations
became stronger. Notably, these unexpected results support the findings of our recent
analysis of the UK NDNS RP 2008-14 (Chapter 4), and therefore this area requires
further exploration. While it is unlikely that the cereal fibre itself is positively
associated with fasting glucose and HbA1c, potentially there is a characteristic of highcereal fibre, low-whole grain diets that are affecting these associations. Within the UK
study, we found that people consuming high-cereal fibre, low-whole grain diets tended
to consume larger amounts of refined grain products such as white bread and white
pasta, therefore still achieving these higher fibre intakes, but not through whole grain
choices that would be typically encouraged as part of a healthful diet. Previously, high
refined grain intake has been associated with T2DM risk, although not consistently (316;
317)

. Certainly, this suggests that the cereal fibre alone may not be the only contributor to

any metabolic benefit that may exist for whole grains. Beyond fibre, other whole grain
constituents such as vitamin E (318), magnesium (93) and phytoestrogens (319) may also
have beneficial effects on glucose metabolism, potentially contributing to associations
seen here. Further, these findings suggest that any benefit that cereal fibre may
contribute could potentially be outweighed by unhealthful characteristics of particular
food choices such as refined grains.

This study has several limitations. The descriptive, cross-sectional design of the AHS
poses a limitation in results, as it is impossible to determine causation between whole
grain and cereal fibre intake and the CVD risk factors examined, and the results can
only determine associations. While careful adjustment was made for covariates within
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the analysis, it cannot be ruled out that observed associations may be affected by
residual confounding, as higher intake of whole grain and cereal fibre were strongly
associated with other healthy lifestyle and dietary factors, and thus intake may be a
proxy of an overall healthy lifestyle. Additionally, as this study is a secondary analysis
of the AHS, the extent of analyses possible are limited by the data originally collected
in the survey, and there may be other relevant CVD risk factors that we were unable to
examine, or relevant confounders that we were unable to adjust for.

The 24-hour dietary recall method can be limited by participant recall bias and under
reporting of intake (320). Notably, the AMPM used to gather participant dietary intake
has also been shown to reduce bias in energy reporting (321), and we have attempted to
further address this through removing under-reporters of energy. Lastly, the 24-hour
recall method is also limited in its ability to capture an accurate representation of dayto-day variation in diet, however, given the large sample size available within the AHS,
this method can produce reasonably accurate estimates of dietary intake at a group level
(322)

.

5.5 Conclusion
This study identifies that whole grains and cereal fibre were each favourably associated
with various CVD-risk factors, although modestly. While both intakes were inversely
associated with anthropometric measures within our study, whole grain intake alone
tended to be associated with favourable blood glucose measures, while cereal fibre
alone was associated with more favourable blood lipid measures, suggesting that there
may be a variety of mechanisms and mediators involved in the protective associations
of whole grains against CVD, some including and others not including an active role of
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cereal fibre. In order to gain insight into the mechanisms involved and the role of cereal
fibre in each of them, longer term intervention studies directly comparing whole grain
and non-whole grain diets matched on cereal fibre (such as through use of bran or
added-fibre refined grain products) are needed.

Generally, the evidence from the previous chapters is supportive of whole grains as the
ideal choice for CVD health. However, given the likely effects could be at least partly
achieved through consumption of cereal fibre and bran, a consideration of consumer
perception of foodstuffs which may not be whole grain but contain bran or just cereal
fibre compared to whole grains may be warranted. While public health guidelines
should always place an emphasis on whole foods, further understanding of the role of
cereal fibre within whole grains may be beneficial to determine if there is potential to
promote grain foods that are well accepted by Australians, and are also healthful (for
example added-fibre or bran foods), which could be positive for improving the quality
of Australian diets. To estimate how such foods may be relevant in the food supply, it is
worthwhile to explore current consumer understanding of whole grain and high-fibre
grain foods, including consumer knowledge, perceptions and attitudes which may
influence grain food choices.
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Chapter 6:
Whole grain and high-fibre cereal foods: how do
knowledge, perceptions and attitudes affect consumption?

A major component of this chapter is the substantive content of the accepted article:

Barrett, EM, Foster, S, and Beck, EJ. (2020) Whole grain and high-fibre cereal foods: how do
knowledge, perceptions and attitudes affect consumption? Appetite. 149, 104630.
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6.1 Introduction
As explored extensively throughout the previous chapters, whole grain foods are
considered beneficial to health, as evidence suggests a clear inverse linear association
between whole grain consumption and the risk of NCDs including CVD, T2DM and
colon cancer (28).

Despite the evidence for the benefits of whole grain intake, as well as the ADG
recommending that when Australians consume grains they choose mostly whole-grain
and/or high-cereal fibre foods (157), whole grain intake within Australia remains low,
with a median daily intake of 21 g for adults (19-85 years) and 17 g for
children/adolescents (2-18 years) (144). Although the ADG do not include a quantifiable
recommended whole grain intake, the Australian not for profit group, the GLNC
recommend a Daily Target Intake (DTI) of 48g whole grains per day (158), more than
double the median intake. Unsurprisingly, Australians are also not consuming enough
total dietary fibre, with average adult daily intakes of approximately 21g/d (159),
compared to recommended AI of 25 and 30g a day for women and men, respectively
(160)

.

Barriers to whole grain intake may include perceived cost differences, longer cooking
and preparation time needed, and an inability to identify whole grain foods (161; 162; 163).
However, dislike of the organoleptic properties (namely the taste, texture, appearance
and smell) of whole grains, with individuals often preferring the taste of less healthful
and lower-fibre refined grain options such as white bread and pasta (162; 163; 170; 171), is
another major barrier commonly reported within the literature. It is not yet entirely clear
whether cereal fibre consumed outside of the whole grain food matrix provides equal
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benefit to consumption of whole grain foods, and encouraging whole food diets within
dietary messaging should always remain a priority. However, a potential solution to
increase fibre intakes despite the common sensory barriers to whole grain intake, is
through modification of refined grain products to include added cereal fibre, such as RS
or processed bran.

As described (Chapter 1), Hi-Maize®, a RS made from high amylose maize (corn) (125),
is one example of a commercial fibre with proven health benefits that may be added to
refined grain to produce a high cereal fibre, non-whole grain alternative. A second
example is OatWell™ , an oat bran product, that consumers can add to their own foods,
or can be added to ready to eat breakfast cereals (323). OatWell™ has been found to
reduce LDL cholesterol (121), attenuate blood glucose response (324), and increase SCFA
production (325), and appears to be most effective when used in foods that retain a high
MW (for example, baking in bread can depolymerise the β-glucan and lower the MW)
(121; 324)

. As shown in Chapter 3, added brans may be more effective than cereal fibre

alone for CVD health, potentially due to the additional components present beyond
fibre.

To consider the usefulness of such products as a tool to improve the health value of
grain choices, an updated insight into Australian consumer perceptions and attitudes
towards whole grain and added-fibre grain foods, including current knowledge of whole
grain and fibre benefits, is needed. Through a series of focus groups, this study aimed to
explore how knowledge, perceptions and attitudes affect current choice of grain foods,
particularly whole grain and added-fibre grain foods, held by Australian consumers.
These findings may help in development of initiatives to address low intakes of whole
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grains and dietary fibre within Australia. This chapter will also provide some indication
of consumer acceptance of added-cereal fibre grain products as a means to increase
cereal fibre intake within Australia, providing insight for both health professionals and
the food industry.

6.2 Methods
This study was based on discussions within focus groups, using a qualitative descriptive
approach. Ethics was approved by the University of Wollongong Ethics Committee
(approval number 2019/053). Initially, convenience sampling was used to recruit
participants within the Illawarra and Greater Sydney regions. The inclusion criteria
required that participants were over the age of 18, and had not received any formal
nutrition or dietetics education. Participants were recruited through flyers distributed
around the University campus, an advertisement posted to the University online staff
newsletter, social media, and word of mouth. Flyers were also provided to local
gymnasiums and organisations within Wollongong and Sydney, with request to
distribute to members. No monetary incentive was offered to prospective participants,
however they were informed that light refreshments would be provided.

Approximately half way through recruitment, a maximum variation sampling technique
was utilised in efforts to target specific demographics that were underrepresented in
recruitment thus far, and therefore widen the overall sample variation. Advertising and
word of mouth were used to recruit older participants and participants without tertiary
qualifications, in a purposive manner. Dietary consumption patterns and the attitudes
and perceptions that may influence these are likely to vary depending on demographics
of participants (326; 327). As explained by Patton (1990), maximum variation sampling is
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therefore an effective technique for capturing "important shared patterns that cut across
cases and derive their significance from having emerged out of heterogeneity” (231).
Analysis of transcripts occurred concurrently such that recruitment of participants
continued until saturation of data occurred (namely, no new themes were emerging from
analysis).

Focus groups were held between March and July 2019 at several sites across the
Illawarra and Greater Sydney regions, based on participant convenience. All focus
groups were moderated by the candidate (EMB), an Accredited Practising Dietitian
(APD), and where possible another facilitator (an APD experienced in focus group
facilitation (EJB), and/or a Dietetics research student (SIF) were present for assistance
and observation. The aim and purpose of the research was described to participants
within a written information sheet. All participants provided informed, written consent
prior to initiation of each focus group. Participants were also provided an optional,
anonymous questionnaire to collect general demographic information of the sample
including age, gender, employment status, educational attainment, community type and
yearly income.

Open-ended, semi-structured questions for use in the focus groups were developed by
the principal investigators (Table 6.1). Questions were broadly grouped into four topics:
defining and identifying whole grain foods, including distinguishing these from refined
grain foods; understanding of the health benefits of whole grains and dietary fibre and
any perceived differences between the two; perceptions of whole grain, refined grain,
and added-fibre grain foods and awareness of whole grain recommendations. Questions
included within the third topic included the use of three packaged breads (whole grain,
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white, and added-fibre bread) for participants to consider visually and order based on
likelihood of purchase, health value and perceived taste. Bread was chosen as the
example product for these discussion questions due to it being a main source of cereal
fibre (20) and whole grain (144) within Australian diets, availability of added-fibre
varieties, and ease at which the three varieties of interest can be clearly distinguished.
At the end of each focus group, participants were educated on the 48g DTI of whole
grains, as recommended by the GLNC (158), and whole grain food choices to meet this
target.
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Table 6.1 Semi-structured focus group guide
Topic 1: Defining and identifying whole grain foods
1. Do you know what the term whole grain means? How is it different to refined
grain?
2. Can you name some whole grain foods?
3. How would you identify whole grain foods at the supermarket?
Topic 2: Understanding of health benefits of whole grains and dietary fibre
4. Can you name any health benefits of whole grains?
5. Can you name any health benefits of dietary fibre? How do these differ from whole
grain benefits?
Topic 3: Perceptions of whole grain, refined grain, and added-fibre grain foods
6. Which of these breads (whole grain, white, added-fibre) are you most likely to
choose, and why?
7. How healthy do you think each of these foods is? Which is the healthiest? Why?
8. How tasty do you think each of these foods is? Which is the tastiest? Why?
9. Do you consider foods labelled whole grain and high-fibre differently? What are
the differences?
Topic 4: Awareness of whole grain recommendations
10. Do you think you eat enough whole grain foods? Should you eat more or less?
11. Are you aware of how many serves of whole grain foods are recommended? What
is a serve?
12. If you had two identical food items, one labelled as containing 16g of whole grain
and one containing 1 serve of whole grain, which would you choose and why?

207

Focus groups were audio-recorded, and the resulting data were transcribed verbatim by
the first and second author within two days of occurrence. Data were analysed using
inductive thematic analysis, following the six phase analysis guide as described by
Braun and Clarke (235). The data were first read for familiarity by two researchers (EMB
and SIF) separately, and any initial ideas were noted. Next, codes were generated
systematically across the data set in duplicate by both authors, and stored within
qualitative data software NVivo 12 Plus (QSR International). These codes were then
discussed by both authors and collated to develop broader, potential themes. Potential
themes were reviewed to ensure cohesion within themed data, and that an accurate
representation of the whole dataset had been established. As recruitment continued until
data saturation was achieved, coding of data occurred simultaneously to data collection,
and themes were continuously reviewed and updated until no new themes emerged.
Once this occurred, themes were further refined for clarity, and eventually finalised with
review from the third researcher (EJB). Meaningful quotes that best capture and reflect
the main themes extracted were identified by the first author and included as examples
after agreement by all authors. To preserve anonymity, quotes have been de-identified
and are labelled only according to focus group, participant gender and number, for
example FG1M1.

6.3 Results
Each focus group included 4 to 8 participants (mean = 6 participants) and ran for 45-60
minutes. There were nine groups, composed of 52 participants in total. A relatively
diverse mix of participants were recruited, with 58% of the total sample women, 48.0%
aged below 45 years, and 46.2% having attained a bachelor degree or higher (Table
6.2). Eight themes were discovered forming three overarching, hierarchically-organised
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concepts: current grain choices (Theme 1); factors potentially influencing grain choices
(Themes 2-5); and strategies to encourage healthy grain choices (Themes 6-8) (Figure
6.1).

Table 6.2 Focus group participant demographics (n=52)
Gender
Man

23 (44.2) Woman

29 (55.8)

18-25 y

15 (28.8) 45-55 y

5 (9.6)

26-35 y

6 (11.5)

56-65 y

17 (32.6)

36-45 y

4 (7.7)

65+ y

5 (9.6)

Age

Employment
Full time

26 (50.0) Retired

8 (15.4)

Part time

3 (5.8)

Student

9 (17.3)

Casual

5 (9.6)

Unanswered

1 (1.9)

4 (7.7)

Master’s degree

3 (5.8)

Educational attainment
Some high school

Completed high school 13 (25.0) PhD/doctoral degree 1 (1.9)
Certificate/diploma

10 (19.2) Unanswered

Bachelor’s degree

20 (38.5)

1 (1.9)

Geographical area
Urban

12 (23.1) Suburban

Rural

2 (3.8)

38 (73.1)

Yearly income
<$50,000

21 (40.4) $120,000-$150,000

2 (3.8)

$50,000-$80,000

15 (28.8) >$150,000

1 (1.9)

$80,000-$120,000

8 (15.4)

5 (9.6)

Unanswered

Values are n (%)
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Figure 6.1 Concepts and related themes emerging from focus groups
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6.3.1 Concept 1: Current grain choices
Theme 1: Participants typically choose a mixture of mostly refined grain and some
whole grain foods
Most participants reported choosing some whole grain foods on a regular basis, almost
always in the form of whole grain-containing breads. Conversely, participants reported
that pasta and rice choices were usually refined grain versions.

Although most participants reported choosing whole grain breads regularly, they
expressed that this may differ on certain occasions depending on the context of
consumption, with other factors such as the composition of the rest of the meal, the
associated memories of the food, their mood, or availability of food, all influencing
their choices in particular situations. For example, a participant may choose whole grain
bread for their regular daily sandwiches, however if they were having a sausage sizzle
(an Australian term for a sausage sandwich) at a party or event, they would choose
white bread, as this is the traditional bread it is made with.

“Even though I like white pasta and rice I pretty much only eat grain
bread, I pretty much don’t eat white bread ever, except maybe in a
sausage sizzle situation.”- FG3W1
“A sausage sizzle that’s from childhood and it has tasted the same
ever since I was a kid and that’s what I need it to taste like now if I’m
going to eat it, I don’t want to be disappointed.” - FG4W1
“If it’s a Friday I want white bread because I’m just over the week
but if it’s a Monday I could go for whole grain.”- FG7W1
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“Working in the hospital we get lunches every Wednesday so it’s
usually like a white roll, Vietnamese roll, so definitely don’t get
anything from that, except its nice and cheap and delicious.” –
FG1M4

Four themes were found to potentially explain participant’s broader patterns of whole
grain and refined grain choices, contained within the second concept.

6.3.2 Concept 2: Factors potentially influencing grain choices
Theme 2: Scepticism and lack of knowledge surrounding the health value of whole
grains
All participants recognised that whole grain foods were a healthier option than refined
grain foods, and most recognised them as a healthy food in general. However,
participants struggled to name long-term health benefits. Participants stated that they
recall whole grains as being promoted as healthy but never knew the specific reasons
why.

“I don’t particularly think I could identify how it is different as such,
like it’s healthy but I don’t know why.”- FG4M1
“And I think you know for years now we’ve been told that white bread
is not as good for you as whole bread and you know without really
even understanding why.”- FG8W1
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Two broad health benefits of whole grains were frequently mentioned. The first relates
to whole grain foods perceived as natural, less-processed, and therefore containing
fewer additives than refined grain foods. Participants also related this to whole grains as
higher in nutrients, although specific nutrients were not named, other than dietary fibre.

“I’d say that with less processing you’d get more different parts of
the grain which means that you’re getting more nutrients.” - FG1M1
“The white one is more processed and that can’t be good because
there’s all sorts of stuff in there like bleach and preservatives.”FG9W1
“I would say the fibre component for me because its unprocessed, it’s
obviously roughage… so you get the physical thing there that I see
that you’re actually taken in, so I would say yeah when I think of
whole grains I think of fibre.” - FG9W2

Although fibre was frequently mentioned as one of the main healthy attributes of whole
grains, almost all participants considered whole grain bread healthier than bread with
added-fibre.

“I guess the whole point is to have something less processed, so it’s
kind of still processed so if you could pick the whole grain option
which didn’t need the additive then why wouldn’t you just do that?” FG3M1
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“I think of that as just added fibre and I think I’d rather get it from
the source itself rather than it being an additive so yeah I would see
the whole grain as healthier.”- FG3W1

Secondly, participants were often also able to name some shorter-term benefits of whole
grains, referring to their glycaemic index for satiety and fibre content for motility and
digestion. Many participants stated that they did not know of any benefits of fibre
beyond digestive motility.

“It makes you feel fuller, so you feel more like satisfied. Seems to last
longer in you, so you don’t get hungry so quickly. That’s all I can
think of. There’s probably lots but I can’t think of any more.” FG9W3
“I guess more energy because it’s low GI, so you’re not going to
burn it off really quickly, so I guess you feel like you’re more filled for
longer parts of the day.” - FG3M1
“I think of whole grains and different fibres and stuff strictly, as gross
as it sounds, just for like stool formation, in terms of benefit.” FG1M2

Fewer participants were able to identify whole grains as being protective against chronic
disease, and those that could were often apprehensive of their knowledge in this area.
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“It’s also heart healthy too isn’t it from memory, yeah and maybe
just reduce the chance of getting a stroke perhaps ...what else did I
read.”- FG2M2
“I’ve heard about cholesterol and stuff but I don’t know really
enough to comment it’s just something I think I picked up
somewhere.” - FG3M2
“I’m feeling a bit blank. Well we talk about things like diabetes and
things like that, don’t you?” - FG3W5

In addition to a lack of knowledge of specific health benefits, participants reported
scepticism regarding the health value of grain foods and carbohydrate-rich foods in
general.

“Then stuff like pasta, I always think of as unhealthy as well but I’m
not sure why.” - FG6W2
“Carbs are my enemy.” - FG9W4
“I don’t associate anything healthy with it (whole grain) really. If
something calls out fibre yes ok I understand, but if something calls
out whole grain, my first thought is wheat, flour, bread, no.” FG5W2
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Grain foods were often not considered as a priority in a healthy diet, and participants
sometimes suggested that a diet that lacked any grain foods could still be healthy. Fruits
and vegetables were consistently named as the markers of a healthy diet.

“Why is it three? (sic serves of whole grain) Because like there’s so
many cultures and… for most of human history we weren’t even
eating grains?” - FG3M1
“I guess I probably don’t eat enough whole grains if there is
something that should be eaten…But that’s not my goal at all, I’d
never think like ‘I haven’t had any whole grains today!’ I would think
‘I haven’t had any vegetables today’.” - FG3W2
“Sometimes it seems like all recommendations and stuff I’ll focus on
fruits and veggies but it’s hard to fit all of the recommended stuff in
each day so I won’t worry about grains as much as I worry about
other stuff.” - FG6W2

Additionally, participants reported to consider content of particular components to be a
better indication of health value in products than whole grain content. Overwhelmingly,
participants considered sugar content as most relevant to the health value of food
products.

“Oh and then I’ll look at the ingredients list and go, sugar! 30%! I’m
not having that cereal.” - FG3W4
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“Sugar is killing us but, I think everything else pales into
insignificance to sugar.”- FG8M1
“If I see the term whole grain in the packaging that usually gets my
attention, but then I find myself looking at the sugar and the fat
contents… and I try and decide whether the fact that its whole grain is
kind of lost by the fact that it’s got other additives in it.” - FG5W3

Theme 3: Limited ability to identify foods high in whole grains
As explained within Concept 1, many participants reported choosing whole grains
breads. Bread also tended to be the most commonly identified source of whole grain,
and participants struggled to name sources beyond this.

“I almost never identify wholemeal with cereal even though on a
more regular basis I’d say I buy wholemeal cereal like All Bran… I
kind of almost completely associated it with bread.” - FG4W2
“Things with their husk…but also as soon as you say whole grain I
just think immediately of bread.” - FG5M1
“I often don’t think about pasta… I think of rice, I certainly think of
rice as a grain intake but I don’t think about pasta.” - FG5W3
“My first thought was not rice whatsoever, not that I’ve ever even
thought where does rice fit in the grand scheme of things but when we
were talking I didn’t even think rice was part of it.” - FG5W2
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Participants across groups tended to agree that identification of whole grain food
products was based mainly on the presence of visible intact grains and seeds, overall
darker colour, and the words ‘whole grain’ printed on the product label.

“Yeah I suppose I mainly thought of bread and then like a really a
brown bread not just a white bread.” - FG5M2
“Yeah I think it’ll be a magic component if you can actually see the
full seeds in there.” - FG1M4
“Oh yeah it always…it states whole grain if it is whole grain. I don’t
think it says anything much if it’s refined.” - FG7W2

When discussing breads specifically, participants sometimes commented that the
absence of intact grains and seeds might suggest that a product is not a source of whole
grains. Participants believed erroneously, that whole grain required seeds, seen as
“grains”.

“If I can’t see the seeds I’m not really going to go for it... I find it
annoying to eat with the seeds but I would never pick it unless it had
the seeds in it, I would go straight to white bread. It’s almost like ok
well I can see the seeds in it and the grains in it so I know… it’s
almost like confirming that I’ve made the right decision.” - FG5W2
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Mixed opinions were expressed as to whether milled whole grains and products that use
milled whole grains, such as wholemeal flour, breads and crackers, would be considered
whole grains.

“I feel like I’d also say like wholemeal flour, I would include, even
though its ground down, it still had the husk included in the
grinding.” - FG3W2
“I think of Weet-bix™ and Vita Brits® or whatever it is and some of
those cereals that are promoted as “whole grain” but I’m never quite
sure how processed they are.” - FG5W3

Theme 4: No awareness of recommended quantities to eat
No participants were familiar with the whole grain DTI within Australia to consume
48g of whole grains (3 servings). Most participants assumed that their daily intake
would be inadequate, and expressed that it is often overwhelming to attempt to meet all
dietary recommendations.

“How could you actually do it because I think with fruit you’re
supposed to have 2 or 3 serves and I have heard 5 serves of
vegetables a day, so then if you want to sort of add grains, it’s very
difficult to sort of say how are you going to meet all of these
nutritional needs because you also have to incorporate protein and
dairy and all of those sorts of things.” - FG5W1
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“I don’t know what is enough but I know I don’t eat it.” - FG2W2
“3 Weet-bix™ would be a serve wouldn’t it?” - FG2M2
“Two slices of bread because then it would be a sandwich.” FG5M2

Many participants were surprised to find the DTI more achievable than they initially
assumed. Participants often found that one or two small changes would allow them to
meet the DTI, and expressed motivation to make that change.

“When you say it like that it seems like it is feasible, that you can do
it, whereas when you’re thinking about it before you said that you’re
thinking oh god how much do I have to eat.” - FG5W4
“That’s actually doable. I used to have 3 Weet-bix™ for breakfast,
now I might only have 2, but I might just jack it up to the 3.” FG9W2

Although, upon learning the DTI, some participants that were meeting or exceeding
recommendations made comment that they must be eating too much, before the DTI
was explained to be a minimum.

“Well yeah my minimum is being reached very easily but I think I’m
eating way more than I need to in a day.” - FG6M2
“Are we over doing it?!” - FG8W1
220

Theme 5: Taste and texture dictate all choices to some extent
Among the participants that consumed some whole grains, they reported preferring the
taste of these products compared to the taste of refined grain counterparts, which some
expressed was a stronger deciding factor than perceived health value. While cost was
also expressed as an additional consideration, it was generally reported that if taste and
perceived health value expectations were met, cost would not be a limiting factor.

“I just prefer the taste I don’t really like the sugar laden white bread
ones… when I was growing up I had parents that would always get
that one so I’ve grown up having that one.” - FG1M1
“I’d go the whole grain. Just for taste. Being better for you doesn’t
really bother me.” - FG7M1
“I’d definitely take the brown because I like the taste of it and I think
it’s better for me, whether it is or not is another thing. So I don’t look
at it and say I’m eating this because of the fibre or whatever, I just
like it.” - FG9W3
“I eat a lot of bread so (cost) wouldn’t really bother me now, I would
have once for sure thought about the cost but not really, I eat it all the
time so it’s just nice to have.” – FG6M2
“With things like bread where I feel like the price point differences
aren’t very significant, I wouldn’t mind paying a dollar more.” –
FG1M2
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Notably however, many participants stated that they choose multigrain bread (which is
not necessarily whole grain) over wholemeal or whole grain breads because they prefer
the taste and texture.

“I like multigrain. I tend to pick multigrain, and then white, and then
wholemeal or whole grain. I don’t like the taste of whole grain, but I
like the taste of multigrain.” - FG3W1
“I think yes, multigrain I would like, like the ones that are sort of
mostly white bread but with grains within them, I’m keen for, but the
breads that are like just brown straight across, dry.” - FG5M1

Similarly, participants reported that they never choose certain whole grain products,
such as wholemeal pasta, because they do not like the taste and texture.

“I’ve tried whole meal pasta it’s like… I assume it’s healthier, but it
doesn’t taste as nice.” - FG6W1
“It’s funny that you mention pastas because I do not like the taste of
wholemeal pastas I will never choose wholemeal pastas.” - FG1W1

While most participants reported to consume some whole grain, there were participants
that reported eating exclusively refined grain foods, and they did so because they did
not like the taste of whole grains.
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“I pick white bread cause I like white bread, I’m sorry.” - FG2M1

Through the focus group discussions, participants described approaches that may
increase incentives to choose healthier grain foods. These have been collated into three
themes, within Concept 3.

6.3.3 Concept 3: Strategies to encourage healthy grain choices
Theme 6: Increased promotion of nutrition benefits of whole grains is desirable
Participants expressed that there is a need for information covering specific health
benefits of whole grains to be more readily available.

“Most people know about the food triangle and most people know
that cereals and whole grains and breads are in that triangle…but it’s
not something that I could honestly say that I’ve heard too much
about…I can’t ever recall having a serving attached to that. So it’s
interesting and I think people would eventually respond to informed,
credible information but I’m not sure that it’s out there that easily.” FG5W3
“Probably there’s not enough talk about whole grain I think there’s a
lot of talk about calories and fat and carbohydrates umm maybe fibre
but not really whole grains and how that the sort of really impacts
you and what you need and that type of thing and I think there’s poor
information.” - FG8W2
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Similarly, many participants stated that they perceived a gap in food product
advertising covering the benefits of whole grains, and that this may also be effective at
increasing incentive to choose whole grain products.

“I think there’s an advertising gap that people probably would
benefit by being more whole grain aware and whether that’s an
intensive advertising promotion at a point in time collectively by all
interested parties I’m not sure but I think that people are trying to
have healthier lifestyles and I think I thought I was fairly aware, had
no idea about the whole grain content 48g, the 3 serves a day.” FG5W3
“They don’t push whole grains as much as they do the high sugar
and the carbs and sodium. You don’t hear as much advertisement
besides the basic.” - FG2F3
“It seems to be everything else, low sugar, low fat, low GI, low… but
you don’t really see...extra grains or whole grains.” - FG2W2

Theme 7: Food based recommendations and targets are preferred
Participants reported that they preferred messages and recommendations that were
simple to understand in the context of their diets, and made reference to the previous
food-based campaigns ‘Gofor2&5©’, an Australian campaign encouraging two pieces
of fruit and five vegetable serves each day.
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“I think I found it most useful if I was like educated on it … the 2 fruit
and 5 veg stuck with me and that’s what I go by each day, so if I was
to know that I had to have the equivalent of three slices of bread a day
I would try to work that into my diet.” - FG1M2
“But I think that the visual stimulus you gave us as well, associating
a serving with an image like you can see one slice of bread is a
serving so you can work out how many servings of bread will equate
to how many servings I need, I think is important as well.” - FG4M3

Similarly, upon learning what one serving of whole grain approximately equated to in
commonly consumed grain foods, participants commented that the Weet-bix™ (whole
grain breakfast cereal) and whole grain bread (one biscuit/one slice of bread = one
whole grain serve) were easy to remember and incorporate into their diets to meet the
whole grain DTI. In comparison, approximate servings of loose whole grain foods such
as oatmeal or rice were provided in household servings (for example, ½ cup), and
participants expressed that these were more difficult to visualise.

“Yeah I thought it would be a lot more than just as I said 3 Weetbix™ or 3 slices of bread, because if I did have wholemeal or
wholegrain I’d actually easily get that because I have two sandwiches
which would be four slices of it.”- FG5M2
“Surely with breads and the morning biscuits it’s easier to judge a
serve whereas if you get out some pasta or some rice you’re not going
to individually count each gram or grain or stick.” - FG1M1
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“I have the …… diet book and one of the things I find really helpful
in that book is that it actually has like images of like a handful of
whatever ingredient that you’re going to use so you can really
visualise it…and I know what size I should be aiming for.”- FG1M3

Theme 8: For avid whole grain avoiders, added-fibre grain foods may be useful
Perceptions of added-fibre refined products, specifically referring to the example addedfibre white bread, were mixed. Among participants who regularly consumed any whole
grain products, there was distrust of added-fibre products health benefits, and many
participants seemed to think the labelling was simply a marketing technique. These
participants tended to report that they would see no difference between these breads and
standard white breads, so the decision between refined grain products would be based
primarily on cost or brand difference.

“I would never buy the (added fibre white) just because of the fact it
says “super” to me that says that they’ve had to add something to it to
make it ok… so it’s obviously been doctored a little bit and has
additives and that means that the original product is not good for you
at all.” - FG1M3
“It also makes you wonder is there any bodies that say yes this is
high fibre you’re allowed to put this advertising on it or do they just
like to slap whatever they want on to it.” - FG1M1
“If I just had two options between these white breads, I would just
choose the cheapest to be honest.” – FG1F1
226

However, participants that do not consume any whole grain, reporting a strong aversion
to the taste and texture, were more likely to accept high-fibre white bread, often
reporting that they perceive these products as a compromise between taste and health.

“I would choose the high fibre bread because I know that I shouldn’t
be choosing white bread but I feel like I’m getting away with it if I’m
choosing that one, like I’m getting some slight health benefit still…
I’m sneaking in the high fibre while tricking myself into thinking I’m
being healthy, and still having white bread.”
- FG5M1
“High fibre bread because it’s white but it’s still high in fibre. Just
tastes better.” - FG7W1

6.4 Discussion
To date, there is limited research exploring the knowledge, perceptions and attitudes
influencing grain food choices within an Australian context. The present study indicates
that there is a lack of understanding regarding how to make healthy grain food choices,
including inadequate knowledge of the health benefits of whole grains, an inability to
identify good sources of whole grains, and limited awareness of recommended intakes,
which were suggested as limiting factors in consumers choosing more whole grain
foods. Although an aversion to the taste and texture of some whole grain products was
an additional consideration in choice, in which case added-fibre products may be of
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value, participants expressed that an increased promotion of whole grain foods may be
effective in encouraging healthy grain choices.

The knowledge findings in the present study are similar to those found in previous
studies in the UK, where participants detailed a basic awareness of whole grains as
being healthier than refined grains (162), and were able to name certain short term
benefits such as increased satiety, but felt unsure of many health benefits beyond this
(170)

. A 2001 questionnaire-based study from the UK found that 18-34% of residents

(depending on area examined) were unaware of any link between whole grain and
chronic disease (328). Despite this research being conducted almost two decades ago, our
results seem to suggest knowledge in this area has not improved.

In addition, participants here reported scepticism regarding the health value of grain
foods and carbohydrate-rich foods in general, which likely adds confusion to opinions
surrounding the health value of whole grains, and may further affect food choice. An
Australian study found that grain intakes within Western Australia are declining, with
people being more likely to actively reduce grain food intake in 2012 compared to 1995,
while also having less knowledge of grain food recommendations (164). While the
proportion of bread consumed as whole grain increased within these years, the decline
in total bread consumed meant that overall intake of whole grain bread had not changed
within the 17 years, a concern given the increased varieties available on the market (164).
Anti-grain and similar low-carbohydrate based diets have gained considerable
popularity globally, explained by Gunnarsson and Elam (2012) as the result of skilful
persuasive communication techniques used by advocators of the diet (329). This is a
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growing challenge that needs to be given specific consideration in efforts to increase
population whole grain intake.

The apparent prioritisation of other food properties over whole grain content in dictating
food choices must be considered in promotion of whole grain foods. Participants
considered sugar content highly relevant to the health value of food products, as also
found in previous studies (330), and were often sceptical that products which may be
labelled as containing whole grain are actually high in sugar and are highly processed,
rendering the whole grain content irrelevant. It is important to consider the value of
whole grains, or any singular nutrient or food, in the context of promoting overall diet
quality. For this reason, it is reasonable that recommended products should be nutritious
beyond their whole grain content. There are calls to restrict whole grain labelling to
foods that contain a minimum amount of whole grain and also meet acceptable
standards for other nutrients, for example being low in sodium, saturated fat and added
sugars (136), so as not to mislead consumers.

Within Australia, the use of whole grain content claims requires food products to meet
the Nutrient Profiling Scoring Criterion, a point system broadly ranking the nutrition
quality of foods (331). However, products are currently permitted to carry the term
‘whole grain' on their label if they contain any amount of whole grain ingredient (24).
Considering whole grain labelling on otherwise non-nutritious products appeared to
contribute to scepticism regarding the health value of whole grains, restrictions of whole
grain labelling to otherwise healthful food, such as employed within other countries
(332)

, may be an important consideration in efforts to improve the effectiveness of whole

grain food promotion. This may be a prudent recommendation to manufacturers and
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regulators, such that merely listing whole grain as an ingredient in an otherwise less
healthful product may be counterproductive.

Participants of the current focus groups suggested that messages and recommendations
that were simple to understand in the context of their diets would be most effective in
influencing their choices, highlighting the importance of food-based recommendations
and food-based campaigns, such as the previous Gofor2&5© fruit and vegetable
campaign, which has proven successful (333). Although the DTI suggested in Australia
is 48g of whole grain, participants thought this information was more effectively
delivered as three serves of whole grain foods per day. Generally, we eat foods not
nutrients, so serve sizes of foods may be the most suitable way to promote intake. For
loose whole grain foods where serving size is provided in household measures (for
example, ½ cup), messaging and recommendations that provide both descriptive (eg ½
cup) and visual (a picture in ‘life-size’ scale) depictions of what is classified as a
serving may be best understood by consumers

The foods focused on within promotional efforts and messaging may also be relevant.
Within the present focus groups, participants reported choosing whole grain breads, and
to a lesser extent breakfast cereals, more regularly than other grain choices such as rice
and pasta, which would typically be refined grain choices. This finding is supported in
intake studies using survey data, which found that breads and breakfast cereals were the
largest contributors to whole grain intake within Australia (144). This may suggest that
certain whole grain foods such as breads are more acceptable than others, and efforts to
increase whole grain intakes may be most successful if centred on choices within this
category. In contrast, participants that reported taste aversions to whole grain foods
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often referred specifically to wholemeal pasta, and so attempted change in choices
within the pasta category would likely be met with greater resistance.

Still, there was evidence of confusion regarding the best sources of whole grain food
choices within breads and cereal choices, where there can be great variation. Many
participants suggested that multigrain breads are a higher source of whole grain than
wholemeal breads (which are whole grain in Australia), perhaps related to the mixed
opinions on the extent to which processing should impact a food’s whole grain
classification. Previous research has also found that UK adolescent participants tended
to equate multigrain with whole grain (162). As multigrain breads within Australia are
typically lower in whole grain content than wholemeal breads, participants relying on
multigrain bread alone may also be overestimating their intakes. For food-based
recommendations and messaging to be most effective they should therefore go a step
further and incorporate specific examples of food products (for example, specific
varieties, or even brands of bread) that are high sources of whole grains, as
recommended previously (330).

Furthermore, increasing ease of identification of whole grain products in store may be
necessary. As part of the Danish Whole Grain Partnership, a successful campaign which
has seen daily intakes of whole grains in Denmark increase from 36g/10MJ to
82g/10MJ since 2008 (332), an orange whole grain logo was created to allow consumers
to easily identify products high in whole grain, as well as to encourage manufacturers to
develop products with higher whole grain content (332). Within Australia, the GLNC
have a similar initiative in the form of a voluntary whole grain content claim. Rather
than a logo, registered manufacturers can include a phrase on packaged whole grain
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foods, ranging from ‘contains whole grain’, ‘high in whole grain’, to ‘very high in
whole grain’, for foods containing at least 8, 16 or 24 grams of whole grain,
respectively (331). However, this is not a legislated label, and as mentioned previously,
food products within Australia that contain any whole grain ingredients may include the
term ‘whole grain’ on labelling, irrespective of the amount (24). Therefore without
government engagement through formal food regulation, consumers may be confused,
and voice this mistrust through avoidance of certain foods.

The majority of participants within the focus groups indicated that due to distrust
regarding the health value of added fibres, they would not readily choose added-fibre
food products. However, the exception to this finding were ‘whole grain avoiders’,
those who reported choosing no whole grain foods. In contrast to other participants,
whole grain avoiders did express interest in added-fibre products as a compromise
between desired taste and perceived health value, with most suggesting that factors such
as potential added cost would not be a disincentive. For these people, whole grain
promotion strategies may not be as effective, and added-fibre grain products may
therefore be a viable solution to increase fibre intakes within this specific target group.
However, given the comparative benefits of added fibres compared to whole grain foods
are not fully established, efforts made within the food industry to increase the health
value of products should also focus on incorporating whole grains into a wider range of
grain products, which also may be more acceptable for consumers who are sceptical of
added-fibre products. Importantly, for such products to be successful and accepted by
whole grain avoiders, whole grain ingredients must be incorporated at an amount that
will make a significant contribution to intake while also not compromising on expected
taste and texture.
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Although many participants here expressed that promotion of whole grain health
benefits would be impactful in encouraging healthier grain choices, previous research
has shown that this is not always enough (334), and additional strategies taking into
account food availability (335) and affordability (336) may also be important. In our study,
these factors were mentioned as potential considerations in choice, although were
generally reported as secondary factors to taste and perceived health value. By contrast,
other studies have shown availability and affordability to be major purchasing
influencers (161; 162; 336).

Previous whole grain promotion campaigns that have been most successful in increasing
intakes, such as the Danish Whole Grain Partnership (332), have utilised multi-pronged
approaches, including efforts to impact the food environment by increasing availability
of whole grain foods. This was achieved through a combined involvement of
government, health promotion agency affiliations and food industry, and included
changes to the national dietary guidelines, targeted communication through social media
promotion, an introduction of the whole grain marketing logo, as well as increased
production and availability of whole grain containing products (337). Therefore, an
approach including promotion of whole grain health benefits, as well as changes to the
food environment such as regulation of whole grain food labelling and innovation in
appealing whole grain products may be most effective in addressing the potential
limiting factors to healthier grain choices identified here. The Australian Government’s
Healthy Food Partnership (338), has the potential to drive such a strategy within
Australia, as it also encourages cooperation of government, food industry and public
health agencies.
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This study utilised a qualitative approach in order to explore the existing perceptions
dictating grain food choices at a greater depth than what would be possible through
quantitative methods such as a survey. The total sample size of 52 participants, made up
of a relatively diverse demographic achieved through purposive sampling, allowed for
collection of a range of opinions and perspectives in shaping the extracted themes.
Despite the relatively large total sample size, each focus group contained no more than
8 participants, and groups tended to be individually homogenous (due mainly to the
location of the groups), which can help facilitate open discussion and engagement of all
participants (230; 232).

Although this study has several strengths, there are some limitations that need to also be
considered. While a relatively diverse sample of participants were recruited, the sample
was still well-educated, with 46% of participants holding a bachelor degree or higher,
compared to approximately 31% of the Australian population in 2018 (339). Furthermore,
as participation was voluntary and mainly based on expressed interest, it is possible that
individuals with a greater interest in health, nutrition or grain foods are more likely to
participate. This self-selection bias may be more likely as a considerable amount of
recruitment was conducted through the University and health-promoting organisations
such as gymnasiums, where attendees may already have higher health literacy or
interest. Given the moderators of the study were APDs, there is also a chance of social
desirability bias in participants comments and discussion. Lastly, because the specific
aims of this research, and subsequently the semi-structured questions asked, focused
primarily on consumer knowledge and perceptions of grain foods, the findings from
these groups may underestimate the role of factors such as cost and availability in
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determining consumer grain food choices. These factors were mentioned and discussed,
but not specifically explored in the groups.

6.5 Conclusion
While participants did report that they tend to choose some whole grain foods,
knowledge of the health benefits of whole grains was lacking, likely limiting incentive
for increased intake. Furthermore, participants were generally unaware of
recommendations surrounding whole grain intake, or specific food choices to help meet
these recommendations. Scepticism surrounding the health value of carbohydrate-based
foods was recurring within the focus groups, and appeared to be an additional barrier
hindering grain food intake in general. While there are likely a multitude of factors that
influence consumer grain food choices, further promotion of the benefits of whole
grains and whole grain foods, with a focus on food-based targets and messaging, may
be useful in encouraging whole grain intake, particularly in groups with few other
limitations (for example cost) on their food choices. In order to achieve this effectively,
a multi-pronged approach is needed including efforts from the government, public
health sector, and the food industry. Added-fibre grain products appear to be a useful
tool for avid whole grain avoiders to increase cereal fibre intakes, as this group is
unlikely to accept whole grain sensory properties. However, innovations by the food
industry in increasing the fibre content of grain foods should occur in conjunction with
efforts to increase availability and variety of naturally high whole grain products that
are palatable and appealing to consumers. This is particularly important considering the
comparative benefits of added-fibre products are not yet clear, and further research
directly comparing the effects of added-fibre intake to whole grain intake is still needed.
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Chapter 7: Summary of findings, recommendations and
conclusions
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7.1 Summary of findings
Substantial literature exists indicating that whole grain intake is protective against
various chronic diseases including CVD. However, this literature does not clarify the
extent to which the cereal fibre component of the whole grain is responsible for this,
and therefore whether grain foods high in cereal fibre but not whole grain, such as bran
and added-fibre grain foods, would offer similar benefits. Reviewing background
literature identified a disconnect at multiple levels in the translation of evidence to
enhance public health. Firstly, between the evidence base and current recommendations,
as there was little consistent evidence accurately differentiating the effects of high-fibre
and bran foods from whole grain foods; and secondly, between dietary
recommendations and dietary intakes; as despite recommendations encouraging whole
grains, intakes remain low within Australia (144). This thesis aimed to address this
disconnect by exploring the differential health associations of whole grains and cereal
fibre, and the potential value and acceptability of added-fibre and bran foods (that is,
high fibre grain foods) as a healthful alternative to whole grains within Australia.

The hypothesis of this thesis was that high cereal fibre intake and high whole grain
intake are both similarly associated with favourable CVD-related outcomes, indicating
that the cereal fibre component of whole grains may be the most important for
cardiovascular health. Therefore, although whole grain foods should continue to be
recommended and promoted as part of a healthy diet, high fibre grain foods that are not
whole grain may present a suitable alternative where sensory barriers to whole grain
foods exist.
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However, the results of this body of research suggest that this may not be the case.
Although it was found that both high whole grain and cereal fibre intakes were
associated with some favourable CVD-related health outcomes, whole grain intake
appeared to offer a slight advantage over cereal fibre intake when analysed separately.
The results of this thesis contribute to the growing evidence in nutrition science which
suggests that whole foods cannot be simply reduced to the sum of their nutrients, or at
least, the multitude of nutrients contained within whole foods each play important roles
in health pathways, beyond what can be achieved through separating isolated
components. In addition, the findings here appear quite positive for whole grains from a
health promotion perspective. Our qualitative research indicates that although whole
grain intakes are low, consumers may be willing to increase their intakes, and may
respond positively to promotional efforts encouraging this. In order for this to be
effective, adequate focus must be placed on improving public knowledge of whole grain
health benefits, high whole grain food choices, and how to meet quantifiable, foodbased whole grain targets.

Within this thesis, a comparison was made between the CVD-protective benefits of
whole grains and cereal fibre using various methods. In the first instance, this process
utilised systematic review methods to evaluate the extent and quality of the existing
evidence. Interventional and observational evidence were assessed separately to
consider the cohesiveness of the total body of evidence. The existing evidence is scarce,
as few intervention studies exist, and many observational studies use inconsistent
methodology in defining and estimating whole grain intakes.
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This presented challenges for the systematic review process, making it difficult to draw
sound conclusions from this alone. When observational evidence did use the accepted
definition of whole grain as an ingredient (including all fractions of the grain in natural
proportions) and estimated intakes systematically as total grams per day, inverse
associations found for whole grain and bran to CVD-related health outcomes were often
stronger, and less prone to attenuation after adjustment for cereal fibre. This indicates
that perhaps the full range of nutrients present in these components were more
accurately captured in these methods, and looser, food-based definitions and
categorisation systems may have diluted the overall quality of intakes and blunted the
contribution of nutrients beyond cereal fibre. However, this could not be confirmed
through concurring interventional evidence, as to date, there are very few studies
directly comparing whole grain and cereal fibre or bran exposures.

Secondary analysis of two population-representative dietary data sets was then
performed as a means of comparing whole grain and cereal fibre intakes using an
accepted definition and systematic categorisation system first-hand. Here, modest
inverse associations were found between whole grain and cereal fibre intakes and
various CVD-related health outcomes. Whole grain and cereal fibre intakes were both
consistently inversely associated with anthropometric measures, namely waist
circumference and waist-hip ratio. This is of relevance within Australia and the UK,
where the data was collected. In both countries, obesity rates continue to rise (340; 341),
and central adiposity is independently associated with other chronic diseases including
CVD and T2DM (8). Other modest associations were found between diets high in whole
grain and cereal fibre and other CVD-related outcomes, including CRP, homocysteine,
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blood glucose measures and blood lipid markers, although these were not consistent
across both the UK and Australian datasets.

Although significant inverse associations were not always consistent across datasets, the
results did tend to indicate that when inverse associations were found, they were often
more pronounced for whole grain intake compared to cereal fibre intake, suggesting
some advantage of the whole food intake compared to cereal fibre intake alone. The
exception to this was that cereal fibre in the Australian dataset was inversely associated
with lipid constituent levels while whole grain intake was not associated, so perhaps
some mechanisms for the protective benefits of whole grains may feature a more active
role of cereal fibre than others. For example, soluble fibres associated with attenuation
of serum cholesterol may not require other whole grain components to be effective. The
large, population representative sample and systematic process used to estimate whole
grain and cereal fibre intakes were strengths of this research, and contribute to the
limited evidence base in which precise methods have been used to separate and define
intakes.

The last component of this thesis incorporated a qualitative research approach through
use of focus groups, to explore consumer perceptions that may influence grain food
choices. The purpose of this was to assess the potential effectiveness of whole grain
food recommendations compared to high fibre grain food recommendations, that is, to
explore which healthful grain food items may be more appealing to consumers to
incorporate into their diets. This could then be used to consider the most effective
promotion and messaging approaches to encourage healthful grain intake within
Australia. The use of a qualitative approach allowed a richer understanding as to why
240

Australians make certain grain food choices, and the sample of 52 participants,
consisting of a relatively diverse demographic, meant that a variety of opinions and
perspectives were considered.

The findings from the focus groups indicate that consumers are open to choosing more
whole grain foods, particularly within the breads and cereals categories, but they have
limited knowledge on the benefits of whole grains, or which foods to choose to get the
most benefit, which limits incentive to change their choices. There was also evidence of
initial scepticism surrounding health effects of grain foods, and in fact, this scepticism
was more present towards added-fibre grain foods, which were seen as ‘unnatural'.
Although it is not clear whether knowledge alone would successfully improve whole
grain intakes to an adequate level, campaigns of this nature in other countries (332), or
with different foods (333), have proved successful in the past, so the findings indicate
there is promise in such actions. However, in order for whole grain promotional
campaigns to be most impactful, they must combine efforts at the government, health
promotion agency, and food industry level, to ensure that consumers are not only
provided with the knowledge to make informed choices, but are also provided with a
range of easily available, affordable, healthy and appealing choices. Added-fibre grain
foods, although less appealing to many participants, may still play a role in the diets of
whole grain ‘avoiders’, those consumers that are particularly adverse to the sensory
properties of whole grains and would unlikely sway based on increased health
knowledge.
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7.2 Limitations
The limitations specific to each study have been discussed throughout this thesis in the
corresponding chapters, however, overarching limitations in exploration of the research
question are also relevant to consider.

A major limitation in addressing the research question within this thesis was the
difficulty in separating cereal fibre exposure from whole grain exposure, in attempts to
understand its individual health associations, and potential contribution to the CVD
benefits of whole grain. Partly, this issue is heightened within the literature due to the
historical confounding of estimated whole grain intakes with non-whole grain
components including bran, germ and mixed grain intakes. Although careful and precise
methods were used to separate whole grain and cereal fibre intakes as accurately as
possible within this thesis, there remains inherent limitations of the study designs
utilised that restrict our interpretation of findings from the present studies, and call for
further research.

Firstly, the dietary surveys utilised within the NDNS RP and the AHS were not
designed or validated to recall whole grain and cereal fibre intakes specifically, rather to
capture total diet, and so there is the possibility of misestimating grain foods consumed
within the dietary surveys, which may result in subsequent errors in whole grain and
cereal fibre intakes. Estimating grain food intakes can be particularly complex, as there
can be considerable discrepancy in the whole grain or fibre content of different brands
of grain foods within the same categories, for example, whole grain breads. The use of
cross-sectional data from surveys is also limited in its ability to fully answer the
research question, as cross-sectional analysis lacks temporality and cannot ascertain
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causation. That is, we cannot be sure that associations found between dietary exposures
and CVD-related outcomes indicate a cause-effect relationship. Furthermore, British
and Australian diets were chosen to explore varied food supplies, but the dietary
patterns between the two countries are similar, and so it cannot be assumed that the
same associations would be found in non-Western populations with more diverse diets.
The results cannot be full extrapolated to a global scale. Additionally, due to the
observational nature of the research, there is the possibility of confounding from other
dietary and lifestyle factors. Participants that report consuming more whole grain and
cereal fibre were also found to generally consume less saturated fat, exercise more, and
smoke less, which all may contribute to an overall healthier lifestyle associated with
more favourable CVD-related outcomes. Although adjustment was made to correct for
these potential confounders, there is still the possibility of residual confounding.

The relevance of related diet and lifestyle factors leads appropriately to the second
overarching limitation in this thesis. Here, whole grains and cereal fibre have not been
considered in the context of total diet and dietary patterns. It is therefore difficult to
conclude that the health benefits of singular components of a diet such as whole grains
or cereal fibre exist to the same extent outside of the broad dietary pattern they might be
associated with, which may include other healthful components such as a high intake of
a variety of fruits, vegetables, nuts, and fish, for example. Adjustment for a total dietary
quality index within our analyses may have gone some way to elucidate the individual
associations of whole grains and cereal fibre. However, we are continuing to learn
within nutrition science that the link between diet and health is likely most reliant on
broad dietary patterns, rather than singular nutrients or even singular foods (149). In this
sense, although it remains valuable to accurately explore the potential value of singular
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foods or nutrients that make up these dietary patterns within a research setting perhaps
this must always be viewed with the aim of developing insights into these healthful
broader dietary patterns, which are likely to include cereal fibre, and particularly whole
grains. Ultimately, it is these healthful broader dietary patterns that should then form the
basis of recommendations to the public, in efforts to prevent chronic disease.

7.3 Recommendations and future work
With consideration of the findings from this thesis, several recommendations can be
suggested at different points of the trajectory which may improve the effective
translation of whole grain evidence into improvements in public health.

1. A universal approach to estimating whole grain intakes within research must be
adopted
This thesis highlights the need for researchers examining health effects and associations
of whole grains to adopt a consistent and systematic approach to estimating whole grain
intake. This means use of an accepted definition of whole grain as an ingredient, such as
the definition recently released for this purpose by the WGI (22), rather than use of foodbased whole grain definitions prone to variation and imprecise estimation. Accordingly,
estimation of total whole grain intake must also be in grams per day, rather than
servings of whole grain foods which may vary between jurisdictions.

This precision is important for the integrity of the whole grain evidence base, which has
proved limiting in the past, to the point of inhibiting the introduction of a health claim
for whole grains within Australia. In 2006, a high level health claim was proposed for
the relationship between whole grain intake and cardiovascular health. An external
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review of the literature was conducted to determine the evidence for the claim (342),
however FSANZ ultimately ruled that the evidence for whole grain alone was
insufficient, as a considerable proportion of evidence is instead for cereal fibre (343). In
addition to improving the integrity of the evidence, defining whole grain correctly, at
the ingredient level and in grams, may also result in an elucidation of the greater health
benefits of whole grain (and perhaps also bran) when it is defined correctly and at less
risk of confoundment by non-whole grain components (Chapter 3).

2. Good-quality interventional evidence exploring this topic is needed to support
observational evidence
RCTs directly comparing the effects of whole grain intake with added-fibre or bran
intake from the same grain on CVD-related health outcomes, including those examined
within this thesis, will provide researchers and regulators with the best level of evidence
to determine the differential effects that may exist. However, although RCTs produce
the highest quality of evidence available, this study design does risk inevitably reducing
our vision to singular foods, which as explained in the previous section, can be an
overly reductionist approach that may not align with the means by which total dietary
patterns influence health. Therefore, whole grain or cereal fibre exposure would ideally
occur as part of an overall healthy dietary pattern, such as one in accordance with the
ADG. To ensure dietary arms are comparable, they will need to be matched on cereal
fibre, and be otherwise nutritionally equivalent.

As dietary intakes may be more likely to exert effects over a longer period of time with
regular intakes, short intervention trials and meal studies may not be sufficiently
sensitive to capture dietary-related effects on CVD-related outcomes. If effects are
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found in shorter term trials, it is not clear whether they would be sustained over time.
For these reasons, trials exploring these dietary exposures in the longer term (for
example, 12 weeks or longer) are needed to indicate any sustained effect.

3. A multi-faceted approach to encourage whole grain intake must be actioned
Although the evidence shows that whole grain intake should continue to be promoted
and encouraged as first choice, it is clear from the consistently low intakes that new
strategies are needed to do this effectively. Our focus group research showed that
participants tended to feel positive about eating more whole grains once they were
educated on their long term health benefits, examples of good quality food sources to
choose, and how much they must consume to meet recommendations (3 serves a day).
Their existing lack of knowledge in these areas, coupled with scepticism regarding grain
foods’ health effects, were limiting incentive to increase intakes. Therefore, impactful
strategies to address these barriers is essential.

Promotion of whole grain health benefits through an official marketing campaign is
needed. Previously, the Australian government has successfully implemented the 2&5
campaign to promote fruit and vegetable intake (333), however, no such campaign has
been initiated for whole grain intake. The success of the Danish Whole Grain
partnership, which saw daily whole grain intakes increase from 36g/10 MJ to 82g/10
MJ in 12 years (332), suggests promising effects are possible here too. The scepticism
surrounding the health effects of grain foods is a concern that cannot go unaddressed
and highlights the need for such a campaign immediately. To combat this scepticism,
educational campaigns must work to clearly distinguish whole grain foods from
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discretionary grain foods such as pies, pastries and cakes, or any refined grain foods
which are particularly low in fibre.

Messaging may be most effective if specific, food-based targets are provided. For
example, presenting the GLNC’s DTI as 3 whole grain serves a day (158), rather than 48g
of whole grain per day, was unanimously more clearly understood by focus group
participants. It may also be more impactful than the broad messages included within
both the Australian ADG and the UK Eatwell guide, which state that individuals should
choose “mostly whole grains” (ADG) (157) or “choose whole grains” (Eatwell guide)
(282)

, without providing a precise target, which may be too difficult for consumers to

quantify. Highlighting specific food varieties and choices that are high sources of whole
grain may also be useful, particularly within breads and breakfast cereals, which
appeared to be the most appealing whole grain choices to participants. So as not to
mislead consumers or undermine efforts to promote a healthy overall diet, these foods
should otherwise be nutritious.

In accordance with this, efforts to influence the food environment by increasing the
availability of easily identifiable, appealing and high whole grain products, with a focus
on breads and breakfast cereals, is also needed. Clearer whole grain labelling
requirements, whereby only nutritious foods that meet a whole grain content minimum
can be labelled as whole grain, may be needed within Australia. In contrast to the
research space, food-based whole grain definitions, with percentage cut-offs to define
whole grain foods, are most useful for these purposes, because they allow
differentiation between foods that contain a small amount of whole grain from those
that would contribute significantly to daily whole grain recommendations. Furthermore,
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a ‘whole grain and cardiovascular health’ high-level health claim permitted for use in
Australia may assist consumers with choosing high whole grain foods, while also
reinforcing the long-term benefits associated with whole grain intake. Although the
previous attempt at passing a health claim for whole grain and cardiovascular health
was unsuccessful, this occurred almost 15 years ago. Since 2006, more consistent
research (9; 28), including this thesis, supports the link between whole grains and
cardiovascular health, and therefore it is justified to reconsider this once more.

At the industry level, food companies should continue to develop wide varieties of
appealing whole grain products. Added-fibre grain foods may serve as a valuable
supplement for those strongly averse to the sensory properties of all whole grain foods,
and so innovation within this area should also continue. As mentioned consistently,
change must be in the context of healthy dietary patterns, so it is necessary that
innovations in this way are only developed in products that are otherwise healthful
choices, rather than discretionary items.

It is clear that change needs to occur at multiple levels, as efforts occurring at singular
levels appear prone to limitation. For example, current whole grain marketing at the
industry level alone may not be trusted by consumers, as participants in our focus group
research saw it simply a marketing ploy. However, previous literature shows that health
claims on food labels are most effective if the consumer is already familiar with the
relevant diet-disease relationship (344), suggesting that such labelling may be more
trusted if coupled with widespread, government-led educational campaigns. On the
other hand, educational campaigns alone, without efforts to clearly identify a wide range
of appealing whole grain foods, may also fall short, as consumers will likely remain
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unsure on suitable action to take to attain benefits. Therefore, an approach including an
educational, food-based campaign at the government level, in combination with change
to the food environment including regulation of whole grain food labelling and
increased production of appealing whole grain products is recommended.

7.4 Concluding remark
This thesis adds to the evidence base that suggests that higher whole grain intake is
associated with more favourable cardiovascular health beyond that associated with
cereal fibre intake alone. It is likely that whole grains are protective against CVD in
various ways, and through some pathways, such as reduced body weight and lipid
profile management, cereal fibre may play a primary role, but additional aspects of a
high whole grain diet appear to contribute further. The existing evidence may suggest
that bran, which is higher in cereal fibre than whole grain (per gram) but also contains
various other nutrients and bioactive components that would not be present with an
extracted fibre alone, may be equally as beneficial as whole grains, but this thesis did
not explore the specific associations of bran beyond the existing literature (Chapter 3).
However, it is clear that in order for future research to elucidate this question and
continue to clarify evidence surrounding grain foods and cereal fibres, it is imperative
that a universal approach to estimating total whole grain intake is adopted by
researchers worldwide.

In conclusion, this thesis suggests that current recommendations of three serves of
whole grains per day are appropriate, and should continue to be encouraged by health
professionals as part of a healthy diet. However, adoption of new and more robust
strategies are important to effectively encourage such intakes. A focus on breads and
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cereals choices, with clear and quantifiable food-based targets and messaging, is
needed. As cereal fibre does appear to offer some advantage for health independently,
some refined grain foods may still be consumed to provide variety to grain food choices
and overall diet, and foods with added fibre are likely a useful tool for supplementation
of some whole grain servings. The focus should remain on promotion of the whole
food, which it appears, may be better accepted than originally hypothesised.
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Appendix 1: Systematic review search strategies
Medline search strategy (Chapter 3a)
(((((cholesterol OR dyslipid* OR hyperlipid* OR lipid* OR triglycerides OR weight
OR "body mass index" OR BMI OR "waist circumference" OR adiposity OR obes* OR
"blood pressure" OR hypertension OR systolic OR diastolic OR "blood glucose" OR
HbA1c OR CRP OR "c-reactive protein" OR cardiovascular)) AND full text[sb] AND
Humans(345) AND English[lang])) AND (((bran OR fibre OR fiber)) AND full text[sb]
AND Humans(345) AND English[lang])) AND ((("whole grain" OR wholegrain OR oat*
OR rice OR wheat OR barley* OR millet OR quinoa OR buckwheat OR amaranth OR
maize OR sorghum OR rye OR corn)) AND full text[sb] AND Humans(345) AND
English[lang]) AND (full text[sb] AND Humans(345) AND English[lang])

Scopus search strategy (Chapter 3b)
( TITLE-ABS-KEY ( cardiovascular OR coronary OR stroke OR cholesterol OR
triglycerides OR lipids OR obes* OR glucose OR overweight OR diabetes )
AND TITLE-ABS-KEY ( wholegrain* OR grain* ) AND TITLE-ABS-KEY (
cereal* OR bran ) AND TITLE-ABS-KEY ( fibre OR fiber ) ) AND ( LIMIT-TO (
EXACTKEYWORD , "Human" ) OR LIMIT-TO ( EXACTKEYWORD , "Humans"
))
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Appendix 2: Meta-analysis of intervention trials (Chapter 3a)
Methods
Due to the limited number of studies returned for most CVD risk factors assessed as
outcomes, a meta-analysis was only performed on studies comparing the effects on total
cholesterol levels. For these studies, a meta-analysis was performed using Stata
software version 15.0 (StataCorp LP, College Station, Tx.) and a random effects model
was applied. The analysis was based on end of treatment mean values for the whole
grain exposure and bran/added fibre exposure derived from each trial. Where standard
deviation was not reported, it was calculated from standard error of mean. Where one
study assessed multiple doses of whole grain and bran (115), the median dose was
included in the meta-analysis. In another study, sufficient data were missing for all
participants except those in the highest quartile of baseline cholesterol (n=8) (239). This
study was included in the analysis using data from these eight participants only. Effect
sizes are presented as weighted mean differences with 95% CI within a forest plot. A
priori subgroup analyses were conducted for study design (cross-sectional vs parallel),
baseline total cholesterol (hypercholesterolaemia vs healthy) and background diet
(calorie restricted vs unrestricted). Meta-regression was then performed to assess the
significance of subgroup effects as well as treatment length. Inter-study heterogeneity
was examined using the Cochrane Q-statistic and quantified using the I2 statistic with
statistical significance set at P<0.10. Publication bias was tested by inspection of funnel
plots and use of Egger’s test, with evidence of statistical significance set at P<0.05.

282

Results
No difference was found between whole grain and bran or added fibre interventions in
total cholesterol response (weighted difference = -0.02, 95% CI: -0.31, 0.26; P=0.86)
(Figure 1). Subgroup analyses showed that the effects were not modified by study
design, baseline cholesterol levels or background diet (Figure 2). Furthermore, metaregression analyses did not reveal significant associations between study design,
baseline cholesterol levels, background diet, or treatment length (data not shown).

There was evidence of moderate inter-study heterogeneity present (I2 = 32.1%, P=0.21).
Visual inspection of funnel plot (Figure 3) suggest no asymmetry in the analyses, and
Egger's test was not significant (P=0.95).
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Figure 1: Forest plot of studies investigating the effects of whole grain and bran/added fibre on total cholesterol (mmol/L). Values are weighted mean
differences (WMD) with 95% CI, using a random effects model. For each study, the square represents the point estimate of the intervention effect,
with horizontal lines joining lower and upper limits of the 95% CI of the effect. The diamond represents the pooled mean difference. Inter-study
heterogeneity was quantified by I2 at a significance of P<0·10.
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(i)

285

(ii)

286

(iii)

Figures 2: Forest plot of studies investigating the effects of whole grain and bran/added fibre on total cholesterol (mmol/L) according to study design
(i), baseline cholesterol (ii) and background diet (iii). Values are weighted mean differences (WMD) with 95% CI, using a random effects model. For
each study, the square represents the point estimate of the intervention effect, with horizontal lines joining lower and upper limits of the 95% CI of
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the effect. The diamonds represent the subgroup mean difference and pooled mean difference. Inter-study heterogeneity was quantified by I2 at a
significance of P<0·10.
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Figure 3: Contour-enhanced funnel plot assessing publication bias and effect of small and/or imprecise study effects for total cholesterol. The shaded
region indicates areas of statistical significance, and non-statistical significance (P>0.10) is represented in white. This funnel plot shows no evidence
of publication bias (Egger’s test, p=0.95).
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Appendix 3: Summary tables of included studies in Chapter 3a
Study

n, setting Age
(yrs.)

Costabile, 31 (15M: 25.0
2008 (239) 16F), UK

Baseline
condition

Design

Diet

WG/d

Nil

C, 3
weeks

Prebiotic WG wheat
/probiotic (WG) cereal
restricted 48g

Comparison
/d

Measure of
effect

Wheat bran
Baseline v.
(B) cereal 48g post-Tx

Outcomes

Hypercholesterolaemia

P, 6
weeks

NCEP
step 1

Oatmeal
Oat bran (B): Baseline v.
(WG):
28g, 56g, 84g post-Tx.
28g, 56g, 84g Farina control
(C): 28g

P

TC (mmol/L) Reported in highest quartile of <0.05
TC only (n=8)
WG: 5.576 (SD 0.421) v. 4.216
(SD 1.006)

HDL-C
TAG
Insulin
Fasting
glucose
Davidson, 140 (80M: 52.7
1991 (115) 60F),
USA

Results

Reported in highest quartile of
TC only (n=8)
B: 5.576 (SD 0.421) v. 4.385
(SD 1.093 )

<0.05

Not reported

N.S

TC (mmol/L) C: 6.77 (SD 0.83) v 6.79 (SD
0.85)

-

WG 28g: 6.82 (SD 0.54) v 6.54 N.S
(SD 0.68)
B 28g: 6.95 (SD 1.00) v 6.72
(SD 0.89)

N.S

WG 56g: 6.84 (SD 0.74) v 6.63 N.S
(SD 0.81)
B 56g: 6.89 (SD 0.84) v 6.20
(SD 0.76)

0.003

WG 84g: 7.11 (SD 1.15) v 6.56 0.02
(SD 0.92)
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HDL-C
(mmol/L)

B 84g: 6.84 (SD 0.87) v 6.34
(SD 0.78)

0.03

C: 1.31 (SD 0.30) v 1.34 (SD
0.26)

-

WG 28g: 1.45 (SD 0.35) v 1.48 N.S
(SD 0.33)
B 28g: 1.41 (SD 0.47) v 1.49
(SD 0.43)

N.S

WG 56g: 1.28 (SD 0.36) v 1.34 N.S
(SD 0.38)
B 56g: 1.31 (SD 0.41) v 1.37
(SD 0.42)

N.S

WG 84g: 1.36 (SD 0.29) v 1.40 N.S
(SD 0.39)

LDL-C
(mmol/L)

B 84g: 1.38 (SD 0.32) v 1.44
(SD 0.49)

N.S

C: 4.77 (SD 0.60) v 4.79 (SD
0.73)

-

WG 28g: 4.78 (SD 0.52) v 4.47 N.S
(SD 0.61)
B 28g: 4.91 (SD 0.86) v 4.61
(SD 0.79)

N.S

WG 56g: 4.88 (SD 0.63) v 4.67 N.S
(SD 0.75)
B 56g: 4.89 (SD 0.72) v 4.09
(SD 0.76)

0.0009

WG 84g: 5.12 (SD 1.12) v 4.56 0.02
(SD 1.00)
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TAG
(mmol/L)

B 84g: 4.72 (SD 0.68) v 4.16
(SD 0.70)

0.02

C: 1.50 (SD 0.69) v 1.42 (SD
0.54)

-

WG 28g: 1.27 (SD 0.64) v 1.28 N.S
(SD 0.61)
B 28g: 1.37 (SD 0.64) v 1.38
(SD 0.74)

N.S

WG 56g: 1.48 (SD 0.47) v 1.34 N.S
(SD 0.38)
B 56g: 1.49 (SD 0.57) v 1.62
(SD 0.78)

N.S

WG 84g: 1.37 (SD 0.70) v 1.31 N.S
(SD 0.80)

Lappi,
2014 (240)

21 (9M:
12F),
Finland

38.065.0
(range
only)

SelfC, 4
reported GI weeks
symptoms
post-grain
consumption

None

Sourdough
WG rye
bread (WG):
6-10 slices

White wheat
bread + rye
bran (B): 6-10
slices
White wheat
bread run-in
control (C):
6-10 slices

Post-Tx.
comparison
between all
exposures

B 84g: 1.58 (SD 0.70) v 1.61
(SD 1.01)

N.S

Weight (kg)

WG: 72.0 (SD 14) v. B: 72.0
(SD 13) v. C: 72.0 (SD 14)

0.133

Fasting
glucose
(mmol/L)

WG: 5.0 (SD 0.5) v. B: 5.0 (SD 0.449
0.5) v. C: 5.1 (SD 0.4)

TC (mmol/L) WG: 5.0 (SD 0.7) v. B: 5.4 (SD 0.006*
0.9) v. C: 5.2 (SD 0.9)
TAG
(mmol/L)

WG: 1.0 (SD 0.6) v. B: 0.9 (SD 0.499
0.4) v. C: 0.9 (SD 0.4)
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Van
Horn,
1986 (241)

208
(108M:
100F),
USA

43.7

Nil

P, 6
weeks

AHA
step 1

Oatmeal
(WG) 56g

Oat bran (B)
56g
No oat control
(C) 0g

Baseline v.
post-Tx.
significance
compared to
control

Post-Tx
change from
baseline
compared
between all
exposures
Lu, 2004
(123)

15 (6M:
9F),
Australia

60.0

T2DM (non- C, 5
insulin
weeks
dependent)

None

50% WG
wheat
bread/muffins
(WG) 4-5
slices bread,
1-2 muffins

50% WG
Baseline v.
wheat
post-Tx.
bread/muffins
+ 14% added
Arabinoxylanrich (AX)
wheat fibre
4-5 slices
bread, 1-2
muffins

TC (mmol/L) WG: 5.05 (SD 0.96) v. 4.88
(SD 1.05)

0.038

B: 5.08 (SD 1.13) v. 4.94 (SD
1.08)

0.078

C: 5.19 (SD 1.15) v. 5.16 (SD
1.09)

-

HDL-C
(mmol/L)

WG: +0.06, B: +0.04, C: +0.08

0.470

LDL-C
(mmol/L)

WG: -0.23, B: -0.23, C:
-0.11

0.271

TAG
(mmol/L)

WG: -0.01, B: +0.07, C: +0.007 0.538

Fasting
glucose
(mmol/L)

WG: 7.3 (SEM 0.3) v. 7.6
(SEM 0.3)

2h postOGTT
glucose
(mmol/L)

WG: 14.5 (SEM 0.9) v. 15.0
(SEM 0.8)

N.S

AX: 15.2 (SEM 0.9) v. 13.4
(SEM 0.9)

<0.05

Weight (kg)

WG: 77.5 (SEM 3.3) v. 78.2
(SEM 3.3)

N.S

AX: 77.8 (SEM 3.3) v. 78.1
(SEM 3.3)

N.S

Fat mass (kg) WG: 28.7 (SEM 2.2) v. 29.1
(SEM 2.1)

N.S

AX: 28.7 (SEM 2.2) v. 28.7
(SEM 2.2)

N.S

N.S

AX: 7.6 (SEM 0.3) v. 7.0 (SEM <0.05
0.3)
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Systolic bp
(mmHg)

WG: 140 (SEM 5) v. 139 (SEM N.S
5)
AX: 139 (SEM 4) v. 136 (SEM N.S
4)

Diastolic bp
(mmHg)

WG: 75 (SEM 2) v. 77 (SEM 2) N.S
AX: 77 (SEM 2) v. 75 (SEM 2) N.S

TC (mmol/L) WG: 5.43 (SEM 0.23) v. 5.33
(SEM 0.24)

N.S

AX: 5.31 (SEM 0.25) v. 5.31
(SEM 0.23)

N.S

WG: 1.06 (SEM 0.04) v. 1.04
(SEM 0.05)

N.S

AX: 1.04 (SEM 0.05) v. 1.04
(SEM 0.04)

N.S

WG: 3.53 (SEM 0.22) v. 3.35
(SEM 0.26)

N.S

AX: 3.36 (SEM 0.26) v. 3.32
(SEM 0.21)

N.S

WG: 1.86 (SEM 0.27) v. 2.06
(SEM 0.39)

N.S

AX: 2.01 (SEM 0.35) v. 1.86
(SEM 0.29)

N.S

HDL-C
(mmol/L)

LDL-C
(mmol/L)

TAG
(mmol/L)

WG, whole grain; M, male; F, female; C, cross-over design; df, dietary fibre; Tx., treatment; TC, total cholesterol; TAG, triglycerides; P, parallel design; GI,
gastrointestinal; OGTT, oral glucose tolerance test; bp, blood pressure; AHA, American Heart Association.
*WG significantly different to B.
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Appendix 4: Summary table of included studies in Chapter 3b: Initial analysis
(i) Whole grain intake
Study

Country

Design

Cohort

Participants

Outcome

Intakes

Covariates

Results

P

He, 2010

USA

PCS

NHS I

7822 F with
T2DM

CVD
death

4.8 32.6 g/d

Age, smoking status, BMI, alcohol intake,
physical activity, parental history of MI,
menopausal status and use of hormone
therapy, duration of diabetes mellitus.
Intake of total energy, PUFA, saturated fat,
trans fat, Mg and folate.

RR 0.70 (95% CI 0.46,
1.06)

0.07

RR 0.89 (95% CI 0.69,
1.14)

0.11

Age, BMI, added bran intake, added germ
intake, energy intake, smoking status,
alcohol intake, physical activity, family
history of MI, use of vitamin E supplement,
intakes of PUFA, saturated fat, trans fat,
fruit, vegetables and fish.

HR 0.84 (95% CI 0.71,
0.98)

0.02

+ Whole grain constituent intake: dietary
fibre, folate, glycaemic load, dietary
vitamin B-6, vitamin E, Mg and Mn

HR 0.85 (95% CI 0.71,
1.02)

0.06

Age, BMI, smoking status, alcohol intake,
physical activity, aspirin use, HbA1c,
history of hypertension or
hypercholesterolemia, postmenopausal
hormone use, glycaemic index, and Mg.

Q1 6.60 v. Q5 5.52

0.03

Q1 316 v. Q5 306

0.19

Q1 65.6 v. Q5 65.4

0.96

Q1 2647 v. Q5 2435

0.017

(110)

All cause
death

Jensen,
2004 (142)

Qi, 2006
(246)

USA

USA

PCS

Crosssectional

HPFS

NHS I

42,850 M

902 F with
T2DM

CHD

CRP
(mg/l)
ICAM-1
(ng/ml)
Eselectin
(ng/ml)
TNF-R2
(pg/ml)

3.5 42.4 g/d

4.8 35.4 g/d
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Wu,
2015 (247)

de
Munter,
2007 (143)

USA

USA

PCS

PCS

NHS I
&
HPFS

74,341 F,
43,744 M

NHS I

167,737 F

CVD
death
All cause
death

T2DM

NHS II

Flint,
2009 (112)

USA

PCS

HPFS

4.2 47.8 g/d

3.7 31.2 g/d
6.2 39.9g/d

31,684 M

Hypertension

3.3 46.0 g/d

Age, ethnicity, BMI, smoking status, pack
years smoked, years since quitting for past
smoker, alcohol intake, physical activity,
family history of diabetes, cancer and heart
disease, multivitamin use, aspirin use at
least once per week, history of
hypertension, high cholesterol or diabetes
at baseline, total energy intake,
postmenopausal status and postmenopausal
hormone use, modified alternative healthy
eating index (excludes whole grains).

HR 0.88 (95% CI 0.82,
0.96)a

0.001

HR 0.92 (95% CI 0.89,
0.96)a

<0.001

Age, smoking status, physical activity,
alcohol intake, use of hormone replacement
therapy, oral contraceptive use, family
history of T2DM, intake of coffee, sugarsweetened soft drinks and fruit punch (nonalcoholic), total energy intake, processed
meat intake, PUFA to saturated fat intake
ratio, BMI.

RR 0.75 (95% CI 0.68,
0.83)

<0.001

RR 0.86 (95% CI 0.72,
1.02)

0.03

Age, energy intake, family history of CHD
and hypertension, smoking status, alcohol
intake, marital status, profession, height,
fruit and vegetable intake, Na intake,
physical activity, multivitamin use,
cholesterol screening.

RR 0.81 (95% CI 0.75,
0.87)

<0.0001

+ Cereal fibre intake

RR 0.94 (0.84, 1.05)

0.23
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KohBanerjee,
2004 (113)

USA

PCS

HPFS

27,082 M

Weight
change
over 8
years
(kg)

-14 g/d
change
to +23.8
g/d
change

Age, baseline exposure, smoking status,
baseline weight, baseline values and
changes in refined grains, total energy
intake, physical activity, alcohol intake,
protein intake and trans, saturated, MUFA
and PUFA intake.

Q1 1.24 (SD 0.23) v.
Q5 0.75 (SD 0.22)

<0.0001

PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; HPFS,
Health Professionals Follow-up Study; M, male; HR, hazard ratio; CRP, C-reactive protein; ICAM-1, intercellular adhesion molecule 1; TNF-R2, TNF
receptor 2.
a
Pooled HR for whole grain intake without added bran/germ. Located within Wu, 2015 online supplementary material Table S4.
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(ii) Cereal fibre intake
Study
He, 2010

Country
USA

Design
PCS

Cohort
NHS I

(110)

Participants
7822 F with
T2DM

Outcome
CVD death

Intakes
1.9g - 6.3 g/d

All cause death

Qi, 2006

USA

(246)

Crosssectional

NHS I

902 F with
T2DM

CRP (mg/l)

N/A

TNF-R2
(pg/ml)

KohBanerjee,
2004 (113)

US

PCS

HPFS

27,082 M

Weight change
over 8 years
(kg)

-2.2 g/d
change to
+5.1 g/d
change

Covariates
Age, smoking status, BMI, alcohol
intake, physical activity, parental
history of MI, menopausal status and
use of hormone therapy, duration of
diabetes mellitus. Intake of total
energy, PUFA, saturated fat, trans fat,
Mg and folate.

Results
RR 0.89 (95% CI
0.57, 1.41)

P
0.41

RR 0.86 (95% CI
0.66, 1.12)

0.10

Age, BMI, smoking status, alcohol
N/A
intake, physical activity, aspirin use,
HbA1c, history of hypertension or
hypercholesterolemia, postmenopausal
hormone use, glycaemic index, and
Mg.

0.03

Age, baseline exposure, smoking
Q1 1.10 (SD 0.20) v.
status, baseline weight, baseline values Q5 0.76 (SD 0.20)
and changes in refined grains, total
energy intake, physical activity,
alcohol intake, protein intake and
trans, saturated, MUFA and PUFA
intake.

0.0002

0.01

PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; CRP, Creactive protein; N/A, not available; TNF-R2, TNF receptor 2; HPFS, Health Professionals Follow-up Study; M, male.
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(iii) Bran intake
Study
He, 2010 (110)

Country Design
USA
PCS

Cohort
NHS I

Participants Outcome
7822 F with CVD death
T2DM

Bran
Totala
Addedb

All cause
death

Total
Added

Jensen, 2004

USA

PCS

HPFS

42,850 M

CHD

Added

(142)

Qi, 2006 (246)

USA

CrossNHS I
sectional

902 F with
T2DM

CRP (mg/l)
ICAM-1
(ng/ml)
E-selectin
(ng/ml)
TNF-R2
(ng/ml)

Total

Intakes Covariates
0.8 Age, smoking status, BMI, alcohol
9.7 g/d intake, physical activity, parental
history of MI, menopausal status
N/A
and use of hormone therapy,
duration of diabetes mellitus.
0.8 Intake of total energy, PUFA,
9.7 g/d saturated fat, trans fat, Mg and
folate
N/A

Results
RR 0.65 (95% CI
0.43, 0.99)

P
0.04

RR 0.36 (95% CI
0.24, 0.54)

<0.001

RR 0.72 (95% CI
0.56, 0.92)

0.01

RR 0.45 (95% CI
0.36, 0.57)

<0.001

0.0 6.9 g/d

HR 0.72 (95% CI
0.61, 0.84)

<0.001

HR 0.71 (95% CI
0.59, 0.85)

<0.001

1.6 10.9
g/d

Age, BMI, added germ intake,
energy intake, smoking status,
alcohol intake, physical activity,
family history of MI, use of
vitamin E supplement, intakes of
PUFA, saturated fat, trans fat,
fruit, vegetables and fish.
+ Whole grain constituent intake:
dietary fibre, folate, glycaemic
load, dietary vitamin B-6, vitamin
E, Mg, and Mn.

Age, BMI, smoking status, alcohol Q1 6.29 v. Q5 4.96
intake, physical activity, aspirin
Q1 319 v. Q5 303
use, HbA1c, history of
hypertension or
hypercholesterolemia,
Q1 67.2 v. Q5 68.1
postmenopausal hormone use,
glycaemic index, and magnesium.
Q1 2603 v. Q5 2462

0.007
0.11
0.86
0.06
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Wu, 2015 (247)

USA

PCS

NHS I &
HPFS

74,341 F,
43744 M

CVD death

All cause
death

de Munter,
2007 (143)

USA

PCS

NHS I

167,737 F

T2DM

NHS II

Flint, 2009 (112)

USA

PCS

HPFS

31,684 M

Hypertension

Total

N/A

Added

0.0 ≥6.0g/d

Total

N/A

Added

0.0 ≥6.0g/d

Total

0.6 9.6 g/d

Total

1.1 12.0
g/d

Total

0.3 12.0
g/d

Age, ethnicity, BMI, smoking
status, pack years smoked, years
since quitting for past smoker,
alcohol intake, physical activity,
family history of diabetes, cancer
and heart disease, multivitamin
use, aspirin use at least once per
week, history of hypertension,
high cholesterol or diabetes at
baseline, total energy intake,
postmenopausal status and
postmenopausal hormone use (for
women), modified alternative
healthy eating index (excludes
whole grains).

HR 0.80 (955 CI
0.73, 0.87)

<0.001

HR 0.76 (95% CI
0.70, 0.83)c

<0.001

HR 0.94 (95% CI
0.90, 0.99)d

0.02

HR 0.93 (95% CI
0.89, 0.97)c

0.006

Age, smoking status, physical
activity, alcohol intake, use of
hormone replacement therapy,
oral contraceptive use, family
history of T2DM, intake of coffee,
sugar-sweetened soft drinks and
fruit punch (non-alcoholic), total
energy intake, processed meat
intake, PUFA to saturated fat
intake ratio, BMI.

RR 0.72 (95% CI
0.65, 0.80)

<0.001

RR 0.84 (95% CI
0.71, 1.00)

0.07

Age, energy intake, family history
of CHD and hypertension,
smoking status, alcohol intake,
marital status, profession, height,
fruit and vegetable intake, Na
intake, physical activity,
multivitamin use, cholesterol
screening.

RR 0.85 (95% CI
0.78, 0.92)

0.002
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Koh-Banerjee,
2004 (113)

USA

PCS

HPFS

27,082 M

8yr weight
change (kg)

Added

0.0 g/d
to +7.3
g/d
change

Age, baseline exposure, smoking
status, baseline weight, baseline
values and changes in refined
grains, total energy intake,
physical activity, alcohol intake,
protein intake and trans, saturated,
MUFA and PUFA intake, baseline
and changes in natural bran.

Q1 1.16 (SD 0.23) v. 0.01
Q3 1.00 (SD 0.20)

PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; N/A, not
available; HPFS, Health Professionals Follow-up Study; M, male; HR, hazard ratio; CRP, C-reactive protein; ICAM-1, intercellular adhesion molecule 1;
TNF-R2, TNF receptor 2.
a
Bran consumed naturally within whole grains and bran added to food/consumed separately
b
Bran added to food/consumed separately only
c
Located within Wu, 2015 online supplementary material Table S7
d
Located within Wu, 2015 online supplementary material Table S6
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Appendix 5: Summary table of included studies in Chapter 3b: Expanded analysis
(i) Whole grain intake
Study

Country

Design

Cohort

Jensen,
2006 (111)

USA

CrossHPFS &
sectional NHSII

Participants

Outcome

Intakes

Covariates

Results

P

468 M +
470 F

Total
cholesterol
(mmol/L)
HDLcholesterol
(mmol/L)

8.2 - 43.8
g/d

Age, sex, total energy intake,
alcohol intake, smoking status,
BMI, physical activity,
hypercholesterolemia, intakes
of fruit, vegetable, saturated
fat, MUFA and PUFA.

Q1 5·7 (SE 0.08) v. Q5
5·6 (SE 0.07)

0.02

Q1 1·7 (SE 0.03) v. Q5
1·6 (SE 0.03)

0.05

Q1 3·3 (SE 0.07) v. Q5
3·2 (SE 0.06)

0.10

Q1 5.50 (SE 0.04) v. Q5
5.49 (SE 0.04)

0.83

Q1 91·7 (SE 4.9) v. Q5
78·5 (SE 5.6)

0.13

Q1 2.13 (SE 0.08) v. Q5
1.84 (SE 0.08)

0.03

Leptin (ng/mL)

Q1 9.02 (SE 1.03) v. Q5
8.03 (SE 1.04)

0.03

CRP (mg/L)

Q1 0.92 (SE 1.07) v. Q5
0.88 (SE 1.07)

0.63

Fibrinogen
(g/L)

Q1 2·2 (SE 0.03) v. Q5
2·2 (SE 0.03)

0.77

IL-6 (pg/mL)

Q1 1.20 (SE 1.04) v. Q5
1.13 (SE 1.05)

0.87

LDLcholesterol
(mmol/L)
HbA1c (%)
Insulin
(pmol/L)
C-peptide
(ng/mL)

Age, sex, total energy intake,
alcohol intake, smoking status,
BMI, physical activity,
hypercholesterolemia, intakes
of fruit, vegetable, sucrose and
fructose.
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Liu, 1999

USA

PCS

NHS I

75,521 F

Homocysteine
(μmol/L)
CHD

(248)

Juan, 2017
(139)

USA

PCS

NHS I &
HPFS

71750 F +
42823 M

Stroke

0.1 - 2.7
servesa/d

F: 4.4 33.2 g/d
M: 5.0 47.9 g/d
Pooled:
N/A

Q1 13.2 (SE 0.6) v. Q5
10.9 (SE 0.3)
RR 0.75 (95% CI 0.59,
0.95)

<0.001

+ Whole grain constituent
intake: dietary fibre, folate,
vitamin B-6, and vitamin E.

RR 0.79 (95% CI 0.62,
1.01)

0.07

Age, BMI, smoking status,
alcohol intake, physical
activity, family history of
diabetes mellitus, cancer and
heart disease, multivitamin use,
hypertension or high
cholesterol at baseline, total
energy intake, modified
alternative eating index score
(did not include whole grains),
menopausal status and
postmenopausal hormone use.

HR 1.03 (95% CI 0.88,
1.21)
HR 1.06 (95% CI 0.85,
1.32)

0.35

Pooled HR 1.04 (95% CI
0.91, 1.19)

0.97

Age, BMI, smoking status,
alcohol intake, family history
of MI before 60y, self-reported
history of hypertension or
hypercholesterolemia,
menopausal status, protein
intake, aspirin use, use of
multiple vitamin or vitamin E
supplements, vigorous activity,
total energy intake and
saturated fat, MUFA, PUFA
and trans fat intakes.

0.01

0.37

302

Fung, 2002

USA

PCS

HPFS

42,898 M

T2DM

(114)

Montonen,
2003 (51)

Meyer,
2000 (50)

McKeown,
2004 (249)

Finland

USA

USA

PCS

PCS

FMC

IWHS

CrossFOS
sectional

4316 F+M

35,988 postmenopausal F

2834 M+F

T2DM

T2DM

Mean HOMAIR

0.4 - 3.2
serves/d

Age, time period, physical
RR 0.70 (95% CI 0.57,
activity, energy intake, missing 0.85)
food frequency questionnaire,
smoking status, family history
of diabetes, alcohol intake,
fruit intake, vegetable intake
and BMI.

0.0006

+ Cereal fibre intake

RR 0.98 (95% CI 0.76,
1.26)

0.98

RR 0.65 (95% CI 0.36,
1.18)

0.02

+ Cereal fibre intake

RR 1.14 (0.49, 2.66)

0.63

Age, total energy intake, BMI,
waist-to-hip ratio, education,
smoking status, alcohol intake
and physical activity.
+ Cereal fibre intake

RR 0.79 (0.65, 0.96)

0.0089

RR 0.93 (0.75, 1.16)

0.46

Age, sex, BMI, waist:hip ratio,
smoking status, total energy
intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use, physical
activity and treatment for BP.
+ Cereal fibre intake

Q1 6.8 (6.6, 7.1) v.
Q5 6.6 (6.4, 6.9)

0.05

Q1 6.8 v. Q5 6.7

0.34

79.0 - 302.0 Age, sex, geographic area,
g/d
energy intake, smoking status,
BMI and intakes of fruit,
berries and vegetables.

1.0 - 20.5
serves/wk

0.9 - 20.4
serves/wk
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Metabolic
syndrome

Huang,
2015 (108)

USA

PCS

NIHAARP
Diet &
Health
Study

367,442 M+F

CVD death

All cause death

0.1 - 1.2
oz./d

Sex, age, smoking status, total
energy intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use and physical
activity.

OR 0.67 (95% CI 0.48,
0.91)

0.01

+ Cereal fibre intake

OR 0.77 (95% CI 0.55,
1.09)

0.20

Age, sex, smoking status,
race/ethnicity group, alcohol
intake, education level, marital
status, health status, obesity,
physical activity, intake of red
meat, fruit and vegetable, total
energy intake and hormone
usage.

HR 0.83 (95% CI 0.78,
0.88)

<0.001

+ Cereal fibre intake

HR 0.95 (95% CI 0.88,
1.03)

0.19

Age, sex, smoking status,
race/ethnicity group, alcohol
intake, education level, marital
status, health status, obesity,
physical activity, intake of red
meat, fruit and vegetable, total
energy intake and hormone
usage.

HR 0.83 (95% CI 0.81,
0.86)

<0.0001

+ Cereal fibre intake

HR 0.94 (95% CI 0.90,
0.97)

0.002

304

Jacobs,
2000 (250)

USA

PCS

IWHS

11,040 post
menopausal F

CHD death

Other CVD
death
All cause death

Erkkila,
2005 (251)

USA

PCS

ERA

229 postmenopausal F
with coronary
atherosclerosis

Change in min.
coronary artery
diameter (mm)

1.3 - 4.7 g
whole grain
fibre/8368
kJ
(2000 kcal)

Age, energy intake,
educational status, marital
status, hypertension, diabetes,
heart disease, cancer, BMI,
waist-hip ratio, age at first
birth, physical activity score,
smoking status, pack years of
cigarette smoking, alcohol
intake, vitamin supplement
use, hormone replacement
therapy use, percent energy
from total fat, saturated fat and
carbohydrates, intake per 4184
kJ (1000 kcal) of fibre from
non-grain sources, intake of
red meat, fish and seafood.

HR 0.89 (95% CI 0.66,
1.20)

>0.05

HR 0.75 (95% CI 0.54,
1.06)

>0.05

HR 0.83 (95% CI 0.73,
0.94)

<0.05

≤6 or >6
Age, location of coronary
Lowest intake: -0.10 (SD
serves/week segment, BMI, smoking status, 0.02) v. highest intake: use of cholesterol lowering
0.06 (SD 0.02)
medication and hormone
replacement therapy, diabetes,
education, clinic, time of
follow-up, alcohol intake,
coronary artery bypass,
percutaneous transluminal
coronary angioplasty, energy
intake, saturated fat, PUFA and
cholesterol intake, serum total,
HDL, and LDL cholesterol,
TAG and systolic BP.

0.04
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Newby,
2007 (147)

USA

CrossBLSA
sectional

1516 F+M

Diastolic BP
(mmHg)

0.6 - 45.4
g/d

Systolic BP
(mmHg)

Total
cholesterol
(mmol/L)

0.6 - 45.6
g/d

HDLcholesterol
(mmol/L)

4.1 - 54.0
g/d

LDLcholesterol
(mmol/L)

3.9 - 54.8
g/d

Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin supplement
use, smoking status, percentage
energy from saturated fat,
alcohol and refined grains,
BMI, use of BP lowering
medication and hypertension.

Q1 79.8 (SE 0.6) v. Q5
79.2 (SE 0.7)

0.42

Q1 129.2 (SE 1.0) v. Q5
128.3 (SE 1.0)

0.79

Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin supplement
use, smoking status, percentage
energy from saturated fat,
alcohol and refined grains,
BMI, use of lipid-lowering
medication and
hypercholesterolemia.

Q1 5.71 (SE 0.06) v. Q5
5.49 (SE 0.06)

0.02

Q1 1.27 (SE 0.02) v. Q5
1.22 (SE 0.02)

0.07

Q1 3.16 (SE 0.06) v. Q5
2.96 (SE 0.06)

0.04

Q1 1.23 (SE 0.05) v. Q5
1.16 (SE 0.05)

0.22

Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin supplement
use, smoking status, percentage
energy from saturated fat,
alcohol and refined grains,
BMI, oral hypoglycaemic
medication and diabetes.

Q1 5.49 (SE 0.06) v. Q5
5.49 (SE 0.06)

0.57

Q1 8.24 (SE 0.170 v. Q5
7.32 (SE 0.17)

0.006

Q1 71.6 (SE 3.9) v. Q5
71.8 (SE 4.1)

0.90

Q1 479 (SE 38.0) v. Q5
414 (SE 39.1)

0.43

Age, age2, sex, total energy
intake, decade of visit, race,

Q1 25.5 (SE 0.2) v. Q5
24.8 (SE 0.2)

<0.0001

TAG (mmol/L)
Fasting glucose
(mmol/L)

0.6 - 45.4
g/d

2-hr glucose
(mmol/L)

1.1 - 50.6
g/d

Fasting insulin
(pmol/L)

2. 2 - 51.5
g/d

2-hr insulin
(pmol/L)

2.4 - 51.7
g/d

BMI (kg/m2)

0.7 - 46.0
g/d
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Weight (kg)

McKeown,
2009 (137)

Van de
Vijver,
2007 (252)

USA

Cross3yr trial
324 M+F
sectional (vitamin
K & bone
loss)

Netherlands CrossNLCS
sectional

4237 M+F

education, vitamin supplement Q1 75.0 (SE 0.7) v. Q5
use, smoking status, percentage 72.6 (SE 0.2)
energy from saturated fat,
Q1 87.4 (SE 0.6) v. Q5
alcohol and refined grains.
85.0 (SE 0.6)

0.004

Age, sex, total energy intake,
percent energy from fat,
physical activity, smoking
status, alcohol intake and
multivitamin use.

Q1 26.8 (25.7, 28.1) v.
Q4 25.8 (24.6, 27.1)

0.08

Q1 34.5 (32.7, 36.3) v.
Q4 32.1 (30.1, 34.1)

0.02

Trunk fat mass
(%)

Q1 43.0 (40.4, 45.5) v.
Q4 39.4 (36.7, 42.1)

0.02

Change stenosis
(%)

Lowest intake: 3.62 (SD
0.86) v.
highest intake: 1.69 (SD
0.90)
M: β -0.03 (-0.05, -0.02)
F: β -0.04 (-0.06, -0.01)

0.09

Waist
circumference
(cm)

0.9 - 49.3
g/d

BMI (kg/m2)

0.2 - 2.9
serves/d

Body fat (%)

BMI (kg/m2)
Overweight risk

Obesity risk

N/A

Age, energy intake, intake of
animal protein, education,
smoking status, number of
cigarettes, intake of fruit and
vegetables.

0.002

<0.01
<0.01

M: OR 0.98 (95% CI
<0.01
0.96, 0.99)
F: OR 0.98 (95% CI 0.96, <0.01
0.99)
M: OR 0.90 (95% CI
<0.05
0.84, 0.98)
F: OR 0.96 (95% CI 0.93, <0.05
0.99)

HPFS, Health Professionals Follow-up Study; NHS, Nurses’ Health Study; M, male; F, female; CRP, C-reactive protein; IL-6, interleukin 6; PCS, prospective
cohort study; MI, myocardial infarction; RR, relative risk; HR, hazard ratio; T2DM, type 2 diabetes mellitus; FMC, Finnish Mobile Clinic Health Examination
Survey; IWHS, Iowa Women’s Health Study; FOS, Framingham Offspring Study; HOMA-IR, homoeostatic model assessment of insulin resistance;
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ERA, Estrogen Replacement and Atherosclerosis trial; BLSA, Baltimore Longitudinal Study of Aging; BP, blood pressure; NLCS, Netherlands Cohort Study;
N/A, not available.
a
1 whole grain serve (s): 1 slice bread; 1 cup breakfast cereal, rice, pasta, other grain, popcorn, cooked oatmeal; 1 tablespoon bran, wheat germ.
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(ii) Cereal fibre intake
Study
Montonen,
2003 (51)

Country
Finland

Design
PCS

Cohort
FMC

Participants
4316 M+F

Outcome
T2DM

Intakes
0.5 - 12.0 g/d
to 24.5 111.0 g/d

Meyer,
2000 (50)

USA

PCS

IWHS

35,988 F

T2DM

2.7 - 9.4 g/d

McKeown,
2004 (249)

USA

Crosssectional

FOS

2834 M+F

Mean
HOMA-IR

Metabolic
syndrome

2.6 - 8.0 g/d

Covariates
Age, sex, geographic area,
energy intake, smoking status,
BMI and intakes of fruit,
berries and vegetables.
Age, total energy intake,
BMI, waist:hip ratio,
education, smoking status,
alcohol intake and physical
activity.

Results
RR 0.39 (95% CI
0.20, 0.77)

P
0.01

RR 0.64 (95% CI
0.53, 0.79)

0.0001

+ Whole grain intake

RR 0.66 (95% CI
0.53, 0.83)

0.0001

Age, sex, BMI, waist:hip
ratio, smoking status, total
energy intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use, physical
activity and treatment for BP.

Q1 6.8 (6.5, 7.0)
v. Q5 6.6 (6.3,
6.8)

0.02

+Whole grain intake

Q1 6.9 v. Q5 6.5

0.003

Sex, age, smoking status, total
energy intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use and physical
activity.

OR 0.62 (95%
CI 0.45, 0.86)

0.002
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Huang,
2015 (108)

USA

PCS

NIH-AARP
Diet &
Health Study

367,442 M+F

CVD death

2.0 - 10.2 g/d

All cause
death

Erkkila,
2005 (251)

USA

PCS

ERA

229 postmenopausal F
with coronary
atherosclerosis

Change in
min.
coronary
artery
diameter
(mm)

≤3g or >3g/
4184 kJ
(1000 kcal)

Change
stenosis
(%)

Newby,
2007 (147)

USA

Crosssectional

BLSA

1516 M+F

Diastolic
BP
(mmHg)
Systolic BP
(mmHg)

2.2 - 9.4 g/d

Age, sex, smoking status,
race/ethnicity group, alcohol
intake, education level,
marital status, health status,
obesity, physical activity,
intake of red meat, fruit and
vegetable, total energy intake
and hormone usage.

HR 0.80 (95%
CI 0.75, 0.85)

<0.0001

HR 0.81 (95%
CI 0.79, 0.84)

<0.0001

Age, location of coronary
segment, BMI, smoking
status, use of cholesterol
lowering medication and
hormone replacement therapy,
diabetes, education, clinic,
time of follow-up, alcohol
intake, coronary artery
bypass, percutaneous
transluminal coronary
angioplasty, energy intake,
saturated fat, PUFA and
cholesterol intake, serum
total, HDL, and LDL
cholesterol, TAG and systolic
BP.

Lowest: -0.09 v.
highest: -0.04

0.03

Lowest: 3.44 v.
highest: 1.79

0.10

Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, use of BP
lowering medication and
hypertension.

Q1 79.5 (SE 0.8)
v. Q5 79.2 (SE
0.8)

0.90

Q1 128.7 (SE
1.0) v. Q5 129.7
(SE 1.0)

0.27
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Total
cholesterol
(mmol/L)

2.2 - 9.6 g/d

HDLcholesterol
(mmol/L)

2.9 - 11.5 g/d

LDLcholesterol
(mmol/L)
TAG
(mmol/L)

2.2 - 9.6 g/d

Fasting
glucose
(mmol/L)

2.3 - 9.7 g/d

2-hr
glucose
(mmol/L)

2.4 - 10.4 g/d

Fasting
insulin
(pmol/L)

2.5 - 11.6 g/d

Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, use of lipidlowering medication and
hypercholesterolemia

Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, oral
hypoglycaemic medication
and diabetes.

2-hr insulin
(pmol/L)
BMI
(kg/m2)
Weight
(kg)

2.2 - 9.5 g/d

Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy

Q1 5.73 (SE
0.06) v. Q5 5.44
(SE 0.06)

0.005

Q1 1.23 (SE
0.02) v. Q5 1.25
(SE 0.02)

0.59

Q1 3.13 (SE
0.06) v. Q5 2.99
(SE 0.06)

0.07

Q1 1.24 (SE
0.05) v. Q5 1.15
(SE 0.05)

0.12

Q1 5.55 (SE
0.05) v. Q5 5.52
(SE 0.05)

0.95

Q1 8.05 (SE
0.21) v. Q5 6.48
(SE 0.21)

0.02

Q1 68.9 (SE 4.0)
v. Q5 73.0 (SE
4.0)

0.68

Q1 438 (SE
38.8) v. Q5 413
(SE 8.2)

0.33

Q1 25.7 (SE 0.2)
v. Q5 24.3 (SE
0.2)

<0.0001

Q1 75.6 (SE 0.7)
v. Q5 71.4 (SE
0.8)

0.0004
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McKeown
2009 (137)

USA

Crosssectional

3yr trial
(vitamin K &
bone loss)

324 M+F

Waist
circumference
(cm)
BMI
(kg/m2)

2.3 - 9.7 g/d

from saturated fat, alcohol
and refined grains.

Q1 87.4 (SE 0.6)
v. Q5 84.1 (SE
0.6)

<0.0001

2.4 - 9.3 g/d

Age, sex, total energy intake,
percent energy from fat,
physical activity, smoking
status, alcohol intake and
multivitamin use.

Q1 27.3 (26.1,
28.6) v. Q4 25.4
(24.2, 26.7)

0.01

Q1 34.7 (32.8,
36.6) v. Q4 31.5
(29.4, 33.5)

0.004

Q1 42.8 (40.2,
45.4) v. Q4 37.8
(35.0, 40.6)
M: b -0.04 (0.06, -0.02)
F: b 0.01 (-0.03,
0.05)

0.001

M: OR 0.98
(95% CI 0.96,
0.99)
F: OR 1.00 (95%
CI 0.97, 1.02)

<0.01

M: OR 0.97
(95% CI 0.92,
1.02)
F: OR 1.03 (95%
CI 0.98, 1.07)

>0.05

Body fat
(%)
Trunk fat
mass (%)
Van de
Vijver
2007 (252)

Netherlands

Crosssectional

NLCS

4237 M+F

BMI
(kg/m2)

Overweight risk

Obesity
risk

N/A

Age, energy intake, intake of
animal protein, education,
smoking status, number of
cigarettes, intake of fruit and
vegetables.

<0.01
>0.05

>0.05

>0.05

PCS, prospective cohort study; FMC, Finnish Mobile Clinic Health Examination Survey; F, female; M, male; T2DM, type 2 diabetes mellitus; RR, relative
risk; IWHS, Iowa Women’s Health Study; FOS, Framingham Offspring Study; HOMA-IR, homoeostatic model assessment of insulin resistance; HR, hazard
ratio; ERA, Estrogen Replacement and Atherosclerosis trial; BLSA, Baltimore Longitudinal Study of Aging; BP, blood pressure; NLCS, Netherlands Cohort
Study; N/A, not available.
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(iii) Bran intake
Study
Jensen,
2006
(111)

Country
USA

Design
Crosssectional

Cohort
HPFS
&
NHS II

Participants
468 M +
470 F

Outcome
HbA1c (%)

Results
Q1 5.45 (SE 0.04) v. Q5 5.50
(SE 0.05)

P
0.53

Q1 86.8 (SE 4.9) v. Q5 76.4 (SE
3.5)
Q1 2.11 (SE 0.10) v. Q5 1.84
(SE 0.06)

0.14

Q1 8.67 (SE 1.04) v. Q5 8.5 (SE
1.04)

0.88

Q1 5.8 (SE 0.09) v. Q5 5.6 (SE
0.07)

0.06

Q1 1.7 (SE 0.03) v. Q5 1.6 (SE
0.03)

0.06

LDLcholesterol
(mmol/L)

Q1 3.3 (SE 0.08) v. Q5 3.2 (SE
0.06)

0.13

CRP (mg/L)

Q1 0.99 (SE 1.09) v. Q5 0.77
(SE 1.08)

0.08

Fibrinogen
(g/L)

Q1 2.2 (SE 0.03) v. Q5 2.2 (SE
0.03)

0.87

IL-6 (pg/mL)

Q1 1.13 (SE 1.05) v. Q5 1.13
(SE 1.13)

0.82

Homocysteine
(μmol/L)

Q1 12.9 (SE 0.5) v. Q5 11.5 (SE
0.4)

0.02

Insulin
(pmol/L)
C-peptide
(ng/mL)

Bran
Totala

Intakes
1.4 13.6 g/d

Covariates
Age, sex, smoking status,
BMI, physical activity,
hypercholesterolemia,
alcohol intake, total energy
intake, intake of fruit,
vegetable, germ, sucrose
and fructose.

Leptin
(ng/ml)
Total
cholesterol
(mmol/L)
HDLcholesterol
(mmol/L)

Age, sex, smoking status,
BMI, physical activity,
hypercholesterolemia,
alcohol intake, total energy
intake, intake of fruit,
vegetable, germ, saturated
fat, MUFA and PUFA.

0.05
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Liu,
1999

USA

PCS

NHS I

75521 F

CHD

Addedb

0 - 1.0
servesc/d

BMI, smoking status,
alcohol intake, family
history of MI before 60y,
self-reported history of
hypertension or
hypercholesterolemia,
menopausal status, protein
intake, aspirin use, use of
multiple vitamin or vitamin
E supplements, vigorous
activity and total energy
intake

RR 0.63 (95% CI 0.42, 0.95)

0.001

USA

PCS

NHS I
&
HPFS

71750 F +
42823 M

Stroke

Total

F: 1.1 8.5 g/d

Age, BMI, smoking status,
alcohol intake, physical
activity, family history of
diabetes mellitus, cancer
and heart disease,
multivitamin use,
hypertension or high
cholesterol at baseline, total
energy intake, modified
alternative eating index
score (did not include
whole grains), menopausal
status and postmenopausal
hormone use.

HR 1.00 (95% CI 0.86, 1.16)

0.62

HR 0.73 (95% CI 0.60, 0.88)

<0.001

Pooled HR 0.89
(95% CI 0.79, 1.00)

0.004

(248)

Juan,
2017
(139)

M: 1.3 11.9 g/d
Pooled:
N/A

HPFS, Health Professionals Follow-up Study; NHS, Nurses’ Health Study; M, male; F, female; CRP, C-reactive protein; IL-6, Interleukin 6; PCS, prospective
cohort study; RR, relative risk; HR, hazard ratio.
a
Bran consumed naturally within whole grains and bran added to food/consumed separately
b
Bran added to food/consumed separately only
c
1 serve (s) of bran = one tablespoon
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